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Abstract
Neuroprosthetic systems are designed to interface with the nervous system, for the replace-
ment or restoration of damaged functions in the motor and/or sensory systems. In order
to have an efﬁcient communication with the nervous tissue leading to optimized clinical
outcomes, achieving neural stimulation with high selectivity is essential. This thesis aims
at ﬁnding technological routes to enable spatial, structural and cell-type selective surface
neuromodulation using electrical and optogenetic stimulation and to validate them in in vivo
models.
Thin and conformable electrode arrays enable close contact with the target tissue, thereby
leading to minimal distances with the target neurons and maximal spatial selectivity. Flexible
polymer technologies based on polyimide (PI) are used to design thin (< 10μm thick) electrode
arrays with small feature size (< 100 μm), resulting in miniaturized conformable arrays for
surface stimulation. PEDOT conducting polymer coatings are used on the miniaturized elec-
trical stimulation sites (100 μm diameter) to improve their charge injection properties. This
implant is used for auditory brainstem stimulation in a rat model, and is shown to generate
robust activation of the auditory system. Analysis of the multiunit recordings obtained from
the inferior colliculus (IC), an auditory structure of the midbrain, led to the identiﬁcation of
different phases in the responses, with various frequency tuning properties. The stimulation
conﬁguration is shown to inﬂuence the tonotopic organisation of the frequency-tuned re-
sponses. Bipolar stimulation with small interelectrode distances (400μm) is shown to generate
responses that are more frequency-selective than with larger interelectrode distances (800μm).
The orientation of the electrode pair and the waveform of stimulation current are also shown
to inﬂuence the response properties. An updated design of the clinical auditory brainstem
implant(ABI) is then proposed, integrating higher electrode density and guidelines for a more
tissue-conformal format. The main steps in the road towards improvement of ABI outcomes
are then discussed, with proposed changes in the stimulation protocol and electrode array in
parallel.
Another approach to cell-speciﬁc neuromodulation is the implementation of optogenet-
ics. This requires not only genetic engineering of the neurons but also the manufacturing of
implantable light-emitting devices. Here, we introduce a fabrication process for the integra-
tion of thin (50 μm) LEDs into a polyimide-based device. A proof-of-concept in vivo study
iii
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shows that stimulation of the spinal cord of a mouse model generates robust EMG responses
in both legs over the course of several weeks. The walking integrity is conﬁrmed, showing
the absence of functional damages to the spinal cord. These results show that the presented
LED array can provide a way of stimulating key elements of the locomotor neural circuitry,
potentially leading to a greater understanding of the role of each neuronal subtypes in the
spinal cord.
Through the applications of ABI and spinal cord stimulation, this thesis thus highlights the
importance and potential use of speciﬁcally tailored technologies enabling selective surface
stimulation of the nervous system.
Keywords: neuroprostheses, auditory brainstem implant, ﬂexible electronics, conductive
polymers, spinal cord stimulation, electrical stimulation, optogenetics
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Résumé
Les neuroprothèses sont des interfaces avec le système nerveux utilisées pour le remplace-
ment ou la restoration de fonctions endommagées des systèmes moteurs et/ou sensoriels.
Pour avoir une communication efﬁcace avec le tissu nerveux et générer des résultats cliniques
optimaux pour les patients, une grande sélectivité de stimulation est essentielle. Cette thèse
a pour but de développer des technologies permettant une stimulation de surface du tissu
nerveux avec une sélectivité spatiale, structurelle ainsi qu’une sélectivité des types de neurons
stimulés en utilisant une stimulation électrique ou optique, et de valider ces technologies
dans des modèles in vivo.
Les champs d’électrodes ﬁns et conformes permettent un contact optimal avec le tissu ner-
veux, générant donc une distance minimale avec les neurones a stimuler et une sélectivité
spatiale maximale. Des technologies basées sur le polyimide (PI), un polymère ﬂexible, sont
utilisées pour fabriquer des champs d’électrodes ﬁns (< 10 μm d’épaisseur) avec des très
petites dimensions (< 100 μm), ce qui permet d’obtenir des champs d’électrodes conformes
pour la stimulation de surface. Une couche de polymère conducteur est déposée sur les sites
de stimulation électrique miniaturisés (100 μm de diamètre) pour améliorer les propriétés
d’injection des charges. Cet implant est utilisé pour la stimulation du tronc cérébral auditif
dans un modèle de rat, et il est montré qu’une activation robuste du système auditif peut
être générée . L’analyse des enregistrements obtenus dans le colliculus inférieur (IC), une
structure auditive du mésencéphale, permet d’identiﬁer différentes phases de réponses avec
des propriétés variables de sélectivité fréquentielle. La conﬁguration des électrodes de stimu-
lation a une inﬂuence sur l’organisation tonotopique des réponse avec une haute sélectivité
fréquentielle. Il est démontré que la stimulation bipolaire avec des paires d’électrodes de
faible espacement (400 μm) génère des réponses avec une meilleure organisation tonotopique
que les paires d’électrodes plus distantes (800 μm). L’orientation des paires d’électrodes ainsi
que la forme de l’impulsion de courant électrique ont aussi une inﬂuence sur les propriétés
de la réponse du système auditif. Un nouveau design clinique d’implant auditif sur le tronc
cérébral (ABI) intégrant une plus haute densité d’électrodes ainsi qu’un substrat conforme
au tissu neuronal est donc proposé. Les étapes principales qui permettront d’améliorer les
performances cliniques de cet implant sont discutées, intégrant en parallèle des changements
dans le protocole de stimulation et dans le champ d’électrodes.
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Une autre approche pour la stimulation de types de neurones spéciﬁques est l’optogénétique.
Cette technique nécessite, en plus de l’ingénierie génétique des neurones, le développement
de dispositifs implantables pour l’illumination du tissu nerveux. Ici, nous présentons un
procédé de fabrication pour l’intégration de diodes (LEDs) ﬁnes (50 μm) sur un substrat en
polyimide. Une preuve de principe in vivo montre que la stimulation optique de la moelle
épinière d’une souris génère des réponses EMG robustes dans les deux jambes, pendant
plusieurs semaines. L’intégrité de la marche est conﬁrmée, ce qui montre que le dispositif ne
génère pas de dommages fonctionnels a la moelle épinière. Ces résultats démontrent que le
champ de diodes développé peut fournir un moyen de stimuler des éléments clés du circuit
neuronal de la locomotion, ce qui peut mener a une meilleure compréhension du role de
chaque type de neurones dans la moelle épinière.
A travers les applications de stimulation du tronc cérébral auditif et de la moelle épinière, cette
thèse met donc en évidence l’importance et l’utilité potentielle de technologies ciblées pour
chaque application permettant une stimulation sélective de la surface du tissu nerveux.
Mots-clés : neuroprothèses, implant auditif sur le tronc cérébral, électronique ﬂexible, poly-
mères conducteurs, stimulation de la moelle épinière, stimulation électrique, optogénétique
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1 Introduction
Implantable neuroprostheses are an ensemble of systems engineered to provide an interface
between the central or peripheral nervous systems and man-made devices. They can include
stimulation and/or recording capabilities, and are used for the replacement or restoration of
damaged sensory or motor function. They have thus a great therapeutic potential for many
patients suffering from chronic nervous system deﬁcits [100].
The multitude of neuroprosthetic devices currently used in clinics or in research can be
of several different types. Sensory neuroprostheses seek to replace damaged function in the
sensory system. The cochlear implant is the most successful sensory neuroprosthesis on the
market with more than 300’000 implanted patients[143,183] (Fig. 1.1A). Retinal implants were
recently approved for clinical use (Argus II retinal prosthesis system, CE mark in 2011 and
FDA approval in 2013, Fig. 1.1B), and are implanted in more than 100 patients[116]. Auditory
brainstem implants[201](Fig. 1.1C) and spinal cord stimulation implants to alleviate chronic
neuropathic pain[191] (Fig. 1.1D) have also been used clinically for several years.
Alternatively, motor neuroprostheses are used to improve or replace motor functions. Deep
brain stimulation (DBS) of the subthalamic nucleus can be used to reduce drug-resistant
motor symptoms in patients with Parkinson’s disease[146] (Fig. 1.1E). The use of electrochemi-
cal neuroprostheses in rehabilitation following spinal cord injuries has also been the subject
of intense research[30,198]. Some neuroprostheses consist of a bidirectional interface, such
as the system allowing simultaneous motor control and sensory feedback of a robotic arm
in amputee patients, which is the subject of a clinical trial [160]. Other applications include
vagus nerve stimulation for the treatment of epilepsy and mood disorders[67,182](Fig. 1.1F) and
sacral nerve stimulation for the treatment of bladder dysfunction[82]. In addition to reducing
Parkinson’s disease motor deﬁcits, DBS is also envisioned to treat other conditions, such as
bipolar disorder[58], obsessive compulsive disorder[6] or Tourette syndrome[179] by targeting
different parts of the brain.
All the mentioned neuroprostheses share some common features in terms of technology,
1
Chapter 1. Introduction
in order to achieve safety and efﬁciency of stimulation and long-term durability. Since they all
aim at providing an interface with the nervous system, technological improvements, methods
or protocols developed for one speciﬁc application can potentially be transferred to other
applications.
1.1 The need for selectivity in the context of neuroprosthetics
When trying to replace or restore lost function, the ﬁrst challenge is to understand with pre-
cision the system to stimulate, including its normal function but also the potential changes
due to injury and the mechanisms of recovery of the system[131,162]. This step is of critical
importance in complex systems, in order to identify which neuronal populations are linked to
the function to restore and to select the best targets for artiﬁcial stimulation. This includes the
selection of the structure to stimulate (in the central or peripheral nervous system), as well as
the target neuronal population within that structure.
A B C
D E F
Figure 1.1: Examples of clinical implantable neuroprostheses A) Cochlear implant (Cochlear
corp.) [48], B) Argus II retinal prosthesis[116], C) Auditory brainstem implant (Cochlear
corp.) [180], D) Spinal cord stimulator for neuropathic pain[118], E) Deep brain stimulation
device[146], F) Vagus nerve stimulator[182]
In order to reach high levels of performance, the neuroprosthetic interface must communicate
efﬁciently with the nervous system. Usually, that means developing a stimulation protocol that
corresponds as closely as possible, in space and time, to the natural activation of the system.
The ultimate goal is to mimic the natural function, but this is currently often impossible to
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achieve due to the great complexity of most neural systems and the limited numbers of chan-
nels available. A neural mechanism that is of critical importance in this context is the neural
plasticity, the ability of the brain to adapt and reorganize in a stimulus-dependent way[158].
This mechanism is responsible for the neuronal reorganization following injury[47,175,195] and
for the adaptation to the artiﬁcial stimulus[47,131,154]. It enables an optimization of the perfor-
mance of the stimulation even if the stimulus is not exactly similar to the natural activation of
the system. Neuroplasticity is inﬂuenced by many factors, such as the duration and onset of
injury and the time of implantation[47]. However, even with efﬁcient neuroplasticity, the ﬁnal
performance achieved with a neuroprosthetic device is highly dependent on the quality and
resolution of the artiﬁcial stimulation[56,103].
One of the keys for improving the detailed understanding of a neural system and achieving a
stimulation that is as close as possible to the natural function of the tissue is the selectivity of
stimulation, or the ability to stimulate a speciﬁc neuronal element without stimulating the
rest of the tissue.
Stimulation with 
high spatial 
selectivity
A B C
Activation 
volume Stimulation with 
low spatial 
selectivity
Stimulation 
selective for fibers 
of passage
Stimulation 
selective for 
neuronal somata
Spatial selectivity Structural selectivity Cell-type selectivity
Stimulation selective 
for 
Stimulation selective 
for 
Figure 1.2: Schematic illustration of the spatial (A), structural (B) or cell-type (C) selectivity
of stimulation of neural tissue showing the volume of activation and the activated neuronal
elements in color. A) Stimulation with high and low spatial selectivity, resulting in activation of
different volumes of tissue. B) Illustration of a stimulation protocol with structural selectivity
for ﬁbers of passage and for neuronal somata. C) Illustration of cell-type selective stimulation
of two different neuronal type.
Spatial selectivity refers to the ability to stimulate a speciﬁc volume of tissue without stim-
ulating neighbouring areas, as illustrated in ﬁgure 1.2A[134]. It is for instance important in
cochlear stimulation, to avoid channels interaction[190], and in deep brain stimulation, to
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avoid stimulation of off-target areas[95]. Structural selectivity is the preferential stimulation
of speciﬁc tissue structures, including neuronal somata, axons, or ﬁbers of passage of spe-
ciﬁc diameters[124] (Fig. 1.2B). It can be for example useful to target neuronal somata in a
tissue with mixed neuronal somata and ﬁbers of passage. Most neural tissue being composed
of a mix of different neuronal types, cell-type selectivity refers to the targeting of a speciﬁc
neuronal type (Fig. 1.2C), thus potentially activating only a speciﬁc function in a network of
interconnected neurons[50]. Exploring ways to optimize selectivity in its different aspects is of
critical importance and can lead to the improvement of many neuroprosthetic devices.
Electrical and optical stimulation are two of the main modes of stimulation of neural tis-
sue, with possibilities to achieve various levels of spatial, structural and cell-type selectivity. In
this thesis, these two modes of stimulation will be considered, to investigate whether a more
selective stimulation can improve existing functionality, or even lead to new functionalities.
To achieve this goal, it is ﬁrst necessary to review the mechanisms of neural stimulation with
each of these two modes of stimulation.
1.2 Surface electrical stimulation
1.2.1 Mechanisms of electrical stimulation
The transmembrane potential of a neuron, the difference between the extracellular and in-
tracellular membrane potentials, is controlled by both passive mechanisms, the capacitive
effect of the lipid bilayer, and active mechanisms, through the ion channels (mainly Na+ and
K+ channels) [134]. If the extracellular potential is driven negative compared to the intracellular
potential, the neuron is depolarized and an action potential (AP) can be generated if the
depolarization threshold is reached[193]. The AP is generated by the sequential activation
and inhibition of the different membrane ion channels, as described in the Hodgkin-Huxley
model[84].
As charge is injected into the tissue during neural stimulation, the resulting change of extracel-
lular potential can artiﬁcially induce the generation of APs in neighboring neurons through
a depolarization of portions of the axon membrane[84,134]. In the simplest case of a current
source I (A) being placed near an isotropic excitable tissue of conductivity σ (S/m), the ex-
tracellular potential Ve at a distance r from the current source can be modeled as Ve = I4rπσ .
The activating function, describing the activation of the neurons, was shown to vary with the
second derivative of this potential [161]. However, real stimulation conditions are very different
due to the complex structure of most neural tissue, constituted of a mix between neuronal
cell bodies and ﬁbers of passage, in different proportions and orientations. For instance, the
conductivity of the white matter and gray matter are very different, the gray matter having an
isotropic conductivity of about 0.2 S/m, and the white matter having a higher conductivity in
the direction of the ﬁbers (1 S/m) than across the ﬁbers (0.1 S/m)[95]. The size and orientation
of the ﬁbers, as well as the membrane properties of different neuronal types can also result in a
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complex electric ﬁeld distribution, altering the response properties of a neural tissue[125] [213].
The excitability of each neuronal type thus have to be taken into account in order to optimize
the efﬁciency of stimulation[197].
1.2.2 Selectivity of electrical stimulation
Spatial selectivity, determined by the volume of activation (Fig. 1.2A), is strongly dependent
on the efﬁciency of stimulation to generate activation in the target neuronal elements. An
efﬁcient stimulation will generate activity at smaller current levels, thus generating less current
spread. Spatial selectivity can be inﬂuenced by many parameters, including geometrical and
stimulation protocol parameters.
First, geometrical parameters of the stimulation electrode inﬂuence the spatial selectivity,
as the distance to the target neurons is a critical factor determining the necessary current
level [15,214]. Here, two main categories of geometries can be discriminated. First, penetrat-
ing electrodes have small areas (usually below 10’000 μm2) and can be implanted in close
proximity to the target neurons. A high spatial selectivity can thus be achieved because of
the low current thresholds. However, a major drawback of penetrating electrodes is that
rigid shanks are usually used, inducing chronic inﬂammation due to micromotion-induced
tissue damage[71]. Second, macroelectrodes located at the surface of the tissue have geometri-
cal areas usually larger than 0.001 cm2 and are less invasive than penetrating electrodes[44].
However, because of the greater distance to the target neurons and the higher electrode area
compared to penetrating electrodes, current thresholds are higher and spatial selectivity is
lower. An implant with the low invasiveness of surface electrodes and the spatial selectivity of
penetrating electrodes would combine the advantages of both approaches. An optimization
of surface stimulation combining minimally invasive, safe and efﬁcient stimulation with close
contact to the tissue and a high density of electrode sites is thus the approach chosen here.
In addition to the geometrical parameters, the current level used for stimulation also depends
on the stimulation protocol. The structure and composition of the target elements in the tissue
have a large inﬂuence on the most efﬁcient stimulation protocol to use, as ﬁbers of different
diameters and cell somata do not have the same response properties to electrical stimula-
tion[125]. For instance, high frequency stimulation was shown to generate greater neuronal
output in ﬁbers of passage than in local cells, whereas speciﬁcally designed asymmetric pulses
could efﬁciently target local cell bodies[124,125]. Some level of ﬁber diameter selectivity is also
possible since thicker ﬁbers can be stimulated with lower currents than thinner ﬁbers[125,173].
This variability in excitability properties enables a certain level of structural selectivity during
electrical stimulation. This, in turn, can achieve some cell-type selectivity depending on
the properties of the target tissue. A true cell-type selectivity is however not achievable with
electrical stimulation, which is one of the reasons of the development of optogenetics, as
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described in the next section.
1.3 Optical stimulation
1.3.1 Optogenetic stimulation of neural tissue
Optogenetics is a technology that enables cell-type speciﬁc, millisecond-scale control of neu-
ral activity. It is based on genetic targeting and modiﬁcation of speciﬁc neuronal types with a
light-sensitive ion channel, followed by optical illumination of the neural tissue. This control
is possible in intact brain tissue and in freely moving animals[50].
Figure 1.3: Illustration of the three main types of opsins: Channelrhodopsin (ChR), a cation
channel (peak absorption: 473 nm); Halorhodopsin (HR), a chloride pump (peak absorption:
570 nm); Bacteriorhodopsin (BR), a proton pump (broad spectrum, peak absorption: 570
nm)[215]
The light-sensitive ion channels used in optogenetics originate from microbial opsins, light-
gated ion channels present in the membrane of some microorganisms. Three main types
of opsins, channelrhodopsin (a cation channel), bacteriorhodopsin (a proton pump) and
halorhodopsin (a chloride pump) can be used for precise activation or inhibition of neu-
rons[50] (Fig. 1.3). From the initially discovered versions of these three different types of
opsins, genetic engineering lead to an expansion of the library of available opsin properties.
Speciﬁcally tailored opsins for deﬁned physiologic effect with various kinetic properties, light-
sensitivities and wavelength sensitivities are thus available[215]. Widely used in neuroscience,
type 2 channelrhodopsin (ChR2) can be used for fast excitation of neurons, is characterized by
a τo f f time constant of about 10 ms, and is sensitive to blue light (peak sensitivity at 473 nm).
Due to its fast kinetics and high light sensitivity, it was selected for the experiments presented
in this thesis.
The cell type selectivity of optogenetics is enabled by genetically targeting the expression of
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light-gated proteins. To achieve this, the gene coding for the light-sensitive protein (ChR2 here)
is placed under the control of a cell type speciﬁc promoter. Only the neurons corresponding to
the cell type selectivity of the promoter will thus express ChR2. Transfection can be achieved
through several different techniques, including but not limited to viral promoters (lentiviral
vectors or adeno-associated vectors) or transgenic approaches[215]. While viral promoters are
injected locally, transgenic approaches generate ChR2 expression in speciﬁc cell-types in the
entire animal, and light can be delivered at any location. For instance, a mouse line expressing
ChR2 under the control of the Thy1 promoter was developed (Thy1::ChR2-EYFP). This mouse
line expresses ChR2 in projection neurons, and can be used in the study of several different
systems involving stimulation of these neurons[215].
Successful optogenetic stimulation is also critically dependent on the light delivery system.
First, the wavelength of the delivered light must correspond to the wavelength sensitivity of the
selected light-sensitive protein. The intensity of the light must also be sufﬁcient to generate
activation of the ion channels. As an example, the peak of wavelength sensitivity of ChR2 is
473 nm, and the threshold of activation of single proteins is 1-5 mW/mm2 [215]. Light power
decreases exponentially with tissue depth, so in vivo experiments require higher light power to
compensate for the losses when the target neurons are not located at the surface of the tissue.
In vivo optogenetics thus requires the use of devices enabling chronic, localized, temporally
determined, safe and efﬁcient light delivery[153]. These requirements will be further detailed
in Chapter 2 of this thesis.
1.3.2 Selectivity of optogenetic stimulation
The activation or inhibition evoked by optogenetic stimulation can be speciﬁc to any neuronal
type (Fig. 1.4), provided that the opsin gene can be put under the control of a cell-type speciﬁc
promoter. Although a lot of work in the genetics ﬁeld is required to enable the targeting of
each speciﬁc cell type, many possibilities for targeting neuronal types already exist.
Since light does not spread in the same manner as electrical current (Fig. 1.4), only the
neurons in the beam of light are stimulated during optical illumination. The spatial selectivity
of optogenetics can thus be very high, and is strongly dependent on the focusing of the light.
The volume of activation is also dependent on the optical properties of the tissue and the
wavelength of the light, which both inﬂuence the exponential decay of light in the tissue[1,215].
A ’natural’ structural selectivity is present in optogenetics, where ﬁbers of smaller diame-
ter are usually recruited before ﬁbers of larger diameter[110], an order of recruitment similar to
physiological recruitment. In contrast, electrical stimulation usually generates activation of
larger diameter ﬁbers before smaller diameter ﬁbers[125]. In addition, structural selectivity
can result from cell-type selectivity, if the different structural elements can be genetically
targeted independently. Since the optical threshold of activation is also dependent on the
level of expression of ChR2 on the membrane, structural selectivity could also be achieved by
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targeting discrete subcellular domains, such as the soma or the dendrites[62].
Figure 1.4: Illustration of cell type selectivity in optogenetics, with possibilities to activate or
inhibit speciﬁc cell types, as opposed to unspeciﬁc electrical stimulation[50]
The spatial and cell type selectivity achievable with optogenetics has generated a lot of interest
from a variety of different ﬁelds, including neuroprosthetics. In auditory prostheses, the
number of channels and resulting spectral resolution of stimulation are often limited by the
spread of electrical current. Thus, optogenetics is investigated as a way to improve stimulation,
in the peripheral [140] and central [76] auditory systems. In the ﬁeld of retinal prostheses,
optogenetics is also a promising technique to increase spatial selectivity, to target speciﬁc
cells types in the retina, but also to selectively induce inhibition of certain cell types[19], and is
the subject of a recently initiated clinical trial [163]. A better understanding of the underlying
neural mechanisms of DBS[60] is also an example of an application enabled by optogenetic
targeting of the different neural components.
1.4 Technological requirements
As mentioned in the previous sections, achieving a high spatial selectivity with electrical and
optical stimulation is dependent on two essential points: a close proximity to the target tissue
and a high density of stimulation sites. Most structures of the human body have curvilinear
shapes. Examples of radii of curvature found in the central nervous system are 1.5 mm for the
brainstem[167], ∼9 mm for the cortex[24] and ∼10 mm for the spinal cord[34]. A technological
requirement to be in close proximity to the target tissue for surface implants is thus the con-
formability of the substrates.
In addition, the necessity for a high density of stimulation sites, in order to have many spatially
addressable stimulation sites and to increase the spatial resolution, is linked to a miniaturiza-
tion of the design of the stimulation devices. As detailed in the second chapter of this thesis,
minimal feature sizes lower than 100 μm are often required.
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Technologies for conformable arrays enabling feature sizes smaller than 100 μm are thus
necessary in order to develop high quality interfaces with the nervous system tissue. The
development and tailoring of such technologies for speciﬁc applications in the central nervous
system is the main focus of this thesis.
1.5 Outline of the thesis
1.5.1 Chapter 2: Technologies for conformal surface neural stimulation
The second chapter of this thesis presents the development of conformable devices designed
for surface electrical and optical neuromodulation. The technical challenges for improved
electrical and optical stimulation are presented, and designs are proposed for each application.
For electrical stimulation, the use of small electrode sites requires the implementation of a
coating on the electrode sites in order to achieve safe and efﬁcient neural stimulation. For
optical stimulation, a device integrating an array of LEDs for spatially addressable stimulation
is presented.
1.5.2 Chapter 3: New generation auditory brainstem implant
The third chapter presents an application of surface electrical stimulation for a sensory neuro-
prosthesis: the auditory brainstem implant (ABI). The ABI is an alternative hearing strategy for
patients suffering from sensorineural hearing loss who cannot beneﬁt from cochlear implants
(CIs) because of a disconnection between the peripheral and central auditory systems. ABIs
provide auditory sensations and help with lipreading for most patients. However, speech
hearing performance is relatively poor compared to the high outcomes obtained in most
patients with CIs. One hypothesis for this is the spread of electric current leading to low spatial
selectivity and stimulation of extra-auditory neurons, causing side-effects. Based on this
hypothesis, improving the spatial selectivity of stimulation is a route for improving the ABI
clinical outcomes.
Using a high-density microfabricated ABI array with the ﬂexible implant technology presented
previously, the possibility to generate frequency-tuned responses with spatially selective stim-
ulation is investigated. Different components of the multiunit recordings obtained from an
animal model are separately analyzed, in order to improve the understanding of the neural
correlates of the auditory brainstem stimulation. The effect of stimulation electrode conﬁg-
uration and of the waveform of stimulation on the tonotopic organization of responses are
tested.
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1.5.3 Chapter 4: Optogenetic stimulation of the spinal cord
The fourth chapter presents a proof of principle for chronic optical stimulation of the spinal
cord with a LED-based optical stimulation array. Optogenetics, as mentioned earlier, enables
cell type selectivity, which is not achievable with electrical stimulation. This technique could
lead to a better understanding of the spinal cord circuits and of the role of each neuronal type
in the recovery, and potentially also to improved recovery following spinal cord injury.
These experiments are performed using a transgenic mouse model (Thy1:ChR2) showing high
levels of expression of channelrodopsin in projection neurons, and, as a result, low activation
thresholds. Evoked motor responses are recorded in the leg muscles, and the effect of stimula-
tion with a single LED or with pairs of LEDs is investigated. Optical stimulation of the spinal
cord is also characterized by analyzing the lateral selectivity of stimulation and the effect of
changing stimulation parameters (LED current, pulse rate and duration). Chronic variations
of stimulation thresholds and other parameters over time as well as safety of stimulation are
also analyzed and discussed in this chapter.
10
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neural stimulation
Abstract
Surface neuromodulation implants enable minimally invasive stimulation of neural tissue
compared to penetrating implants in many neuroprosthetic devices. However, there are
unique challenges associated with this type of stimulation, both in electrical and optical stim-
ulation. In electrical stimulation, the stiffness of the traditional silicon substrates (> 100 GPa)
prevents a good conformability to soft neural tissues (∼ 1-100 kPa) that often have complex
shapes. Additionally, safe stimulation requires relatively large electrode sites (several hundreds
of μm) due to the limited charge injection properties of the stimulation electrode materials.
These two elements lead to high current thresholds and low spatial selectivity of stimulation.
In optical stimulation, laser-ﬁber coupled implants provide the highest optical power (tens of
mW), but they cannot be fully implanted and are highly limited in the number of channels.
LEDs-based implantable devices with multiple spatially addressable channels must combine
a sufﬁcient optical power in order to stimulate target neurons that might not be at the surface
of the tissue with limited thermal heating (< 2◦C ) to avoid chronic thermal damage at the
surface of the tissue.
In this chapter, we present a technology for conformal surface stimulation implants based
on thin polyimide substrate, combining the advantages of a stable microfabrication process
with small feature sizes and conformability due to the ﬂexible substrate. A coating based
on PEDOT:PSS, a conducting polymer with high effective area and efﬁcient charge trans-
duction properties is presented as a means to improve the transduction of charges at the
electrode/tissue interface, enabling high safe injectable charge with small electrode areas. For
optical stimulation, a fabrication process for the integration of thin (50 μm) LEDs on a ﬂexible
polyimide substrate is presented. The parameter space allowing thermally safe chronic optical
stimulation is identiﬁed with a model of thermal heating of the tissue.
Publication: Guex, A., Vachicouras, N., Hight, A.E., Brown, M.C., Lee, D.J., Lacour, S.P., Con-
ducting polymer electrodes for auditory brainstem implants, J. Mat. Chem. B (2015)
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2.1 Introduction
2.1.1 Interfacing with the central nervous system
The human body, and particularly the nervous system, is composed of soft tissues with com-
plex shapes. In the central nervous system, the Young’s modulus of the brain tissue is ∼ 1-10
kPa[36] and that of the spinal cord is ∼ 100 kPa[74]. The radii of curvature can be as small as
∼1.5 mm for the brainstem[167], ∼9 mm for the cortex[24] and ∼10 mm for the spinal cord[34].
Interfacing with these speciﬁc structures thus requires materials that can conform to curvilin-
ear shapes, making traditional hard electronics (> 100 GPa) not adapted for this purpose.
In addition, in many aspects of neural surface stimulation in the context of neuroprosthet-
ics, spatial resolution is a key feature to generate the desired function. In retinal implants,
increasing the stimulation resolution is a very important challenge in order to improve visual
acuity[103]. In spinal cord stimulation, spatial selectivity is critical to activate speciﬁc segments
that generate the desired motor function in ﬂexor or extensor muscles[206]. In the auditory
system, the different frequencies of the sound are encoded in different locations, an organiza-
tion called ’tonotopy’ that is conserved along the entire auditory pathway[84]. A high spatial
resolution is then required to stimulate independent frequency channels.
Most present clinical technologies are based on thick platinum or platinum-iridium elec-
trodes (> 1 μm) with stimulation electrode areas larger than 0.2 mm2 and stainless-steel wires
embedded in millimeter-thick silicone matrix[100,201]. These properties make them not able to
conform to small radii of curvature and complex shapes found in the nervous system or to
achieve high spatial resolution in stimulation. Technologies for conformable surface implants
allowing a very small minimal feature size are thus necessary in order to develop efﬁcient
interfaces with the nervous system.
2.1.2 Technologies for conformable implants
Several technologies can be considered to fabricate a conformable surface implant. The main
solution is the use of soft substrates with Young’s moduli as similar as possible to the tissue to
interface. Among these materials, we can cite elastomers (∼ MPa) or ﬂexible polymers, such
as polyimide or parylene (3-5 GPa).
Elastomeric materials can be used to develop devices that can conform to complex surfaces
with non-gaussian curvatures. [71] Polydimethylsiloxane (PDMS) is one of the main materials
used as an elastomeric substrate. Several techniques can be used to deposit stretchable met-
allization onto the substrate in order to fabricate stretchable implants for neuroprosthetic
applications. These techniques include the evaporation of a microcracked gold ﬁlm[54,99,129],
or the design of serpentine structures of metal [53].
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One major challenge of these approaches is the feature size limitation of about 100 μm. As
mentioned earlier, when using surface stimulation with a high density of spatially distributed
of electrodes, the fabrication technique needs to accommodate small feature sizes (below 100
μm), especially in a research context where the target structures are often much smaller in
animal models than in humans[100].
Despite their higher Young’s modulus compared to elastomeric materials, ﬂexible polymer
substrates such as polyimide or parylene are of high interest here because they are adapted
to standard microfabrication processes and can have micrometer-size features. Flexible im-
plants can be used as penetrating implants inserted into neural tissue[35,132](Figure 2.1A) or
as surface electrodes[78,142,171] (Figure 2.1B-E). The presented examples are fabricated with
parylene[55,166] or polyimide[2,35,78,88,132,142,171] of various thicknesses.
Several different strategies can be used to compensate for the higher Young’s modulus of
ﬂexible polymer substrates compared to elastomers. First, the bending stiffness (S) can be
decreased by reducing the thickness (t ) of the substrates, as shown by the bending stiffness
equation :
S = E × t
3
12× (1−μ2)
Where E = Young’s modulus of the substrate and μ = Poisson ratio
A B C
D
E
Figure 2.1: Flexible polymer devices. A) Polymide neural probe (20 μm thick)[132]. B) Polymide
ECoG (10 μm thick)[171]. C) Parylene retinal implant (15 μm thick)[166]. D) Polyimide mesh
electrode array (7 μm thick) with dissolvable silk ﬁbroin membrane[88]. E) Polyimide mesh
electrode array (6 μm thick)[14].
To maximize the conformability of the substrate and adapt it to each application, the thickness
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can thus be reduced to the minimum allowing correct handling of a free-standing ﬁlm in
the absence of a carrier substrate. As seen in ﬁgure 2.1D-E, mesh-like structures can also
be designed to further increase conformability of devices, particulary around non-gaussian
curvatures[14,88].
In the context of surface neural stimulation, using a thin polyimide-based substrate thus
combines several advantages, while limiting the drawbacks due to its relatively high Young’s
modulus. Its compatibility with standard microfabrication processes and possibility to design
small feature sizes (down to the μm) can be used to quickly fabricate prototypes with a very
high design ﬂexibility.
2.1.3 Electrical stimulation
Electrodes diameter
In order to investigate the limits of spatial selectivity achievable with surface implants, the
density of electrodes on the array is increased, taking advantage of the small feature sizes
enabled by the microfabrication technique described earlier. An increase in the density of
electrode sites has to be associated to a decrease in their area, which raises new challenges.
A major limitation to reducing electrode area is the associated higher density of charges
sent through the electrode-electrolyte interface for the same total charge, which leads to
lower damage thresholds. In order to design a safe, efﬁcient and selective neural stimula-
tion protocol, it is essential to understand the electrode-electrolyte interface, where complex
electrochemical and physiological processes are occurring.
The electrode/tissue interface
At the electrode-electrolyte interface, a transduction of charge carriers from electrons in the
electrode to ions in the extracellular ﬂuid occurs during stimulation. [44] This transduction can
happen through two main mechanisms. First, the capacitive, or non-faradaic charge transfer
is associated to a redistribution of charges on both sides of the interface, without any electrons
being transferred. It is a fully reversible process. Second, the faradaic charge transfer involves
electrons transfer at the interface through oxidation and reduction reactions (Figure 2.2).
The rate of these reactions is deﬁned by the reaction kinetics, at potentials close to equilibrium,
and by the mass transport rate, when the potential is driven far away from equilibrium. The
reversibility of the reaction is determined by the relative rate between kinetics and mass trans-
port. Indeed, a fast kinetics induces a reversible reaction, all the reaction products staying
close to the interface, whereas a slow kinetics induces the reaction products to diffuse away,
making the reaction irreversible. In this case, a change in the chemical environment is induced
and can lead to damages to the tissue or the electrode[134]. Themechanisms involved in charge
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transfer in each case are highly dependent on the electrode material, the electrochemical
potential and the waveform used for stimulation.
Figure 2.2: Illustration of the faradaic and capacitive charge transfer mechanisms[134].
Electrode sites are usually characterized using several different methods. Electrochemical
impedance spectroscopy (EIS) describes the complex impedance modulus and phase over
the frequency spectrum and can help determine whether the charge injection mechanism
is capacitive or faradaic for the different frequencies. Cyclic voltammetry (CV) is used to
determine the cathodic charge storage capacity of an electrode during a slow potential sweep
between the limits of water electrolysis, -0.6 and 0.8 V.
The cyclic voltammetry is often used to characterize the total cathodic charge that can be
stored at the interface. However, it is poorly relevant for electrical stimulation as it is a slow
sweep, whereas the changes in current during stimulation pulses are very rapid, allowing only
the very rapid charge transfer reactions to happen. The charge available during electrical
stimulation (or charge injection capacity, CIC) will thus be dependent on the stimulation
pulse parameters, and can be characterized by analyzing voltage transients associated to
speciﬁc stimulation pulses[44,205]. The voltage transients are composed of several phases,
including the ohmic drop, the initial voltage drop due to the resistance of the solution, and the
overpotential. The overpotential of the interface depends on many parameters, including the
electrode material properties, the pulse waveform and frequency and the electrolyte composi-
tion. During neural stimulation, the overpotential has to be kept within safe limits to avoid
irreversible reactions, usually deﬁned by the limits of water electrolysis, -0.6 and 0.8 V (‘water
window’) [193]. The CIC is the maximal charge generating an overpotential of the interface that
remains within the water window, and is deﬁned for each speciﬁc waveform.
The CIC is expressed in charge density because of its dependence on the area of contact
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between the electrode material and the electrolyte. Reducing the diameter of stimulation sites
thus induces a decrease in this contact surface, resulting in an increase in impedance and
a decrease in charge injection capacity. Since the charge injection capacity highly depends
on the material, it can be increased by using materials with highly efﬁcient charge injection
mechanisms. Particular care thus has to be taken when selecting the electrode material in
order to ensure a charge injection capacity that is high enough to allow safe charge injection
at efﬁcient levels with small electrode areas.
Stimulation electrode material
The material chosen for the electrodes must have a satisfying charge injection capacity and
not be damaged or induce damage upon electrical stimulation[134]. The electrode material is
also chosen depending on the mechanism used to inject charges. Capacitive mechanisms,
fully reversible and non-damaging, are the most desirable mechanisms. However, the maxi-
mal double layer charge density is very limited. Faradaic reactions, based on reduction and
oxidation reactions, can induce changes in the electrochemical environment that can lead to
tissue damage if the overpotential is driven too far from the resting potential [44].
Noble metals, including platinum or platinum/iridium alloys, are the most common ma-
terials for neural stimulation[44]. They use both capacitive and faradaic charge injection
mechanisms, but show limited charge injection capacity of about 0.05 - 0.15 mC/cm2. In order
to increase the electrochemical surface area, platinum can be electroplated on the electrode
sites, forming platinum black. This results in a decrease of impedance and an increase in
charge injection capacity. Platinum black is the most widely used electroplated platinum
coating, although its structural stability is weak and its use for neural stimulation is limited.
Another version based on a slower electroplating protocol has been developed, platinum grey,
and shows better structural stability. This coating is the subject of a patent (US 6974533 B2)
and is used in the clinically-approved Argus II retinal implant[116].
Iridium oxide coatings, either formed by activation of the iridium surface (AIROF), elec-
trodeposition (EIROF), sputtering (SIROF) or thermal deposition (TIROF) were also shown
to greatly increase the charge injection capacity of electrode sites compared to platinum or
platinum/iridium metals, with values up to 5 mC/cm2 [44]. The charge injection mechanism
of this coating is based on reversible reduction and oxidation reactions between the Ir3+ and
Ir4+, and on an increased effective surface area thanks to its porous microstructure. However,
a positive inter-pulse bias must be used to reach high CIC values, which is not advantageous
in terms of safety and requires more complex current sources[43].
Conducting polymer coatings
Conducting polymers (mainly Polypyrrole, PPy, and poly(3,4-ethylenedioxythiophene), PE-
DOT) have gained substantial interest over the past ten years for recording and stimulation
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electrodes[10]. Although PPy properties have been extensively studied in the literature, PEDOT
is generally preferred for biomedical applications because of its higher electrochemical stabil-
ity[49](Figure 2.3).
PEDOT
PSS
Figure 2.3: PEDOT and PSS formulas[202]
The surface of a PEDOT ﬁlm is usually rough, resulting in an increase of the surface of contact
with the electrolyte[10], and an increase in charge injection capacity compared to a smooth sur-
face. The conductivity of PEDOT (and other conducting polymers) is linked to the conjugated
double bonds, allowing charge mobility along its backbone. However, without the presence of
a doping ion, this mobility is limited because of an energy gap in the electronic spectrum and
the polymer is not conductive. Doping introduces charge carriers that neutralize the unstable
polymer backbone, allowing charge mobility and generating electrical conductivity[69,85? ].
The conductivity thus has electronic and ionic components, and the charge transfer is highly
efﬁcient because of the high mobility of the electrons.
PEDOT coatings under stimulation conditions show excellent biocompatibility, with good
neuronal adhesion and growth in vitro[164] and in vivo[114]. In vivo PEDOT electropolymer-
ization has also been demonstrated, with good electrical performance and no impairment of
function[150]. PEDOT has also been used to improve electrode properties for auditory system
applications. In the cochlea, PEDOT was integrated with a functionalized alginate hydrogel
for low impedance electrodes with concurrent drug delivery[37]. PEDOT-coated microelec-
trodes provided efﬁcient microstimulation of the auditory cortex[92]. PEDOT was also shown
to improve the recording SNR of hydrogel-coated electrodes in the auditory cortex[89]. The
possibility to functionalize PEDOT coatings with bioactive molecules is also of high interest
for many applications[10]. Although some studies report on a limited stability of PEDOT under
repeated pulsing in chronic conditions[61], it appears as a good alternative to metal ﬁlms in an
acute application aiming at improving charge transduction properties of electrode sites.
Implementing PEDOT-coated electrode sites can thus enable safe neural stimulation with
small electrode sites at efﬁcient current levels. This in turn allows for the design of an electrode
array with small and dense electrode sites on a thin ﬂexible substrate, thus combining of
minimal invasiveness, maximal conformability and maximal electrode density. An implant
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with such properties will have a close proximity to the target neurons, leading to an optimal
level of spatial selectivity.
2.1.4 Optical stimulation
Optogenetics is a very important tool when trying to achieve cell-type and spatial selectivity
in neural stimulation. However, the development of optogenetics and its use for chronic stim-
ulation in animals is highly dependent on the development of safe and efﬁcient light delivery
devices. High optical power, low energy, high spatio-temporal resolution and good integration
in the tissue are necessary features to achieve successful chronic optical stimulation.
A B C
D E F
Figure 2.4: Fiber-coupled optical stimulation devices. A) Glass optrode array[1]. B) Hybrid
optrode-MEA device[203]. C) Multipoint-emitting optical ﬁber[155]. D) Polymer-based device
with ﬂuidic channel, waveguide and recording electrodes[172]. E) Flexible optrode[109]. F)
Optetrode for combined optical ﬁber stimulation and four tetrode bundles readout[8].
Laser ﬁber devices
The ﬁrst category of systems for optogenetic stimulation consists of a laser ﬁber that can
be coupled to a waveguide penetrating into the tissue to deliver the light close to the target
neurons[1,27] (Figure 2.4). These interfaces can be developed with the possibility to simul-
taneously readout the generated neuronal activity (Figure 2.4B,F)[8,28,203], and also to inject
viruses at the same location for transfection of neurons prior to optical stimulation (Figure
2.4D)[172]. Flexible probes have also been developed (Figure 2.4E)[28,109], as well as multipoint
ﬁbers, allowing the addressing of neurons at several different depths in the tissue with a single
shank device(Figure 2.4C)[155].
Although these interfaces have the possibility to bring high power in close proximity to the
neurons, there are several different limitations. First, the number of channels is very limited,
as one laser ﬁber per channel must be present. In the case of multipoint ﬁbers, several depths
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can be accessed with the same ﬁbers, but the number of independently controlled emitting
point is very limited[155]. Additionally, an efﬁcient coupling between the laser ﬁber and the
waveguide is challenging, and losses occur at the interface[172,203] and in the waveguide it-
self [1]. Finally, developing a chronic interface based on a laser ﬁber is challenging because
the laser sources are not fully implantable. All chronic systems of this kind will thus remain
tethered, unless miniaturized implantable laser sources are developed.
LEDs-based devices
Substrate-integrated light-emitting diode (LED) arrays can potentially overcome the chal-
lenges associated to ﬁber-based devices. Each LED being individually addressable, different
volumes of tissue can be targeted. It is also possible to develop fully implantable systems,
since a laser is not required. Losses due to coupling with the laser source are also avoided.
Figure 2.5 shows examples of LED-based optogenetic stimulation arrays.
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Figure 2.5: LED-based optical stimulation devices. A) LED array for in vitro neurons stimula-
tion[65]. B) Injectable multimodal probe[90]. C) Flexible LED array for cochlear stimulation[59].
D) 3D optrode for optogenetic stimulation and electrophysiological recording[12]. E) Slanted
optrode array[98]. F) Soft wireless optoelectronic system[151].
The possibility to optogenetically stimulate neurons with an LED array was validated in vitro
(Figure 2.5A)[65] and can help dissect the neural circuits. Devices for in vivo implantation can
be divided into two categories: penetrating and surface arrays. Penetrating probes with optical
stimulation and electrophysiological recording capabilities open a wide range of potential
applications (Figure 2.5B,D)[12,90,120] since the light is delivered in close proximity to the target
neurons. However, the invasive nature of penetrating probes can be a limitation, and lead to
the development of surface LED arrays.
In the cochlear implant application, the spiral ganglion neurons (SGN) can be targeted by
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the light, provided that the LED array can be inserted in the complex shaped cochlea. A ﬂexi-
ble device integrating a linear array of LEDs (50 x 50 μm2 each) was then developed (Figure
2.5C)[59]. A fully implantable system with LEDs, and a stretchable wireless radio power and
controls system, integrated into a PDMS substrate was developed and tested on the sciatic
nerve and the spinal cord, showing the possibility to modulate the pain response of a mouse
(Figure 2.5F)[151]. This option presents a soft device that can be used wirelessly, with however
a relatively large thickness (700 μm).
One of the challenges with surface stimulation is that the target neurons are often not in
the ﬁrst layer of the tissue. The optical power necessary to stimulate the target neurons is thus
higher, due to the light dissipation through tissue (this will be described in the next section).
In the cases where the optical power is not sufﬁcient, it is thus necessary to penetrate through
the ﬁrst layers of tissue. To this purpose, an optrode array was developed with a waveguide
under each LED (Figure 2.5E)[98]. This however reduces the chronic integration of the implant
in the tissue, due to the stiff implanted waveguides. Another strategy to optimize the optical
power extraction is to add a reﬂecting micromirror at the back of the device, and a focusing
microlens in front of the LED, resulting in an increase of about 70% of excitable tissue[21]. A
tradeoff must then be found between efﬁciency and invasiveness, depending on the speciﬁc
application and the location and accessibility of the target neurons.
Attenuation of optical power through neural tissue
In order to develop an efﬁcient surface LED array, the delivered light must be sufﬁcient to
stimulate neurons at the required depth. The attenuation of optical power through tissue is
due to absorption and scattering, both being dependent on the composition and structure
of the tissue, as well as on the wavelength of stimulation. The wavelength of interest here is
460-470 nm, corresponding to the peak of wavelength sensitivity of the channelrodopsin used
in the experiments presented in chapter 4 of this thesis. At this wavelength, tissue absorp-
tion is dominated by hemoglobin and melanin, but the overall power attenuation is largely
dominated by scattering (Figure 2.6). Other versions of photosensitive opsins with different
wavelength sensitivities can be used, and the attenuation of optical power through tissue can
vary and has to be taken into account.
The optical transmittance of the tissue as a function of depth follows an exponential decay[4].
Scattering is highly inﬂuenced by the structure of the tissue, so it is important to consider
the type of tissue targeted by the stimulation to obtain the parameters of the exponential
decay. For instance, grey matter, consisting primarily of neuronal somata, and white matter,
consisting primarily of axons, have very different scattering properties.
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Figure 2.6: Tissue attenuation spectrum showing absorption and scattering properties of
neural tissue components(from Abaya, 2012). Scattering is dominant in the wavelength of
interest for optogenetics (460-470 nm).
Optical properties of mouse[4] and human[212] brain tissue of different types were estimated.
Knowing the estimated power dissipation parameters of the target tissue and the depth of the
target neurons, it seems then possible to estimate the power needed at the surface of the tissue.
This is a good estimation for the activation of single neurons, but for behavioral responses the
minimal volume of activation necessary to generate a measurable response depends on the
application and has to be characterized experimentally. Despite the tools available to predict
the necessary power for an optogenetic application, an experimental step is thus necessary
for a reliable estimation of the threshold.
Thermal dissipation of LEDs
When powered, LEDs generate signiﬁcant thermal heating, which has to be taken into consid-
eration when the device is located against the tissue. Indeed, a chronic increase in temperature
of the tissue can induce profound physiological changes, even without leading to cell damage.
Chronic thermal heating above 1◦C has been shown to generate physiological differences in
neuronal activity[51,119]. Ofﬁcial regulations for biomedical devices prevent chronic heating
above 2◦C (ISO 14708-1:2014). Thermal heating at the tissue surface thus has to be measured
and controlled when using LEDs-based devices.
Measurements of thermal heating at the surface of a device is usually performed with a
thermal camera. This technique is however not possible to measure temperature in the tis-
sue. A ﬁnite element model (FEM) can be developed, approximating a solution to the heat
equation[51,104,119,188]. Direct measurements with a thermocouple can also conﬁrm the FEM
results. [51,104]
The temperature in the tissue for a given device can be inﬂuenced by the power and the
duty cycle, which is determined by the pulse duration and frequency. Changes on the device
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can be made to decrease the heating of the tissue. For instance, coating the device with a
thermal insulator, like PDMS, or optimizing the light extraction of the LEDs can help having
efﬁcient stimulation at acceptable levels of thermal heating.
2.1.5 Goals of the project
• Design and fabricate conformal electrical surface stimulation implants based on thin
polyimide technologies.
• Develop and characterize electropolymerized PEDOT:PSS coatings on the platinum
electrode sites, in order to improve the electrode/tissue interface.
• Design, fabricate and characterize optical stimulation implants integrating an array of
LEDs on a thin polyimide substrate.
• Develop a model for the characterization of the average increase in temperature at the
surface of the tissue generated by the LEDs.
2.2 Electrical stimulation implant
2.2.1 Polyimide electrode array fabrication
The electrode arrays were fabricated using standard microfabrication processes[132,170](Figure
2.7A). A sacriﬁcial layer of Ti(25 nm)/Al(100 nm) was ﬁrst deposited by evaporation on a
silicon wafer. A ﬁrst layer of polyimide (PI2611, HD Microsystems GmbH, Germany) was
then spin-coated and cured (soft bake, 5 min at 120◦C followed by hard bake for 2 hours at
300◦C in a N2 oven). The interconnects layer (Ti/Pt/Ti, 75/350/75 nm) was then sputtered
after O2 plasma surface activation and patterned by photolithography and ion beam etching
(IBE). A second layer of PI was subsequently spin-coated and cured. In the cases where the
polyimide was too thick to be directly patterned (>12 μm), a 500 nm SiO2 layer was deposited
and patterned to serve as an etch mask. Patterning of the SiO2 ﬁlm and the PI deﬁned both
the electrode active sites and the implant external shape. The oxide and polyimide ﬁlms were
etched by reactive ion etching (RIE). The electrode arrays were subsequently released from
the wafer by anodic dissolution of the Al layer (1 V bias, in saturated NaCl solution)[132].
2.2.2 PEDOT electropolymerization
PEDOT:PSS was electropolymerized from a solution of EDOT (3,4-ethylenedioxythiophene,
0.1%w/v) and PSS (polystyrene sulfonate, 0.2%w/v) (both purchased from Sigma Aldrich).
Prior to electropolymerization, the electrodes were cleaned with an air plasma treatment at
100W for 30s. Electropolymerization was performed galvanostatically at 0.75 mA/cm2 with a
platinum counterelectrode and an Ag/AgCl reference electrode. PEDOT:PSS coatings were
electropolymerized with different deposition charges (75-600 mC/cm2) by increasing the
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deposition time. After electropolymerization, the devices were rinsed in dH2O and air dried.
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Figure 2.7: Process ﬂows for the fabrication of the electrical and optoelectronic devices
For the ﬁrst phase of experiments, PEDOT was electropolymerized on platinum embedded
in thick (44 μm) polyimide. Deposition charges of 75, 150, 300, 450 and 600 mC/cm2 were
tested. The thickness of the coating, measured by mechanical proﬁlometry, varied with the
deposition charge, from 0.6 μm at 75 mC/cm2 to 3 μm at 600 mC/cm2(Figure 2.8). For the in
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vivo experiments, a polyimide thickness of 8 μm was selected to optimize the conformability
of the substrate. With this increased ﬂexibility, thick coatings delaminated from the platinum
when the polyimide substrate was free-standing. This is likely due to the increased stress in
the ﬁlm. A deposition charge of 75 mC/cm2 was then selected, as it did not delaminate from
the substrate.
75 mC/cm2 150 mC/cm2
300 mC/cm2 450 mC/cm2 600 mC/cm2
Bare Pt
50 μm
A B
SEM
1 μm
Figure 2.8: A) Optical imaging of PEDOT with various deposition charges, and SEM image
showing the surface roughness of the PEDOT coating. B) Thickness of the PEDOT ﬁlm at
different deposition charges.
2.2.3 Electrochemical impedance spectroscopy
Methods
All electrochemical measurements were made in a 3-electrode setup with a potentiostat
(Gamry Reference 600, Gamry Framework) with a large area platinum counterelectrode and
an Ag/AgCl reference electrode. Measurements were performed at room temperature, in
phosphate-buffered saline(PBS, pH:7.4). Complex impedances were measured by electro-
chemical impedance spectroscopy (EIS), with an AC voltage of 5 mV RMS and no DC bias,
between 100 Hz and 1 MHz.
Results
PEDOT:PSS coating induced a decrease in impedance modulus at 1 kHz of more than one
order of magnitude (from 45.27± 2.62 kΩ for Pt to 2.6± 0.66 kΩ for PEDOT:PSS of 0.6 μm thick-
ness) (Figure 2.9A,B). Moreover, the phase of the impedance is close to zero over the entire
range of measured frequencies, indicating a resistive behaviour associated with PEDOT:PSS
charge-injection mechanism. The change of impedance between the different deposition
conditions is not signiﬁcant (one-way Anova, p>0.05), indicating a negligible effect of the
PEDOT:PSS thickness on the impedance modulus and phase.
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Figure 2.9: A) Electrochemical impedance spectra and B) impedance modulus at 1 kHz follow-
ing PEDOT:PSS deposition with different deposition charges on 200 μm diameter electrodes
(N=5). C) Cyclic voltammograms of 200 μm diameter PEDOT:PSS coated electrodes and D)
cCSC of PEDOT:PSS ﬁlms prepared with increasing deposition charges (N=5). E) Voltage
transients measured during biphasic current pulses and recorded with increasing stimula-
tion currents, before (left) and after (right) removal of the ohmic drop on 100 μm diameter
electrodes. F) Average CIC of PEDOT at different deposition charges (N=5).
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2.2.4 Cyclic Voltammetry / CSCc
Methods
Cyclic voltammetry was performed with the same 3-electrode setup as EIS, by cycling the
potential between the limits of water electrolysis (typically -0.6 to 0.8 V) at a speed of 50 mV/s.
Cathodic charge storage capacity (cCSC) was calculated by integration of the cathodic current
over one cycle of CV.
Results
A non signiﬁcant increase in cCSC between the platinum electrode and the thinnest coating is
obtained (one-way Anova and post-hoc Tukey-Kramer test, p>0.05) (Figure 2.9C,D). Larger
charge deposition generated a substantial and steady increase in cCSC (one-way Anova and
post-hoc Tukey-Kramer test, p<0.05 for all conditions).
2.2.5 Pulse test / CIC
Methods
Charge injection capacity (CIC) is deﬁned as the maximum charge that can be injected without
the overpotential of the interface going beyond the limits of thewater window. It wasmeasured
with the same 3-electrode setup as EIS, for a particular pulse waveform and frequency by
increasing the current level step by step and measuring the voltage transients. This transient
is composed for each phase of several components. The initial quasi-instantaneous drop is
called the ohmic drop and is due to the resistance of the circuit and solution. It was deﬁned as
the drop in potential occuring during the ﬁrst 10μs of the pulse. The potential at the interface
after subtraction of the ohmic drop, or overpotential, was used to measure CIC, the maximum
charge for which the negative and positive potentials remain within the electrochemically safe
window[43].
Results
Figure 2.9E displays an example of charge injection capacity measurement with a biphasic
cathodic-ﬁrst pulse at 20 Hz and 0.2 ms/phase. The voltage transients following current pulses
of increasing amplitudes (0.05 to 0.6 mA) before and after subtraction of the ohmic drop are
plotted. Figure 2.9F shows the behavior of the CIC of PEDOT:PSS-coated electrode sites with
different deposition charges for 100 μm diameter electrode sites. A signiﬁcant effect of the
PEDOT:PSS deposition charge on CIC is obtained (one-way Anova, p<0.05). A Tukey-Kramer
post-hoc test determined that only the 75 mC/cm2 condition is signiﬁcantly different from
other conditions (450 and 600 mC/cm2) (p<0.05).
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2.2.6 Bending tests
Methods
One important feature of the polyimide array is its ﬂexibility. The PEDOT:PSS coating of the
electrode sites must therefore remain intact upon bending to a radius of curvature correspond-
ing to the estimated minimal bending radius of the rat cochlear nucleus, about 1.65 mm in the
auditory brainstem stimulation experiments presented in the second chapter of this thesis.
This value was determined from the 3D reconstruction of a rat brainstem (Fig. 2.10A)[200].
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Figure 2.10: A) 3D reconstruction of a rat cochelar nucleus. The dorsal cochlear nucleus has
an approximate radius of curvature of 1.65 mm[200]. DCN: dorsal cochlear nucleus, AVCN: an-
teroventral cochlear nucleus, PVCN: posteroventral cochlear nucleus. B) Impedance modulus
at 1kHz of PEDOT:PSS coated electrodes (diameter = 200 μm) after increasing compressive
bending. C) Optical images of two electrode sites before bending, after bending to 1.5 mm
radius and to 1 mm radius indicating the absence of cracks or delamination of the coating.
Scale bars: 100 μm
To perform bending tests, the PEDOT coated devices were bent around rods of radius of
curvature ranging from 2, 1.75, 1.5, 1.25 down to 1 mm. The complex impedance spectrum
of the electrodes was measured before the test and immediately after, and so on until the
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smallest bending radius. The coatings were also inspected with an optical microscope to
detect potential cracks or delamination.
Results
Results of the bending tests show no signiﬁcant change in impedance modulus at 1 kHz of
the coated electrode sites, in all deposition charge conditions (One-way Anova, N=5, p>0.05)
(Fig. 2.10B). Furthermore, no cracks nor delamination of the coating were observed during
any tested bending conditions (Fig. 2.10C).
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Figure 2.11: A) Optical images of PEDOT ﬁlms on 100 μm diameter electrode sites before and
after in vivo tests. Scale bars: 50 μm. B) Impedance modulus at 1 kHz before and after in vivo
tests showing no signiﬁcant difference (p>0.05, N=19). C) cCSC of passive and active sites
after explantation, showing no signiﬁcant difference in the electrochemical properties of the
PEDOT:PSS ﬁlm. (p>0.05, N=7 for passive sites, N=19 for active sites)
2.2.7 Coating reliability
Electrode sites from 3 different arrays were analyzed after the acute in vivo tests (see chapter
2) to conﬁrm integrity of the PEDOT:PSS coating. On the 20 explanted electrode sites, 19
appeared intact on the microscope while one PEDOT:PSS coating appeared delaminated and
was not considered for further analysis. Electrochemical tests (EIS and CV) were subsequently
performed on these 19 electrode sites. No signiﬁcant change in impedance modulus at 1kHz
was observed after the in vivo test compared to that of the pristine electrodes (One-way
Anova, N=19, p>0.05, Figure 2.11). Furthermore, cCSC after explantation of active (stimulated)
sites and passive (non-stimulated) sites showed no signiﬁcant change, indicating no loss in
electroactivity of the coating due to stimulation (One-way Anova, N=7 for passive sites and
N=19 for active sites, p>0.05).
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2.3 Optoelectronic implant
2.3.1 Fabrication
Clean room fabrication process
The microfabrication process to fabricate the optoelectronic array is different from the purely
electrical array, to allow for openings on both sides (electrodes on one side, and contacts for
the LEDs wire-bonding and connection pads on the other side) (Figure 2.7B). The electrical
process is then modiﬁed by adding a patterning step of the ﬁrst PI layer, to open electrodes
on the backside of the device. A reﬂow of photoresist is used here to obtain angled PI walls
of about 40◦, thus guaranteing a continuous metal ﬁlm, despite the 4 μm PI step. The rest
of the process is similar to the electrode array fabrication. A window is designed in the PI at
the position of the LED, so that the light can shine through the device without power losses
due to polyimide absorption (transmittance of 460 nm light through 10 μm thick PI ﬁlm was
measured to be only 60-70%).
LEDs integration and encapsulation
After the microfabrication steps, the LEDs (Cree CxxxTR2227-Sxx00) are integrated. First,
some glue (Epotek 302-3M) is dispensed on the windows in the PI with a pick-and-place
machine. The glue is then pre-cured for 15 minutes at 65◦C . The LEDs are pick-and-placed in
the windows, and the curing is completed for 3 hrs at 65◦C . The LEDs are then wire-bonded.
An adhesion promoter is applied (Epotek AP-100), followed by an encapsulation (Epotek
353ND) to mechanically protect the wires. In order to guarantee a good electrical insulation,
the devices are then dip-coated with PDMS (Sylgard 184, 1:10) mixed with heptane (25 wt%)
to decrease its viscosity. After 10 min at room temperature to let the heptane evaporate, the
PDMS was cured for 2 hrs at 80◦C
2.3.2 Electrical characterization
An electrical characterization of the LEDs integrated in the polyimide device was performed
(Figure 2.12). Current was varied between 0 and 20 mA and voltage was measured, for a single
LED and two LEDs in series. The device used for this characterization is presented in chapter
3 of this thesis. For the characterization of a single LED, the switch on voltage is about 2.7 V, as
speciﬁed in the LED datasheet.
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2.3.3 Optical power characterization
Methods
The optical power generated by the devices at a wavelength of 460 nm was measured with an
optical power sensor (Thorlabs S170C). In order to measure the intensity of pulses, the console
was connected to an oscilloscope where the power of the pulses over time was obtained.
Because of the relatively slow response of the power sensor, the power of short pulses (below
20 ms) was obtained by ﬁtting an exponential curve and using the asymptote of this curve as
the maximal power. This approach was conﬁrmed by comparing the measurements of short
pulses with exponential ﬁt to the ones of long pulses.
5 mm
Figure 2.12: I/V curves for two different devices, with one LED or two LEDs in series. Inset:
device for optical stimulation of the spinal cord (see chapter 4) with activation of 2 LEDs in
series at 5 mA.
Results
The optical power at different current levels, for several different LEDs is shown on ﬁgure 2.13.
The power in a pulsed regime was measured, with typical pulses of 5-20 ms. Measurements
recorded with such short pulses show an exponentially growing curve that does not reach
saturation. Assuming perfectly squared current pulses, an exponential ﬁt is performed on
the response of the power sensor, with the equation y = a · (1−e−b·(x−c)), with a,b and c the
ﬁtted parameters. The asymptote of this ﬁt is used as the power value. To conﬁrm this strategy,
measurements with identical power of pulses of 20, 50 and 80 ms were performed. When the
pulses are long enough (50 or 80 ms), the reached plateau corresponds almost exactly to the
exponential ﬁt of shorter pulses, thus validating the exponential ﬁt method.
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Figure 2.13: A) Response of the optical power sensor (black) following 20 ms, 5 mA square
current pulses at 2.5 Hz (red). B) Response of the optical power sensor to a 20, 50 and 80
ms pulse, with exponential ﬁt used to estimate pulse peak power. C) Peak power (in mW)
and peak power density (in mW/mm2) of 20 ms pulses of four individual LEDs, at increasing
current levels.
2.3.4 Thermal dissipation model
Methods
Temperature change at the surface of the device was measured with a thermal camera (FLIR
A325sc), before PDMS encapsulation. The thermal camera is sensitive to wavelengths 7.5 - 13
μm. The PDMS being partly transparent to these wavelengths[26], the measurements at the
surface of the PDMS were not reliable. A bio-heat transfer model was performed with Comsol
(COMSOL Multiphysics 4.3a) to estimate the temperature at the surface of the tissue when
implanted (at body temperature, 37◦C ) from the thermal camera measurements at the surface
of the device (before PDMS encapsulation). A steady-state model was chosen, although the
measured temperature at the surface of the LED is time-dependent. The assumption was
made that the PDMS encapsulation of the device dampens the variations of temperature on
a small timescale. Moreover, the parameter that has to be controlled to avoid physiological
changes in the neuronal activity due to chronic heating of the tissue is the average increase in
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temperature.
A ﬁrst model was developed to estimate the thermal power generated by the LED that leads
to the temperature increase measured by the thermal camera at the surface of the device, at
room temperature and in the presence of convective cooling at the surfaces in contact with air.
An axisymmetric model was used, and a circular LED of same area than the rectangular LED
used was deﬁned, with 50μm thickness. Since the LED is fabricated on SiC substrate, the LED
was approximated as a volume with SiC thermal properties. The glue was was deﬁned as a
2μm thick layer below the LED, and the encapsulation epoxy as a 50μm thick layer on the back
and on the sides of the LED. The back of the devices was placed against a glass slide during
thermal camera measurements, so this glass slide was added to the model. The materials used
were SiC 6H for the LED, Silica glass for the glass slide, and the glue and encapsulation were
estimated with standard non thermally conductive epoxy thermal properties (Table 2.1). The
boundary conditions were 1. Room temperature (20◦C ) on the back and on the sides of the
glass slide. 2. Convective cooling at all surfaces in contact with air (surface of the glue, sides
of the encapsulation). The heat source was modeled as a surface with deﬁned power at the
top surface of the LED (p/n junction). The temperature in the model was estimated at a point
on the axis of symmetry, at the surface of the glue below the LED. A parametric sweep of the
LED power was performed, from 0.1 to 12 mW, with steps of 0.1 mW. The equation solved by
the model is the equation for stationary heat transfer in solids: ρc∇T =∇(k∇T )+Q, with ρ:
density, c: speciﬁc heat capacity, k: thermal conductivity andQ: LED heat source. The LED
power corresponding to each measured temperature could then be estimated.
Material k [Wm-1K-1] c [Jkg-1K-1] ρ [kgm-3]
SiC 6H 370 690 3211
Silica glass 1.38 703 2203
Epoxy 0.2 1000 1030
Tissue[51] 0.5 3650 1050
Table 2.1: Properties for the different materials used in the thermal dissipation model
A second model was then designed to simulate in vivo conditions, with the device previously
encapsulated in PDMS. The PDMS layer was measured to be about 60μm thick, so 30μm
on each side. A 30μm thick PDMS layer was then added on each side of the device. The
glass slide was removed, and instead a large volume of tissue was deﬁned around the device.
Its dimensions are large enough to remove potential boundary effects on temperature. The
boundary condition is body temperature at the borders of the tissue. A parametric sweep
of the LED power was again deﬁned, from 0.1 mW to 12 mW with steps of 0.1 mW. The
temperature of the model was this time probed at the surface of the tissue, below the 30μm
PDMS encapsulation layer, on the axis of symmetry of the model. Increases in temperature
were thus obtained for each LED power, and linked to the original measurements of the
temperature change at the surface of the device made with the thermal camera.
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Figure 2.14: A)Thermal camera measurements at the surface of the device (before PDMS
encapsulation) at different frequencies, pulse durations and current levels. B) Thermal dissi-
pation model used to estimate the increase in temperature at the surface of the tissue. Result
with a LED thermal power of 0.78 mW, corresponding to a maximal heating of the tissue of
1◦C . C) Increase in temperature at the surface of the tissue mainly depends on the duty cycle
and the current in the LED. D) Parameter space generating an average increase of temperature
in the tissue lower than 0.5 ◦C (blue line), 1◦C (green line), 2◦C (orange line) or 5◦C (red line)
Results
The thermal camera measurements of increases of temperature are shown on Figure 2.14A.
They show a time-dependent pattern, with variations depending on the current, pulse duration
and pulse frequency. An average increase of temperature in the ﬁrst pulses was measured,
followed by a stabilization. Mesh convergence analysis showed convergence of the solution
for both models. The complete mesh consisted of 14661 elements for the ﬁrst model, and of
6022 elements for the second model. Figure 2.14B shows an image of the thermal dissipation
model with temperatures in K at each point of the model, in the condition with LED power
of 0.78 mW, the power leading to a 1◦C increase at the surface of the tissue. The temperature
at the surface of the tissue mainly depends on the duty cycle (DC) and the LED power, with
small variations due to the pulse width, as shown in ﬁgure 2.14C. Figure 2.14D shows the
parameters leading to a temperature increase in the tissue lower than 1◦C , deﬁning a safe
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range of parameters for chronic stimulation.
2.4 Discussion
2.4.1 Electrical implant
The fabrication process for a ﬂexible implant based on platinum tracks embedded in poly-
imide shows good stability and reliability. Furthermore, the resulting device is implantable,
and a large freedom in design is possible, thanks to the small feature size achievable by the
photolithography process. The tunable thickness of polyimide leads to devices with var-
ious ﬂexibility levels, thus adaptable to different applications. If the application requires
implantation into tissue without buckling, the substrate will be thicker. On the contrary, if the
application requires bending around a structure, especially on soft tissue like neural tissue, the
chosen thickness will be smaller. A mesh-like structure can even be used to further increase
conformability of the device[88]. In a situation where the array needs to be pushed in the tissue
(like in penetrating microelectrode arrays), a strategy can be envisioned where the probe is
temporarily stiffened by a bioresorbable ﬁlm.
Results of the tests with the conducting polymer PEDOT:PSS electropolymerized on a platinum
substrate showed a large decrease of impedance and increase in CIC. This enables safe and
efﬁcient stimulation with small electrode sites, allowing for a study of electrical stimulation
with high spatial selectivity, with small diameters and high density of electrode sites. The low
thickness (μm) and resulting high ﬂexibility of the substrate create a mechanically challenging
environment for the PEDOT:PSS coating. A 75 mC/cm2 deposition charge was selected, and
proved to have electrical properties, as well as size, thickness and bendability suitable for
surface neural stimulation.
In these experiments, the charge injection capacity was calculated according to the stan-
dard water window limits (-0.6 to 0.8 V), which is a simpliﬁcation of the real electrochemical
window limits. They are often considered to be between -0.6 and 0.8 V for platinum and -0.6
to 0.8 V or -0.9 to 0.5 V for PEDOT:PSS[43,61]. Moreover, these limits highly depend on the
conditions such as the temperature, the electrolyte composition and pH and the counterelec-
trode material. In order to measure them on a case-by case basis, CV cycles can be performed
with very wide voltage limits. The negative voltage where the current drops and the positive
voltage where the current quickly rises reﬂect water electrolysis and are the true limits of the
water window. However, water window limits determined in vitro for this application will still
be different from in vivo limits. The choice was then made to measure all electrochemical
properties with respect to the -0.6 to 0.8 V limits. These values are quite conservative and
widely used in the literature.
The electrochemical limit is not the only safety limit to consider for chronic stimulation.
There is another limit of charge density above which the chronic overstimulation of neurons
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induces neuronal damage, ﬁrst described by McCreery and coworkers[122,134]. This limit can
be calculated with the formula log (
Q
A
)= k− log (Q), withQ: charge per phase, A: electrode
geometrical area and k: a factor varying between 1.5 and 2 depending on the experimental
conditions[185]. With 100 μm diameter electrodes and a standard charge-balanced biphasic
symmetric pulse waveform with 0.2 ms/phase and using a conservative value of k = 1.5, this
limit corresponds to a current level of about 0.25 mA. This current might not be sufﬁcient
to generate efﬁcient stimulation in some applications. In those cases, developing a chronic
stimulation device would then require the use of larger stimulation sites.
Another issue for developing a chronic device is the stability of the coating. Electrochemical
properties of PEDOT:PSS coatings electrodeposited on smooth platinum surface have been
shown to degrade over time[61]. Because of the electrochemical safety of stimulation and the
limited chronic stability of PEDOT:PSS electropolymerized on smooth platinum substrate, the
presented array may not be adapted for use in a chronic neural stimulation model. However,
for short-term experiments, like the one presented in chapter 3 of this thesis, the properties of
this stimulation array are ideal. This is conﬁrmed by the coating reliability studies, showing
that most electrode site properties remain unchanged after acute implantation in a rat, with
28 Hz stimulation for several hours at current levels up to 2 mA.
Several modiﬁcations of the PEDOT:PSS coating resulting in improved chronic stability are
being investigated. One potential solution is to roughen the underlying platinum metal with
a laser prior to deposition, which has been shown to reduce delaminations[61]. However,
laser roughening of the metal surface is challenging on thin ﬁlms because of the low thick-
ness (about 400 nm) of the metal layer. Other solutions include the use of other doping
agents for the PEDOT. Particularly, pTS (para-toluene sulfonate) has been shown to improve
chronic electrochemical stability of the coating under stimulation conditions[61]. Composites
of conducting polymers with other polymers[85] or carbon nanotubes (CNT)[10,115] are also
investigated as a means to improve chronic stability of the coatings. Stabilizing the structure
might be an efﬁcient way to increase the electrochemical stability of conducting polymers, as
the main hypotheses of failure mechanisms are the stress in the ﬁlm or volume changes due
to ion transport [10].
2.4.2 Optoelectronic implant
The fabrication process for the optoelectronic implant leads to devices with stable perfor-
mance. Functional validation is demonstrated in chapter 4 of this thesis. The developed
device is fabricated with a thin polyimide (8 μm) polyimide substrate encapsulated in a PDMS
layer estimated to 60 μm, except at the locations of the LEDs. At these locations, the thick-
ness is much more important, with the 50 μm of the LED, and the space of the wires for the
wire-bonding, plus the epoxy encapsulation for mechanical protection of the wires. The total
thickness is estimated to about 150 μm. Adding a PDMS layer further increases this thickness
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to about 200μm, but as a counterpart decreases the stiffness of the surface felt by the tissue. It
also avoids having to add more epoxy encapsulation layers that would guarantee the electrical
insulation but would make the device much thicker. However, the large total thickness of the
device at the LED locations might generate some damage to the tissue, a point that will be
investigated during functional validation of the device.
Limitations on the density of LEDs are intrinsic to the fabrication process. Due to the in-
tegration process of the LEDs with wire-bonding, two pads need to be designed next to each
LED, leading to a limitation in the density of LEDs. Using an alternative technique than wire-
bonding to connect the LEDs, like eutectic bonding, would allow a greater maximal density of
LEDs, as it does not require the wire-bonding pads that increase the necessary footprint of
each LED. However, increasing the spatial selectivity is also linked to the size of the light beam.
That will thus be associated to a decrease of the size of the LEDs. One possible solution for this
would be to combine growth of the LEDs and device fabrication on the same wafer, in order to
avoid manual manipulation of LEDs[59]. A focusing of the light would also be necessary here,
as the light emitted by these LEDs is not directional, and the lateral stimulation generates
an overlap of the light of closely spaced pairs of LEDs. Better focusing of the light can for
example be achieved by adding a lens in front of the LED[21]. This technique however has the
disadvantage of increasing the thickness of the device with a 100 μm thick SU8 polymer lens.
The presented process has a single metallic layer, which means that there can be no overlap
between the pad and tracks of the LEDs and the electrodes, even if the openings for the
electrodes are on the backside. Optical and electrical stimulation can thus not exactly be at
the same place. However, a bimodal implant with optical and electrical contacts interfacing
with the exact same area can be used to have a local measurement of the optically-generated
activity[98] or to directly compare electrical and optical stimulation. Such devices require
multiple active layers, with at least one layer for the electrodes and one layer for the LEDs,
generating more complexity in the fabrication process. Since the LEDs and electrode sites are
at the same locations, the electrodes layer as well as the substrate must be transparent, in order
to limit the optical power losses. Simultaneous stimulation and measurements are possible
in that case, despite the presence of a light-induced artefact on the recording electrodes, the
photoelectric effect [93].
The power generated by these devices is more limited than with laser ﬁbers, but is well
above the ChR2 activation threshold. At 20 mA, the power generated by a single LED is about
7.5 mW. Considering the area of illumination of the LED, 190 x 230 μm2, it corresponds to
a power density of about 64 mW/mm2. At the cellular level, activation of the ChR2 protein
occurs at about 1 mW/mm2. In between these two values, there are other elements to con-
sider, including power losses due to diffraction of the light in the layer of glue or of PDMS
and scattering in the tissue, which depends on its optical properties and the depth of the
target neurons. Additionally, the stimulation threshold also depends on the ChR2 expression
level, and the minimal amount of activated neurons that are necessary to generate the desired
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functionality. All the power generated by the LED is also not directional and focused, which
decreases the actual power density at a certain location in the tissue. Functional validation
is thus necessary to characterize the activation threshold, and assess the possible use of this
LED array in each considered application.
Another critical element to consider is the safety for the tissue, especially with respect to
temperature changes generated by the LEDs. This depends mainly, as shown in this chapter,
on the current level and the duty cycle. The limitations in the parameters to guarantee efﬁ-
ciency of the device are ﬁrst the pulse width, since it cannot be lower than the activation time
constant of the ChR2 (2-3 ms)[108]. Then, the current must be higher than threshold (although
the threshold can also depend on the pulse width and frequency of stimulation). Limiting
the frequency is thus important, in order not to exceed a certain duty cycle, as shown in the
thermal heating model.
There are several potential sources of imprecision in the presented model of thermal heat-
ing. The ﬁrst one is the fact that a stationary model was used, instead of a time-dependent
model. This choice was made because the main interest here is to limit the average increase of
temperature in the tissue. However, since pulsed current is used to power the LEDs, peaks of
temperature that are higher than the mentioned values can be reached. Other imprecisions
in the model could be due to differences in materials properties or layers thicknesses. For
instance, a total PDMS thickness of 60 μm was used, but this does not take into account the
potential variations from device to device. This study also assumes a homogeneous tissue,
and does not consider the blood ﬂow. However, blood ﬂow was shown to act as a heat sink and
to reduce the heating of the tissue in a similar thermal simulation study[51]. All these sources
of imprecision of the model could modify the results. This is why the threshold of 1◦C was
chosen as the limit, compared to the ofﬁcial limits of 2◦C for chronic heating of biomedical
devices. This conservative limit should guarantee that, even considering the imprecisions of
the model, the 2◦C limit of chronic tissue heating is not reached.
Optogenetics, as mentioned earlier, can potentially be used with several independent wave-
lengths simultaneously, with for instance the activation and inhibition of two neuronal pop-
ulations present in the same tissue and transfected with opsins of different wavelength sen-
sitivities. With LEDs, it could be through the integration of LEDs of different colors on the
same array. However, two LEDs wouldn’t stimulate exactly the same area. Technologies for
multicolor optoelectrodes based on injection laser diodes are being developed and can allow
multicolor stimulation of the same location[83].
Finally, developing fully implantable devices is also a very important step to achieve chronic
optogenetic studies with freely moving animals. It is a challenging problem, especially with
implantable active electronics, requiring more energy than passive devices. Fully implantable
RF-powered systems have been developed and were shown to be suitable to use in optoge-
netics[138,152]. Particularly, a soft stretchable antenna for RF power harvesting was shown[152].
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Further development of these techniques will thus enable the powering of several LEDs simul-
taneously, necessary for the spatiotemporal control of stimulation.
In order to achieve higher power and to limit thermal heating, the development of fully
implantable laser sources might also be envisioned. This could be based on VECSELs (vertical-
external-cavity surface-emitting lasers), a type of lasers allowing a great control on emission
wavelength, a high power and efﬁciency and a compact size (down to a 1.5 cm footprint
cavity) [97,218]. However, these lasers are designed for high power applications (in the order of
W), and implantable versions with low power consumption are still to be developed.
Contributions
The work on PEDOT:PSS coatings was built upon two students semester projects performed
in our lab by D.Watson and N.Vachicouras. Optimization of part of the clean room process for
the optoelectronic implant was performed by P.Joris.
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3 New Generation Auditory Brainstem
Implant (ABI)
Abstract
The auditory brainstem impant (ABI) is a neuroprosthesis that provides sound sensations
to patients who cannot beneﬁt from a cochlear implant (CI) because of a disconnection
between the peripheral and central auditory systems due to tumours, cochlea or cochlear
nerve aplasia or traumas. The ABI stimulation array is placed at the surface of the cochlear
nucleus (CN), the ﬁrst auditory processing nucleus in the central auditory system. The ABI
provides useful hearing sensations to most patients, with however much poorer outcomes
than in CIs, and particularly low spectral resolution in most cases. In this chapter, we explore
the different hypotheses for the limited performance of ABIs, including the lack of spatial
selectivity of stimulation and the low understanding of the neural targets of the ABIs and their
neurophysiological properties. Using the ﬂexible surface implant technology with increased
electrode density presented in Chapter 2 of this thesis, the effect of higher spatial selectivity of
stimulation of the brainstem in a rat model are investigated.
Results show that CN electrical stimulation with the microfabricated electrode array generates
multiunit activity recorded from the inferior colliculus (IC), as well as auditory brainstem
responses (ABRs). The pattern of IC recordings initially shows a high variability, but upon
further analysis, different components of the response showing tonotopic cues are isolated.
Bipolar stimulation with small interelectrode distances provides better tonotopic cues that
with large interelectrode distance. Additionally, the waveform of stimulation is shown to have
an important effect on activation thresholds and response properties. Analysis of timing of
responses and effect of stimulation current lead to hypotheses about the neuronal populations
contributing to the different components of the response. Finally, possible modiﬁcations
of the ABI array and stimulation protocol are proposed to optimize the spectral cues and
hopefully result in improvement of hearing outcomes for ABI patients.
Publication: Guex, A., Hight, A.E., Narasimhan S., Vachicouras N., Lee, D.J., Brown, M.C.,
Lacour, S.P., Auditory brainstem stimulation with a conformable microfabricated array elicits
responses with tonotopically organized components, submitted
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3.1 Introduction
3.1.1 Auditory brainstem implants
The auditory system
The auditory system is composed of several structures sequentially stimulated when activated
by an auditory stimulus. First, the peripheral auditory system (Figure 3.1A) transduces the
sound from a pressure wave in the external and middle ear to ﬂuid motion in the cochlea. This
motion then induces movement of the ciliae of the inner hair cells, generating a depolarization
that propagates to the spiral ganglion neurons, which give rise the VIIIth cranial nerve, the
vestibulocochlear nerve . In the cochlea, a decomposition of the sound into different frequen-
cies occurs, and high frequencies generate activation of the basal inner hair cells, while low
frequencies generate activation of the apical inner hair cells. This correspondence between
sound frequency (’tono’) and location of activity (’topo’) is called tonotopy, and is conserved
throughout the auditory system[42,176].
Cochlear nucleus
Cochlea
Auditory 
nerve
A B
Figure 3.1: A) Schematic of the peripheral auditory system[94]; B) Schematic of the central
auditory system showing the main auditory nuclei and their tonotopic organisation[176].
The vestibulocochlear nerve enters the central nervous system at the level of the cochlear
nucleus (CN), at the surface of the brainstem, which is the ﬁrst relay station for all ascending
auditory information. The cochlear nucleus is organized in different subunits, the dorsal, an-
teroventral and posteroventral cochlear nucleus (DCN, AVCN and PVCN), each with different
structures, functions, organizations and types of neurons. [187] When entering the cochlear
nucleus, the auditory nerve ﬁber shows a branching pattern with ﬁbers projecting to the three
subunits. [121] A parallel processing then occurs, and each of these subunits has its own tono-
topic organization, that is conserved from the vestibulocochlear nerve through the branching
pattern, as shown in ﬁgure 3.1B[42,121,201]. Thus, a tonotopic organization is present in the
DCN, AVCN and PVCN. In the DCN, this tonotopy is present with lower to higher frequencies
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being represented in the ventrolateral to dorsomedial axis [42,121,174]. The projections from
different cell populations in the dorsal and ventral CN give rise to several parallel auditory
pathways (Figure 3.2). They project to higher auditory structures, including the contralateral
cochlear nucleus, the superior olive, the lateral lemniscus and the inferior colliculus on the
ipsilateral or contralateral sides. Third order neurons then project to the thalamus and to the
primary auditory cortex. [29,84,158]
Figure 3.2: Schematic of the main ascending central auditory pathways[66]
Deafness and auditory implants
Different types of hearing loss result from the dysfunction of various structures of the auditory
system. Conduction hearing loss is deﬁned as hearing loss due to a defect in the external
or middle ear affecting sound conduction to the cochlea. External hearing aids, middle ear
implants or BAHA (bone-anchored hearing aids) can be used to restore function of the middle
ear and transmission of the sound vibrations to the cochlea.
Hearing loss due to a defect in the sensory cells or in the nerve cells is called sensorineural hear-
ing loss. The most common solution for the patients suffering from profound sensorineural
hearing loss is the cochlear implant, a neuroprosthetic device consisting of multiple electrical
stimulation sites along a single shank inserted along the tonotopic axis of the cochlea. It
electrically stimulates the spiral ganglion neurons, thus bypassing the inner hair cells. The
cochlear implant is the most successful neuroprosthetic device currently available on the
market. To this day, more than 300’000 children and adults worldwide suffering from profound
sensorineural hearing loss, mostly due to damage to the hair cells, have beneﬁted from this
technology[183].
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Despite the outstanding outcomes associated with the cochlear implant, some patients having
a disconnection between the peripheral and central auditory systems cannot beneﬁt from it.
These patients most commonly suffer from Neuroﬁbromatosis type 2 (NF2), an autosomal
dominant condition occurring in 1 in 40’000 births and characterized by the bilateral growth
of tumors along the vestibulocochlear nerve. [45] Removal or growth of these tumors causes the
destruction of the auditory nerve. Other conditions include cochlear aplasia, cochlear nerve
agenesis or VIIIth nerve sectioning due to traumas. These patients can be implanted with an
auditory brainstem implant (ABI), a type of auditory implant that bypasses the auditory nerve
and directly stimulate the cochlear nucleus (CN)[133].
A B C
D E
Figure 3.3: A-C) Photographs of the three main clinical ABI arrays, from Cochlear (A), Med-
El (B) and Oticon Medical (C); D) External and E) implanted parts of the Cochlear ABI de-
vice(modiﬁed from[201]).
The ﬁrst auditory brainstem implant was developed at the House Ear Institute in Los Angeles,
in the late 1970s and consisted of a pair of ball electrodes[201]. Since then, the number of
electrodes was progressively increased and integrated into an array of about 3-by-8 mm2,
roughly corresponding to the available surface of the CN[45]. Figure 3.3 shows pictures of
the ABI arrays currently used in the clinics by the three main ABI companies, Cochlear (A),
Med-El (B) and Oticon Medical (C). Worldwide, more than 1500 people have already beneﬁted
from this technology[121,181]. In the US, the ABI is currently clinically approved only for adults
with NF2, because the device can be implanted in the same surgery as the tumor resection,
generating minimal additional surgical risk[180]. In Europe, the ABI is also approved for
non-tumor patients[46], as well as for congenitally deaf children for whom the CI is not an
option[183]. A clinical trial for pediatric ABIs is ongoing in the US[144,157].
42
3.1. Introduction
The ABI : implantation and outcomes
Contemporary ABI devices are very similar to CIs except for the electrode array, and consist
of an externally worn microphone and processor (Figure 3.3D), and an internal receiver and
stimulator connected to the ABI electrode array (Figure 3.3E). The array is placed on the CN
surface[201], located at the dorsolateral surface of the brainstem, at the junction between the
medulla and the pons (Figure 3.4A). During surgery, the electrode array is inserted into the
lateral recess of the fourth ventricle and placed over the surface of the CN.[45] This structure
is not directly accessible and the approach is blind, as illustrated in ﬁgure 3.4B. Due to the
complex shape of the cochlear nucleus complex and the anatomical locations of the different
CN subunits, the structures targeted by the ABI are the DCN and part of the PVCN, the rest of
the CN complex being located too deep into the brainstem and thus being unreachable by
a surface implant. [167,201] The DCN seems to be the primary target because the depth of the
PVCN may vary and the DCN is larger[201].
6 to 8 weeks after implantation, the implant is turned on. Several programming steps are
necessary here. First, electrode sites that generate useful auditory stimulation with no side
effects are selected. Then, for each of these electrodes, the threshold (T) and comfort (C)
current levels are determined and the electrodes are pitch ranked at C level and the device is
programmed[113,201].
A B
Figure 3.4: A) Approximate placement of the ABI array at the surface of the brainstem, on the
cochlear nucleus[201]. B) Drawings showing the anatomy (with VIIth, VIIIth and IXth cranial
nerves, as well as the choroid plexus (CP)) and implantation location of the ABI array[180].
In the great majority of cases, ABI patients report useful auditory sensations from their implant.
In pediatric ABIs, most of the patients show improvements in cognitive development, and
some of them can even have a normal auditory development. [183] However, the clinical out-
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comes of ABIs are in general not comparable to CIs, with lower word recognition scores with
ABI alone. Except for a few patients showing excellent outcomes and good speech understand-
ing, most patients use their implant for sound awareness, environmental cues and as a help
for lipreading. [201] [121] Some patients can pitch-rank their electrodes, showing a possibility of
access to some distinct frequencies. [121] ABI users performed much poorer than CI users at
discriminating between frequencies (i.e. spectral cues) [121,184]. If initially the overall results
seemed poorer for NF2 patients than for non-NF2 patients, suggesting a damage of the CN due
to the tumor or its removal [121], other results reported some cases with excellent performances
in NF2 patients with the 12-electrodes Med-El implant. [201] These results suggest that the
surgical approach, implant type and processing might affect the outcome more than the
disease itself. [183]
The overall performance is not necessarily linked to the number of electrodes. Indeed, some
patients using a low number of channels showed good perceptual performance[201]. However,
experience with CIs shows that at least 4 channels are necessary for good speech understand-
ing in quiet, and that this number increases in the presence of background noise[201] or for
understanding of spectral content of speech[211]. Accurate frequency encoding might then be
the main culprit for reduced speech comprehension in ABI users.
Challenges faced with ABIs
One of the challenges with the current ABIs is the extra-auditory side-effects often generated
by some of the electrodes, which need to be deactivated. These side effects can include dizzi-
ness, tingling in the leg or in the tongue, and are due to current spread inducing stimulation of
the neighbouring non-auditory structures by the ABI electrodes, including the VIIth or IXth
cranial nerves[201] [184] and other brainstem nuclei. This phenomenon decreases the number
of usable electrodes, thus preventing the use of electrodes that would potentially give good
auditory sensations.
Additionally, poor spectral resolution seen among ABI users may be the result of electri-
cal stimulation failing to stimulate independent populations of auditory neurons along the
tonotopic axis[46]. This may be the result of poor spatial selectivity and current spread, due
to the relatively large electrode sites used in the contemporary ABIs and the high current
thresholds. These high current thresholds can be partly explained by the fact that the electrode
arrays used in clinical ABIs are thick (0.6 mm) and not very ﬂexible, and they might not be
able to conform to the curvilinear cochlear nucleus surface[167], thus increasing the distance
with the target neurons. The poor frequency selectivity of stimulation might also be due to
the neurophysiological properties of the stimulated structures and their respective frequency
tuning properties. Stimulation of a population of neurons with wide frequency tuning would
lead to a lack of spectral deﬁnition, even in the presence of spatially speciﬁc stimulation. If
the ABI induces stimulation of a mix of several neuronal populations with various frequency
tuning properties, as suggested by the CN neurophysiology, it could be an explanation for the
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mixed outcomes of spectral resolution. It was also suggested that some parts of the frequency
spectrum might not be accessible by surface stimulation[167].
Another possible explanation for the poor outcomes of the current ABIs is the bypass of
the processing steps occurring in the CN. Indeed, it is impossible to stimulate the CN neurons
in the same way than the auditory nerve would in a healthy patient, so some processing would
necessarily be bypassed. Important information about sound modulation and periodicity,
or sound onset and offset might then be lost. [45] Moreover, the processing in the three sub-
units of the CN occurs in parallel, so at least some of it is bypassed by stimulating mainly the
DCN[137]. The question here is: is this bypassed processing so important that no good speech
understanding is achievable with an ABI? It does not seem to be the case since some patients
achieve good speech understanding with ABIs[201].
Finally, the processing strategies used in contemporary ABIs could help explain the mod-
est outcomes. The Med-El ABI uses the CIS (continuous interleaved sampling) strategy, using
high ﬁxed rate stimulation (600-1800 Hz) to a small number of channels in a nonoverlap-
ping fashion, in order to avoid channel interactions. It is adapted to a stimulation giving
very precise temporal information to a low number of independent frequency channels. The
Cochlear ABI device is based on the SPEAK (spectral peak coding) processing strategy, which
analyses the intensity and frequency of the sound and dynamically selects the electrodes to
stimulate, and uses 250-300 Hz stimulation or on the ACE (advanced combination encoder)
strategy, a high pulse rate version of the SPEAK strategy[111,113]. These processing strategies
were developed for cochlear implants, and although some good outcomes were reported using
the Med-El implant[113,181], they might not be optimal for auditory brainstem stimulation. In-
deed, the cochlea and cochlear nucleus are fundamentally different in several ways including
their structure, tonotopic organisation, neuronal properties and role in the auditory system.
Successful ABI stimulation might require targeting of a subset of neuronal types or structures
with speciﬁcally-designed protocols. It is then essential to adapt the processing strategy to
the cochlear nucleus structure and function[13,201], which requires an in-depth study of its
different neuronal populations, their projections and properties.
3.1.2 Neurophysiology of the cochlear nucleus
The CN is a very important relay station in the auditory pathway, but also includes a lot of
processing of the sound. Its size has been measured to 8 mm x 1.53 mm x 3.76 mm at the
maximum in humans[167]. Its complex shape, as well as the volume ratio of 1:5 between the
dorsal and ventral parts has to be considered during the design of a new ABI[167] (Figure 3.5).
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Figure 3.5: A) Views of the right human cochlear nucleus complex, showing the dorsal (red) and
ventral (yellow) cochlear nucleus substructures. B) Dorsolateral view of the human brainstem,
showing the position of the cochlear nucleus complex (from[167]).
The neurophysiology of the CN has been thoroughly characterized in animal models, and com-
pared to the human in some studies[16,17,139]. Many different neuronal types can be identiﬁed
in the CN that differ in their localizations, frequency tuning properties, projections, temporal
patterns of responses to tone burst and functions[201]. We will take a particular interest in the
principal neurons, those that have direct projections to higher auditory structures, which have
been reviewed in several papers[29,121]. Many more types of neurons are involved in internal
processing and are important for the functionality of the CN, but will not be discussed in
depth here.
The AVCN and PVCN contain various types of projecting neurons. The spherical and glob-
ular bushy cells present in the AVCN are thought to be important for sound localization
and binaural hearing[29,121,201]. The type I multipolar cells in higher mammals and humans
(probably corresponding to the T-stellate cells in rodents), located in the central region of the
VCN, are narrowly tuned to sound frequency and project directly to the IC. Their response
properties suggest that they are specialized in amplifying and extracting the envelope of the
sound, and thus that they encode temporal features of sound and are important for speech
perception. [121,137] The octopus cells present in the caudal PVCN respond to tone bursts with
very precise timing and are thought to encode broadband temporal timing information[121].
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The organization of the DCN shows more distinct differences between animal models such as
cats and rats, and humans. The DCN shows a laminar structure in most animals, composed
of three main layer, the molecular, the fusiform and the deep layer (Figure 3.7). The ﬁrst
layer includes the parallel ﬁbers, composed of axons from the granule cells and other sources.
Below, the fusiform cell layer and deep layer present many different types of neurons involved
in the internal processing of the CN. The DCN contains two main types of neurons projecting
to the higher auditory structures. First, the pyramidal (fusiform) cells located in the fusiform
cell layer, below the parallel ﬁbers, receive excitatory input from tonotopically organized
auditory nerve ﬁbers and inhibitory input from tonotopically organized vertical cells [216].
They also receive excitatory and inhibitory inputs from the parallel ﬁbers, the stellate cells
and the cartwheel cells that might be less tonotopically organized, and integrate these inputs
into direct, fast-conducting, tonotopically-organized projections to the contralateral IC via the
dorsal acoustic stria[16,121,216]. Second, the giant cells, located in the deep layer of the DCN,
project to the contralateral IC but also to the contralateral CN.[29] These neurons are located
deeper and are much less numerous than the pyramidal neurons.
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Figure 3.6: A) 3-dimensional reconstruction of a rat CN, as in[200], showing the three subunits
(anteroventral (AVCN), posteroventral (PVCN) and dorsal (DCN) cochlear nucleus), as well
as the auditory nerve (AN) and vestibular nerve (VN) entrances into the CN. B)Tonotopic
organisation of the rat DCN[174].
The role of the DCN in humans is not clear, as it differs in its cytoarchitecture compared to
other mammals[16,139]. Particularly, some neuronal cell types involved in internal processing
of the DCN in animals, such as cartwheel cells, might not be present in humans[139]. Part of
the stratiﬁed structure observed in most mammale is however present[17]. Its relatively low
number of projections compared to the VCN suggests an important role in the processing of
sounds[121], and in particular the coding of sound elevation[145].
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It is difﬁcult to identify the precise neuronal targets of the ABI since little is known about
the CN physiology, about the precise role of the different neuronal types, but also about the
non-projecting neurons and the nature of the connections between the different subunits
of the CN[121]. However, the pyramidal neurons are a potential target in the DCN as they
are located not far from the surface, are more numerous than the giant cells and have direct,
tonotopic projections to the contralateral IC. In the VCN, the type I multipolar cells are also a
potential target, since they are thought to be critically important for speech understanding
and have direct, tonotopically-organized projection to the IC[29].
Figure 3.7: Neurophysiological organisation of the DCN in mammals showing the main cell
types and connections in the three layers (ML: molecular layer; FCL: fusiform cell layer; DL:
deep layer) and the projections to the IC of the two principal cell types, fusiform cells and
giant cells [145].
3.1.3 Hypotheses for ABI improvements
Targeting neurons in the VCN
In ABIs, unlike in CIs, the tonotopic axis is difﬁcult to access since higher frequencies are
located deeper in the DCN.[183] Since more narrowly frequency tuned neurons seem to be
present deep in the VCN with direct projections to the IC, penetrating ABIs (PABIs) were
developed. The advantages of using microstimulation within the CN were thought to be
multiple and to include particularly better access to the tonotopically-organized Type 1 mul-
tipolar cells and lower current thresholds resulting in lower extra-auditory side effects, and
ultimately better frequency selectivity and speech understanding. [123] Clinical trials showed
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that, if indeed lower currents could be used, this did not result in improvement of speech
understanding. [149] Moreover, speciﬁc problems associated with PABI were described. First,
the accurate placement of the PABI is more difﬁcult due to anatomical variations between
patients. Additionally, unlike with surface ABIs, there is no possibility to intraoperatively probe
and change its placement if it is not optimal. Non-auditory sensations were also generated
and the PABI was found more likely to stimulate the deep ﬁbers in the CN instead of the single
neurons, resulting in lack of tonotopic selectivity in some cases.
For these reasons, an optimization of the surface approach is chosen. In some cases, ABI
patients have very satisfying hearing outcomes with access to different frequencies and good
speech understanding. These patients show the possibility to generate useful auditory stimu-
lation with surface ABIs, and work is required to understand what is different in these patients
compared to the ones with low hearing outcomes, as well as what is the potential for improve-
ment of the surface ABI.
Increasing spatial selectivity of surface stimulation
One of the strategies envisioned to improve surface ABIs is to optimize spatial selectivity of
stimulation. There are two main reasons for this. First, one of the main issues with contempo-
rary ABIs is the generation of side-effects due to stimulation of neighbouring non-auditory
structures. Increasing the spatial selectivity of stimulation will allow to limit the current to the
auditory portion of the brainstem, particularly at the edges. Second, decreasing the volume of
activated neurons with spatially speciﬁc stimulation may allow an optimization of the number
of frequencies that can be accessed, thus maximally taking advantage of the tonotopic organi-
sation of the DCN. This will hopefully increase the number and independence of frequency
channels, leading to higher spectral content in the new generation ABI.
There are several directions to improve the ABI’s stimulation selectivity. Contemporary ABI ar-
rays consist of electrodes on a rigid backing (0.6 mm thickness) that conforms only minimally
or not at all to the curvature of the brainstem surface[167]. Using a thin ﬂexible stimulation
array would lead to an implant that conforms to the the CN surface[68], thus minimizing the
distance to the target neurons and the stimulation thresholds.
Decreasing the diameters of electrode sites and increasing their density can also contribute
to an increased spatial selectivity. Clinical ABI arrays consist of electrodes with diameters
varying between 550 and 700 μm and inter-electrode distances of typically 1 mm (center-to-
center) [186,201]. Decreasing electrode diameters and increasing their density can provide a
platform to study the limits of spatial selectivity achievable with electrical stimulation. Addi-
tionally, bipolar stimulation may produce a more focused excitation volume of neural tissue
in cochlear stimulation[135,190,219] and deep brain stimulation[95,148] compared to monopolar
stimulation, currently used in ABIs for power reasons[75]. Although bipolar stimulation is
not always associated with functional beneﬁts in these studies, it can potentially reduce the
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lateral spread of stimulation current, both perpendicular to the electrode pair and deep into
the tissue[22] and might thus be beneﬁcial.
Adapting the stimulation strategy to the CN neurophysiology
Even if the CIs and ABIs target fundamentally different structures, as seen before, all exist-
ing ABI devices use processing algorithms that are CI-speciﬁc, even though the stimulated
neurons do not have the same response properties than the spiral ganglion cells targeted by
CIs. [201] This is a major issue in current ABIs, and a lot of work would be required to precisely
identify the targeted structures and their properties within the CN, so that a new and opti-
mized processing algorithm can be developed.
In this context, investigating the effect of different waveforms of stimulation on the audi-
tory system responses is a ﬁrst step to understand how to stimulate the CN neurons in order
to optimize the tonotopic organisation and the frequency selectivity of stimulation. This
strategy is well known from the literature, and different waveforms of stimulation have shown
to provide various spatial or structural selectivity properties.
For instance, short phase durations have shown to be associated to lower thresholds (in
charge per phase) than longer phase durations[91]. Asymmetric pulses were also tested and
waveforms that stimulated preferentially neuronal somata over ﬁbers of passage, or the op-
posite, were shown in a simulation study[124]. A strategy to inverse the current-distance
relationship, inactivating neurons close to the electrode site while stimulating further neurons
was also presented in an in vitro model [63]. Testing these different waveforms and their effects
on the activation properties of the auditory system might thus enable a better understanding
of the stimulated neurons, and a targeting of neuronal populations with speciﬁc properties.
Improving the ABI placement and the intraoperative assessment
Another issue affecting ABI outcomes is the difﬁculty of reliable placement of the electrode
array during surgery. Even if the placement can be probed by assessing the presence of ABRs
after stimulation from the different electrodes of the array, a good placement is not guaranteed.
Several elements can explain this. First, the approach is blind, and the surgeon has to “slide”
the implant between the cerebellum and the brainstem, within the lateral recess of the 4th
ventricle to reach the CN surface (Figure 3.4). [45] Very few surgical landmarks are available,
and for NF2 patients, the structures might appear very distorted due to the tumor. [149] Second,
the “ABR probing” done intraoperatively is very crude: the electrodes are tested in a bipolar
conﬁguration to minimize the stimulation artefact in the recording and optimize the time of
testing, whereas they are most often used in a monopolar conﬁguration when the implant
is switched on.[180] This can induce important differences in the generation of auditory sen-
sations, but also extra-auditory side-effect, which are often not detectable intraoperatively.
Moreover, the correspondance between the generation of ABRs intraoperatively and the pres-
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ence of auditory sensations in stimulation conditions is not automatic[75,180]. It is not clear
why this is the case, however it is known that the anesthesia has a big inﬂuence on the ABRs
and the electrode array position might not be fully stable during the recovery time.[137]
An improvement of ABI performances will thus most likely be linked to an improvement
both on the array and on the processing side. It is also intrinsically linked to a good under-
standing of the physiology of the stimulated system and the precise targeted neurons. It is our
hope in this project to improve the understanding of the stimulated neurons, as a step in this
direction.
3.1.4 Assessment of auditory system activation properties
The auditory brainstem response
The auditory brainstem response (ABR) is a far-ﬁeld measurement of the auditory system
activation along the brainstem and midbrain, up to the auditory cortex following an auditory
stimulus. In animal models, it is recorded with three subcutaneous electrodes placed at the
vertex, behind the ipsilateral ear and on the back of the animal. Evoked potentials are recorded
following stimulation of the auditory system by subtracting the signal obtained from the
ear electrode to the signal obtained from the vertex electrode, each relative to the reference
electrode on the back of the animal.
The recorded auditory evoked potential can last for several seconds, and the ﬁrst 10ms corre-
spond to the ABR. This multipeaked response can be measured following acoustic stimulation
(aABR) or electrical stimulation (eABR)(Figure 3.8) and the amplitudes and latencies of the
different peaks can provide information about the auditory system activation. Five different
peaks can usually be identiﬁed in acoustically-generated ABRs. It is generally accepted that
they correspond to the sequential activation in the auditory nerve (I), the cochlear nucleus
(II+III), the superior olive (IV), the lateral lemniscus and the inferior colliculus (V), although it
may be more complex[130].
As it is an indirect measure of activity, it has a poor selectivity. In particular, no informa-
tion about the frequency selectivity of auditory system activation can be obtained. However, it
is the only method that can be used clinically during ABI implantation surgery to intraopera-
tively assess the correct positioning of the ABI and reposition it if necessary[75]. It is thus an
important recording method to consider in the design of a new ABI.
Multiunit recordings along the auditory pathway
Multiunit recordings along the auditory pathways can provide very precise information on
the auditory system activation following acoustic or electrical stimulation in animal models.
Thanks to the tonotopic organization conserved from the cochlea throughout the auditory
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system up to the auditory cortex, information about the frequency content and selectivity of
stimulation can be obtained[11,57,117,165]. The central nucleus of the inferior colliculus (IC)
provides two main advantages for recording. First, it is tonotopically organised in isofrequency
laminae along a dorsal-to-ventral axis, with deeper layers corresponding to higher acoustic
frequencies, and shallower layers corresponding to lower frequencies. Thus, by introducing a
single shank multichannel electrode array along this axis, information about the frequency
selectivity of auditory stimulation can be obtained. The second advantage is that most of the
projections from the CN to the higher auditory structures pass, directly or indirectly, via the
IC[29].
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Figure 3.8: A) Example of acoustically-evoked ABRs in a human at different stimulation levels,
with wave V marked, the main wave used for ABR-based diagnosis of various conditions[208].
B) Electrically-evoked ABR during ABI implantation surgery at different locations on and near
the CN[180]. C-D) Acoustically (C) and electrically (D) evoked ABRs in a rat model following
40dB SPL click stimulus (C) and 0.4 mA stimulation on the DCN (D)[200].
The exact link between multiunit recordings from the IC and audiologic perception of speech
and sounds is unclear, as there is some extra processing occuring in higher auditory structures
than the IC including the thalamus, the primary auditory cortex and higher cortical areas.
However, IC multiunit recordings are the best available measure to estimate the frequency
selectivity in animal models and can provide useful information on the activation of the
auditory system.
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3.1.5 Goals of the project
• Use a conformable microfabricated array to stimulate the cochlear nucleus surface in a
rat model and record the evoked activity of the auditory system.
• Investigate whether the tonotopy of the CN can be accessed by this spatially selective
stimulation, by analyzing the different components of the response.
• Develop hypotheses on the neural correlates of the different components of the re-
sponse.
• Investigate the effect of electrodes conﬁguration (bipolar vs monopolar) and in the case
of bipolar stimulation, the effect of distance between the two sites of the stimulation
electrode pair and orientation of the electrode pair
• Investigate the effect of the waveform of stimulation on the parameters of activation
and access to different frequencies.
• Draw guidelines on how to translate the obtained results into improvement of the ABI
array for human use.
3.2 Methods
3.2.1 Acute in vivo experiments
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Figure 3.9: Experimental setup with stimulating array in the left DCN (A) and recording probe
in the contralateral (right) IC (B). Lateral (L), medial (M), rostral (R) and caudal (C) directions
on the DCN surface are indicated. In the IC, the tonotopic axis runs from low CF dorsolateral
to high CF ventromedial. ABRs are recorded with three subcutaneous wires, indicated by the
green stars, on the vertex, behind the right ear and on the back of the animal.
All experimental procedures were performed in accordance with the National Institute of
Health guidelines for the care and use of laboratory animals as well as approved animal care
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and use protocols at the Massachusetts Eye and Ear Inﬁrmary, Boston, MA. In vivo tests were
performed on male Sprague-Dawley rats (350-500 g) within a sound-attenuating chamber.
Animals were anesthetized with Ketamine (100 mg/kg) and Xylazine (20 mg/kg) for the dura-
tion of the experiment. Normal function of the cochlea at all frequencies of the rat hearing
range was checked by measuring the distortion product otoacoustic emissions(DPOAEs). A
left occipital craniectomy was performed and a small portion of the ipsilateral cerebellum was
aspirated. A second craniectomy was performed over the right temporo-parietal suture, to
access the surface of the contralateral IC(Figure 3.9).
Electrical stimulation protocol
The array (described in section 3.4) was placed on the surface of the DCN. Electrical stimu-
lation was induced with custom-made current sources. Stimuli were current-controlled but
expressed in voltage levels due to the presence of a 2 kΩ resistor in parallel with the output
during the experiments. The stimuli were pulse trains (train duration, 500 ms; trains repeated
1/s). Within a train, the pulses consisted of charge-balanced biphasic symmetric pulses at 0.2
ms/phase and 28 pulses/s with alternate polarity unless otherwise speciﬁed (Figure 3.10A).
Stimulation level ranged from 0 to 4 V in steps of 0.5 V. Bipolar stimulation was applied be-
tween two electrode sites of the array, whereas monopolar stimulation was applied between
one electrode of the array and a reference electrode (stainless steel needle placed in the neck
muscles of the animal). Averages of 30 repetitions of 500 ms pulse trains were obtained for
each condition. All runs were performed in a pseudo-random order.
Auditory brainstem responses (ABRs) recordings
Electrically evoked auditory brainstem responses (eABRs) were recorded. These recordings
were made by differentially recording signals from two subcutaneous stainless steel needle
electrodes, one placed on the vertex and the other behind the ipsilateral pinna of the animal,
with a ground electrode placed on the back of the animal. The signals were ﬁltered with an
analog bandpass ﬁlter (30 Hz to 3 kHz) ampliﬁed by 60 dB before A/D conversion with a
sampling frequency of 25 kHz (Ithaco Model 1201, DL Instruments, Ithaca NY) and averaged
over all stimulus presentations.
Multiunit recordings from the inferior colliculus (IC)
A 16-channel penetrating recording probe (A1x16-5 mm-150-177, Neuronexus, Ann Arbor, MI)
was inserted into the central nucleus of the IC. Multiunit recordings from the IC were obtained
simultaneously from 16 recording sites along the silicon shank of the probe with a 25 kHz
sampling frequency. Recording site diameter was 15 μm and center-to-center spacing was 150
μm. The average signal of all sites was used as a global reference.
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Characterization of electrode array position
Accurate placement of the ABI electrode on the DCN surface was conﬁrmed by inserting
pins (0.1 mm diameter Minutien) at the corners of the array and subsequently recovering the
pin-holes in Nissl-stained frozen sections during post-experiment histology.
3.2.2 Signal processing
Data pre-processing
Processing of the data was performed with MATLAB software (The Mathworks Inc., Natick,
MA). The ﬁrst 1 ms of each recording following each stimulus pulse onset was discarded to
eliminate the stimulation artefact. A forward and reverse bandpass Butterworth ﬁlter of order
5 was applied, with cut-off frequencies of 500 Hz and 3 kHz. The ﬁlter was also applied on the
baseline activity. Threshold for spike detection was set to three times the standard deviation
of the ﬁltered baseline. The spike rate was determined after subtraction of the baseline spike
rate, for the 30 ms after stimulus (Figure 3.10).
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Figure 3.10: A: Illustration of the stimulation protocol with alternate polarity. B: Raw IC
recording. C: IC recording after deletion of the ﬁrst millisecond of recordings containing
the stimulation artefact, and ﬁltering. The threshold for spike detection is shown in red. D:
Post-stimulus time histogram (PSTH) following spike count for all 30 averages
Post-stimulus time histograms (PSTHs) were obtained for each condition with a temporal
resolution of 0.1 ms. Spikes were then averaged over a deﬁned time interval for each IC
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recording site and stimulation level to generate IC response maps. Signiﬁcance of activation
for each condition was determined by a student’s t-test between the spike rate of the different
repetitions, and the same data at the zero stimulation level. A p-value < 0.001 was used as the
signiﬁcance criterion. Spike rate of non-signiﬁcant conditions were put to zero.
Response maps parameters measurements
The best threshold of activation was determined for each map as the lowest stimulation level
generating signiﬁcant activity on at least one of the recording sites. For each level l above best
threshold, the centroid of activityCl and the width of activation Wl were calculated with the
following formulas (k: IC recording sites; MAP : 2-dimensional IC response map)[52]:
Cl =
Σkk ∗MAP (k, l )
ΣkMAP (k, l )
Wl = 2∗
√
Σk (k−Cl )2∗MAP (k, l )
ΣkMAP (k, l )
The centroid for electrical and acoustic stimulation were deﬁned slightly above threshold, in
order to provide a greater stability in the measurements. The centroid for electrical stimulation
was deﬁned at a level of 1 V above the best threshold for each IC response map (Figure 3.11).
The centroid for acoustic stimulation was deﬁned at 10 dB SPL above threshold for each
acoustic frequency.
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Figure 3.11: Example response area to illustrate the features that were extracted for analysis.
Scale at bottom shows relationship between IC recording site and characteristic frequency,
which was determined for each animal using acoustic stimulation.
Rate level curves were obtained using the average spike rates at the centroid± 1/2 width. Spike
rates were normalized for each rat to the maximum of the rate level curves across all stimula-
tion conditions. Spike counts were obtained for each run and stimulation level by adding the
spikes recorded from each IC recording site. The range R between two characteristic frequen-
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cies CFmin and CFmax was expressed in octaves, following the equation R = log2(CFmax
CFmin
).
The common activity was calculated by averaging IC response maps with signiﬁcant activity
evoked by all electrode pairs across the DCN. This average map was calculated separately for
the different inter-electrode distances.
3.3 Acoustic stimulation results
Recordings of IC activity following acoustic stimulation is performed at the beginning of
each experiment after insertion of the multichannel recording probe. The probe placement
along the tonotopic axis of the IC can be conﬁrmed and corrected if necessary before starting
electrical stimulation. Tone pips of 20 ms duration are sent to the contralateral ear, between 1
and 46.5 kHz at 2 steps per octave, between 0 and 80 dB SPL (sound pressure level).
Recorded maps show strong activity in the IC following acoustic stimulation at all tested
frequencies (with a few exceptions, for example the 32 kHz run in rat 3)(Figure 3.12). Stim-
ulation with high acoustic frequencies induce activity in the low-numbered recording sites
(located ventromedially in the IC); as frequency is decreased, the activity progressively shifts
to higher-numbered sites (more dorsolateral in the IC). Generated data show variable maximal
spike rates (between 247 and 613 sp/s) and best thresholds (between 10 and 40 dB SPL) in the
different rats.
The shift in activity along the array with sound acoustic frequency is very reliable(Figure
3.13), but the width of activity varies from rat to rat. A general trend to extract from this data in
several rats (1 to 5) is the lower threshold in the middle frequency range (8 - 16 kHz) than in
the low or high frequencies. This trend highlights the range of highest hearing sensitivity in
this species of rats[86].
The centroid of activity following stimulation with each of the acoustic frequencies is calcu-
lated, then a logarithmic ﬁt is used to obtain the characteristic frequency associated with each
IC recording site (Figure 3.13). This logarithmic function is then used as the correspondence
between IC recording site and characteristic frequency in the analysis of electrically-generated
data. Information on the frequency content and selectivity of the IC multiunit activity gener-
ated by electrical stimulation of the DCN is thus possible. Only the IC recording sites for which
acoustically-evoked activity is recorded are considered for analysis of the electrically-generated
data.
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Figure 3.12: Multichannel recordings from the IC following acoustic stimulation at 1, 4, 8, 16
and 32 kHz shown for each of the seven rats. A shift in activity along the recording probe is
observed, from low site numbers at high frequency to high site numbers at low frequency.
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Figure 3.13: Correspondence between centroid of activity and CF is given by a logarithmic ﬁt
of the data obtained with acoustic stimulation for each rat.
3.4 Electrode array design
The thickness of the polyimide has to be small enough for the device to conform to the DCN
surface, which radius of curvature has been estimated to 1.65 mm[68]. The thickness hmax
at which the capillary forces are sufﬁcient for a thin ﬁlm of Young’s modulus E and Poisson
coefﬁcient ν to conform around a cylinder of radius R wetted by a liquid of surface tension γ
can be expressed with the formula: hmax = 3
√
R2 ·24(1−ν2)γ
E
[159]. For the values E = 3.2GPa
and ν= 0.34 for the polyimide thin ﬁlm and γ= 72 ·10−3 N/m for the surface tension of water,
hmax = 10.8μm. Following this calculation, a polyimide thickness of 8 μm is selected for in
vivo tests.
A ﬁnger-like design is used in order to further optimize the conformability of the array (Figure
3.14A and 3.15A). In the context of this application, one desired feature is a high density of
electrodes on the available 1-by-2 mm surface of the surgically exposed rat CN, in order to be
able to precisely tune the stimulation location. An electrode diameter of 100 μm is selected
for this purpose. Under these conditions, PEDOT:PSS with 75 mC/cm2 deposition charge
is selected for further testing. Indeed, the low thickness of the polyimide substrate induces
mechanically challenging conditions, and coatings with higher deposition charges tend to
crack and delaminate from the substrate. As mentioned in the previous chapter, selecting
a 0.6 μm thick coating provides a sufﬁcient mechanical stability without compromising the
electrochemical properties and the safety of stimulation. A plot of the complex impedance
spectrum of over 100 sites before and after coating with PEDOT:PSS at 75mC/cm2 shows
repeatability of PEDOT:PSS coating impedance characteristics (Figure 3.14B).
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For both array designs presented below, the stimulation electrode sites are characterized
by their position on the lateral-to-medial axis (x-axis of the coordinate system) and the caudal-
to-rostral axis (y-axis of the coordinate system), with the origin of the coordinate system at the
center of the array.
3.4.1 14-electrodes array with 200 μm spaced pairs
A 14-electrode array is speciﬁcally designed to test the effect of stimulation with close (200
μm distance) pairs. Seven pairs of electrodes are distributed on the whole CN surface with an
emphasis on the lateral-to-medial axis distribution. A center-to-center distance of 200 μm is
selected for these close pairs, and several other distances (400, 500, 640, 800, 1200 and 1600
μm) can be tested. A range of orientations of the pairs can also be tested with this array. All the
close pairs have an orientation of 90◦, but larger interelectrode distances have orientations of
0◦, ±14◦, ± 36◦, ± 51◦ and 90◦.
A B
L M
R
C
Figure 3.14: A) Picture of the 14-channels stimulation array. Lateral (L), medial (M), rostral (R)
and caudal (C) directions are indicated. B) Impedance modulus and phase spectra of bare Pt
and PEDOT:PSS coated electrodes (diameter = 100 μm). The small values of error bars for the
PEDOT:PSS coated electrodes demonstrate great repeatability of the coating.
One of the limitations with this design when trying to investigate the effect of distance and
orientation of the stimulation electrode pair is the impossibility to decorrelate one from the
other. Indeed, as mentioned before, all 200 μm distance pairs have an orientation of 90◦. For
higher distance pairs, two orientations can be tested : 400-412 μm are associated to orien-
tations of 90◦, or close to 0◦ (± 14◦). 500 μm are associated to orientations of ± 36◦. 640 μm
are associated to orientations of ± 51◦ (Table 3.1). Some information can thus already be
obtained by comparing groups of pairs with the same distance and different orientations,
but the dependence between the two variables to study, orientation and distance, makes any
statistical analyses complicated. Despite this limitations, this design is suitable to investigate
60
3.4. Electrode array design
whether such an array can generate signiﬁcant activation of the auditory system, and whether
200 μm distance pairs can generate tonotopically organized activity in the IC.
The second limitation of this array is the limited coverage of the DCN, particularly in the
corners. The pairwise organisation of electrode sites prevents a regular coverage of the surface
and the axes (with the exception of the lateromedial axis) are difﬁcult to characterize.
200 μm 400 μm 412 μm 500 μm 600 μm 640 μm 800 μm
-51.3° - - - - - 4 -
-36.8° - - - 8 - - -
-14° - - 4 - - - -
0° - - - - - - 4
14° - - 4 - - - -
36.8° - - - 8 - - -
51.3° - - - - - 4 -
90° 7 2 - - 4 - 2
Table 3.1: Number of tested electrode pairs for different stimulation conﬁgurations, described
by their orientation and by the distance between the two electrodes of the pair.
3.4.2 20-electrode array with hexagonal conﬁguration
A B
Tonotopic axis
DCN
AVCN
AN
12-27-15
7-9-15
10-28-15
7-1-15
1-3-16
Lateral Medial
400 μm distance
60˚ orientation
800 μm distance
0˚ orientation
-60˚ orientationL M
R
C
Figure 3.15: A) Photograph of the 20-channels stimulating electrode array. Lateral (L), medial
(M), rostral (R) and caudal (C) directions are indicated. B) Overlaid array schematics from
5 rats, pictured on a colored CN reconstruction (from Verma et al., 2014). Schematics are
positioned according to post-experiment histology.
A 20-electrodes array is developed to provide a regular coverage of the entire DCN surface and
study the independent effect of orientation and distance in a bipolar stimulation conﬁguration,
in comparison with monopolar stimulation. The array hosts 20 microelectrodes patterned in
a hexagonal conﬁguration, with 4 rows, each of 5 electrodes (Figure 3.15). The total surface of
the array is 1.1 mm by 1.9 mm. Each electrode’s diameter is 100 μm. Orientations of -60◦, 0◦
and 60◦ (with respect to the lateromedial axis) and interelectrode distances of 400 and 800
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μm can be studied independently, and linked to the position of the pairs on the surface of the
DCN.
3.4.3 Packaging for in vivo acute testing
Acute experiments require a speciﬁc packaging geometry with the following characteristics:
possible access from the outside of the animal’s head with a rigid shaft, at an orientation
of about 70◦ (elevation), and 45◦ (compared to lateromedial axis). The polyimide device is
composed of three sections. First, the connector section is located outside the skull where a
pin connector is glued, each pin corresponding to one electrode site. Then, the tracks link the
connector to the electrode array on the brainstem. This section is glued to a rigid shaft, in
order to allow easy manipulation during surgery. Lastly, the electrode array is designed at an
angle of 45◦ compared to the tracks, and a bending in the polyimide is induced (by thermal
bending or physical gluing to the shaft). The thermal bending is about 50◦, while the bending
by gluing on the shaft induces a larger bending of 70-90◦. Experiments showed that the latter
allows a greater ease of placement with no need to widen the opening in the skull of the animal.
In both case, the active part of the array is free-standing and can be positioned on the DCN
surface.
1 cm
Figure 3.16: Illustration of the packaging used for acute experiments in rats.
3.5 Electrically generated ABRs
3.5.1 eABRs parameters extraction
In this section, results following stimulation with the 20-electrode array (section 3.4.2) are
presented. Recorded eABRs averaged over the different repetitions are digitally ﬁltered with a
Butterworth bandpass ﬁlter of order 5, with cutoff frequencies of 20 Hz and 2 kHz. For each
run, the eABR threshold is visually determined as the ﬁrst stimulation level with visible peaks.
Labeling of eABR peaks is done manually, after observation of the general pattern of a large
number of recordings. Inspiration was taken from the peaks labeling of human eABRs, as
shown in[75]. Five main positive peaks are identiﬁed, with a range of latencies following the
pattern illustrated in Figure 3.17
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Following peak labeling, several parameters are extracted from the signals: latency and ampli-
tude of each peak (amplitude is deﬁned as the difference between a local maximum - a positive
peak, and the next local minimum - a negative peak), number of peaks, total amplitude and
RMS energy of the signal. For all parameters, the value at a stimulation level of 1 V above
thresold is used in the following analyses.
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Figure 3.17: Electrically-generated ABR following DCN surface bipolar stimulation showing
the ﬁve identiﬁed peaks and their respective latency ranges (shaded areas shown in black
(Peak I - 0.3 to 1 ms), blue (Peak II - 1 to 2 ms), dark green (Peak III - 1.5 to 3 ms), light green
(Peak IV - 2.5 to 4.5 ms) and yellow (Peak V - 4 to 6.5 ms).
Figure 3.18 shows examples of eABRs generated by bipolar stimulation pairs located at
different positions on the surface of the DCN. The ﬁrst observation is the presence of the
multipeaked waveform characteristic of the ABRs on most of the runs. Variations in general
pattern of the ABRs and in the properties of the individual peaks can be observed. Extraction
and analysis of the parameters will allow the study of the effect of stimulation conﬁguration
and location on eABRs parameters across all rats.
3.5.2 Effect of stimulation location on eABRs characteristics
The ﬁrst phase of the eABR analysis attempts to identify potential effects of the location
of stimulation on the different parameters. Figure 3.19A shows color-coded visualizations
of eABR threshold for each individual rat, and ﬁgure 3.19B shows three eABR parameters
following stimulation with all the neighbouring pairs of electrodes at the surface of the DCN
(averaged between the different rats). A strong effect of the stimulation pair rostrocaudal
position on the DCN surface is visible on the threshold, amplitude, number of peaks and RMS.
For this reason, the more detailed analysis on the individual peaks properties focuses on the
effect of location on the rostrocaudal axis.
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Figure 3.18: Electrically-evoked auditory brainstem responses (eABRs) for CN electrical stim-
ulation in 7 rats. Top: Five bipolar pairs of stimulating electrodes (red) located at various
positions on the DCN surface. Bottom: Responses to the ﬁve bipolar pairs in seven rats
following 4 V stimulation.
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Figure 3.19: Effect of stimulation position on eABRs. A) Variations of eABR threshold with
cochlear nucleus lateromedial and rostrocaudal position, for each rat. B) Variations with
cochlear nucleus lateromedial and rostrocaudal position of the eABR, number of peaks, total
amplitude and RMS, averaged over the 6 rats. C) Left: Effect of rostrocaudal position of stimu-
lation on the fraction of runs presenting each individual peak. Right: Effect of rostrocaudal
position of stimulation on the average number of peaks in the generated eABR. D-E) Effect of
rostrocaudal position of stimulation on the amplitude (D) and the latency (E) of the ﬁrst four
peaks of the eABR.
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The analysis of the presence of peaks 1 to 5 as a function of rostrocaudal position (Figure
3.19B) shows that the percentages of presence of peaks 2 and 4 are signiﬁcantly higher at
rostral locations (mult.lin.reg, N=6, p < 0.05). P3 however shows an opposite effect, with higher
percentage of presence on caudal locations (mult.lin.reg, N=6, p < 0.05). No rostrocaudal effect
was identiﬁed on P1 and P5 (mult.lin.reg, N=6, p > 0.05). The effect of rostrocaudal location on
the number of peaks is statistically signiﬁcant (mult.lin.reg, N=6, p < 0.05, Figure 3.19C).
Rostrocaudal effects on the individual peaks amplitudes and latencies are also identiﬁed.
The amplitude of several peaks (P1-P4) is signiﬁcantly larger at rostral locations (mult.lin.reg,
N=6, p < 0.05 for P1-P4, Figure 3.19D). The latency of P2 is signiﬁcantly larger on rostral
locations, and the latency of P4 shows an opposite effect, with larger values at caudal locations
(mult.lin.reg, N=6, p < 0.05 in both cases).
None of the mentioned parameters (eABR amplitude, number of peaks, threshold, RMS
or peaks presence, latency and amplitude) show any signiﬁcant effect of lateromedial position
of the stimulation pair (mult.lin.reg, N=6, p > 0.05 in all cases), conﬁrming that the rostro-
caudal axis is the main axis of variations of recorded eABRs. The absence of lateromedial
effect, particularly on the threshold of activation, is a very important effect as it shows a similar
efﬁciency of stimulation along the longest dimension of the array. This is very likely associated
to a close contact between the array and the underlying DCN, a property due to the ﬂexibility
of the electrode array.
3.5.3 Effect of stimulation pair conﬁguration on eABRs characteristics
With the tested electrode array design, the orientations of the pairs are correlated with their
rostrocaudal locations. Speciﬁcally, all pairs at the most rostral and the most caudal locations
(± 520 μm) are oriented along the lateromedial axis. Considering the important rostrocaudal
effect on eABR parameters highlighted in the previous section, an independent study of the
effect of electrode pair orientation cannot be achieved. For this reason, only the effect of
distance between the two elecrodes of a stimulation pairs is investigated here.
The percentage of eABR presenting each peak for the two different distances (Figure 3.20A)
shows that P2-P5 are present more often with an interelectrode distance of 800 μm compared
to 400 μm. This difference is signiﬁcant for P2 (mult.lin.reg, N=6, p < 0.05), but does not reach
signiﬁcance for P3, P4 and P5 (mult.lin.reg, N=6, p > 0.05 in the three cases). The total number
of peaks is also signiﬁcantly larger with the larger distance (mult.lin.reg, N=6, p < 0.05; Figure
3.20B).
The study of the amplitude of individual peaks shows that all 5 peaks have slightly larger
amplitudes with 800 μm distance compared to 400 μm. However, the signiﬁcance is not
reached in any of the peaks, or in the RMS energy of the signal (mult.lin.reg, N=6, p > 0.05 in
all cases; Figure 3.20C-D).
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Figure 3.20: Effect of inter electrode distance on the fraction of runs presenting each peak (A),
the number of peaks of the eABR (B), the amplitude of each peak (C) and the eABR RMS (D).
Signiﬁcant differences between the two distances are indicated with a star.
3.5.4 Comparison between monopolar and bipolar stimulation
When comparing eABRs generated by monopolar and bipolar stimulation, the ﬁrst element
that needs to be considered is the large stimulation artefact generated by monopolar stimu-
lation (Figure 3.21A), which may also be partly myogenic activity. The two examples shown
here are representative of this effect consistently present across all rats. This artefact contami-
nates P1 and also possibly P2, making the analysis of early peaks amplitude and latency very
challenging. Analysis of properties of the later peaks and of the presence of the different peaks
can however still be relevant for the comparison of monopolar and bipolar stimulation.
The latencies of P1-P4 present a signiﬁcant difference between monopolar and bipolar stim-
ulation. Monopolar stimulation induces earlier P1, P2 and P4, but later P3 than bipolar
stimulation (mult.lin.reg, N=6, p < 0.05 in all 4 cases; Figure 3.21B). The amplitude of P4 is
larger following monopolar stimulation than bipolar stimulation (mult.lin.reg., N=6, p < 0.05;
Figure 3.21C).
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The percentage of eABRs presenting each individual peak also shows differences between
monopolar and bipolar stimulation, with P2 and P4 being more often present following
monopolar stimulation than bipolar stimulation (mult.lin.reg., N=6, p < 0.05 in both cases;
Figure 3.21D). This difference is also reﬂected in the number of peaks, with signiﬁcantly more
peaks present after monopolar stimulation than bipolar stimulation (mult.lin.reg., N=6, p <
0.05; Figure 3.21E). These results highlight differences in the pattern of generated eABRs with
monopolar and bipolar stimulation.
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Figure 3.21: A) Examples of eABRs generated with two bipolar pairs and their corresponding
monopolar stimulation sites (ﬁrst line is from rat 10, second line is from rat 8). B-E) Compari-
son of monopolar and bipolar stimulation on the following eABR parameters: the latency of
each peak (B), the amplitude of each peak (C), the percentage of eABRs presenting each peak
(D) and the average number of peaks (E).
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3.5.5 Discussion
Several effects are identiﬁed on the parameters of the eABRs generated by electrical stimula-
tion of the DCN surface. Stimulation with bipolar pairs with 800 μm distance generate eABRs
with a larger number of peaks than 400 μm distance. Monopolar stimulation generates larger
stimulation artefacts than bipolar stimulation, but also eABRs with a larger number of peaks.
Larger eABR peak amplitudes and number of peaks are also obtained following stimulation at
rostral DCN locations .
The larger eABRs generated at 800 μm interelectrode distances and monopolar stimulation
might correspond to a larger volume of activation, compared to bipolar stimulation with close
pairs. The increase in number of peaks however raises more questions, because the peaks
are thought to be generated by speciﬁc structures of the auditory system, suggesting that the
stimulated pathways are different. In acoustically-generated ABRs in rats, ﬁve different waves
can usually be identiﬁed, wave II being the most reliable wave and presenting the largest
amplitude. It is generally accepted that the waves I to V are mainly generated by sequential
activation of neurons in the auditory nerve (I), the CN (II and III), the superior olive (SO, IV),
the lateral lemniscus (LL, V), and the IC (V)[7,72,130,156].
It is difﬁcult to match the identiﬁed peaks from the eABRs to the generally accepted pat-
tern of acoustically-generated ABR waves. One hypothesis can be based on the fact that in the
recorded data, peak 2 has the largest amplitude and is followed by peak 3, that has the smallest
amplitude. P2 and P3 of the eABRs would then correspond to waves II and III of aABRs in rats.
The presence of peak 1 is then a question, since the auditory nerve is supposed to be bypassed.
In these recordings however, its presence is close to 100%. It might correspond to local activa-
tion of the CN, while peak 2 might be activation of the whole cochlear nucleus complex. This
hypothesis is supported by the fact that P2 presence and amplitude are much higher at rostral
DCN positions, close to the AVCN, so in a better position to stimulate bushy cells, a neuronal
type that is hypothesized to be important for ABR generation[130]. The potential correlation of
the later waves of the eABRs to IC activity might provide more information on the origin of the
eABR peaks.
One hypothesis for the increased number of peaks at rostral locations, with larger inter-
electrode distances or with monopolar stimulation is that these types of stimulation more
efﬁciently stimulate the bushy cells, and activate a different pathway (VCN-SO-LL-IC pathway)
than the direct DCN-IC pathway activated by local stimulation (Figure 3.2), thus generating
more peaks. It is then not excluded that the wave corresponding to IC activity varies depending
on the pathway that is primarily activated.
Even if speciﬁc conclusions on the stimulated neural populations that generate the recorded
eABRs might be difﬁcult to reach, the fact that multipeaked eABRs are generated in most cases
is important to consider in a clinical context, as eABR recordings are used intraoperatively as a
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guide for the correct positioning of the ABIs. As the ABI is tentatively positioned on the CN
surface, stimulation is induced with different pairs across the array, and eABRs are recorded. If
one side of the array does not generate any eABRs, its position can be corrected by the surgeon.
However, although this technique is very useful, the link between eABRs presence and auditory
sensations generated by a given electrode site is not direct. There is some suggestion that
auditory sensations can be better predicted by the presence of a certain peak in the eABR,
rather than by the presence of the eABR itself [75]. In this context, investigating the link between
the eABR parameters and the properties of the direct multiunit recordings from the inferior
colliculus is thus clinically relevant.
3.6 IC response maps post-processing
3.6.1 IC response maps characterization
IC maps and PSTH characteristics
In this section, results following stimulation with the 20-electrode array (section 3.4.2) are
presented. Electrical stimulation using 400 μm spaced bipolar pairs of the array evokes activity
in the IC. These responses are signiﬁcantly larger than spontaneous activity (t-test, N=30
repetitions, see methods for details) in the great majority of runs (372 out of 398, across all
rats and conditions (93.5%)). Activity following each single pulse spans about 20-30 ms after
stimulus onset, with a pattern that varies between runs and IC recording sites.
In most cases, the activity is composed of two speciﬁc phases, a ﬁrst phase with one or
several bursts of sharp, time-aligned spikes, followed by a phase with a wider, longer-lasting
activity (Figure 3.27, on page 78). The average spike rate over the 30 ms time period after
stimulus is calculated and color-coded, for each IC recording site and stimulation current
level, to generate the IC response maps (Figure 3.22).
Example IC response maps in response to stimulation with 5 electrode pairs illustrate the
variety of observed patterns across and within animals (Figure 3.22 shows results for the 7
individual rats). For example, Rat 1 has broad activity and high spike rates in response to most
of the 5 stimulation pairs, whereas Rat 6 has narrow activity with moderate spike rates. Within
a single rat, responses to different pairs can be broad or narrow (e.g., Rat 3). There are some
differences across rats in the evoked spike rates (100 – 400 spikes/s) in response to the highest
stimulation level (4 V). The pattern of thresholds across the DCN (Fig. 3.24) was in some
cases remarkably even (Rats 1-3), and in others there were “clumps” of electrodes with low
thresholds with increased thresholds elsewhere (Rats 5, 6). Electrode pairs with the highest
thresholds or no responses were almost always located on the rostral (Rats 5, 6, 7) or medial (1,
2, 3) edges of the array, indicating that they might be located outside the DCN surface.
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Figure 3.22: Top: Five bipolar pairs of electrodes (red) stimulating different locations on the
DCN surface. Rostal (R), caudal (C), lateral (L) and medial (M) directions are indicated. Bottom:
Responses to the ﬁve bipolar pairs in seven rats. Responses are ﬁring rates (color scales) as a
function of stimulation current plotted at each of the 16 IC recording sites.
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Tonotopic organisation
The stimulating electrode pair position was varied in the ventrolateral-to-dorsomedial di-
mension (simpliﬁed as ’lateromedial’), the tonotopic axis of the DCN[141,192,200] and along the
rostrocaudal dimension, although that dimension has shorter distances across the DCN and
array. For each stimulation pair, the centroid ismeasured from the IC responsemaps (Fig. 3.11,
Methods). The CF of that recording site, as determined from acoustic responses, is plotted as a
function of lateromedial and rostrocaudal position (Figure 3.23). The correlation between the
CF and the stimulation pair position along the lateromedial and rostrocaudal dimensions are
determined with multiple regression (Table 3.2). The CFs are positively correlated with the
pair’s lateromedial positions in 4/7 rats (2, 3, 4 and 5) and with the rostrocaudal position in
6/7 rats (1 to 6), as indicated by p-values smaller than 0.05. In the multiple regression analysis,
the factor of interaction between lateromedial and rostrocaudal position is signiﬁcant in rat 1
(Table 3.2). In the other cases, correlations are not signiﬁcant (p > 0.05). In most cases, CFs
span the middle part of the rat hearing range, with no access to the low frequencies (1-10 kHz),
and very low access to the high frequencies (>32 kHz).
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Figure 3.23: Characteristic frequencies (CFs) as a function lateromedial (A) and rostrocaudal
(B) dimensions for all DCN stimulation bipolar pairs.
Intensity parameters
Variations of the intensity parameters (best threshold, normalized spike rate and width) for
individual rats are shown in Fig. 3.24. The correlation between the intensity parameters
and the stimulation pair position along the lateromedial and rostrocaudal dimensions are
determined with multiple regression (Table 3.2). The correlation between the best threshold
and
at lateral positions (p < 0.05 in both cases), but not for the 5 other rats (p > 0.05). For rats 4 to
7, the best threshold is signiﬁcantly correlated to the rostrocaudal positions (p < 0.05 in all 4
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cases), with larger threshold at rostral sites.
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Figure 3.24: IC map parameters variations over the DCN surface for each individual rat. Color-
coded values of best threshold (A), normalized spike count (B) and width of activation (C) for
all tested pairs of stimulation on the CN surface, for each of the seven rats.
Spike counts are signiﬁcantly correlated with lateromedial and rostrocaudal positions in all
rats (p < 0.05 in all cases), with maximal values on the medial-caudal corner. Width of ac-
tivation is signiﬁcantly correlated to lateromedial position in rats 5 and 7 (p < 0.05 in both
cases), with a lower width on the lateral part of the implant. Width has signiﬁcant rostrocaudal
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dependence for 6/7 rats (all except 4, p < 0.05 in the 6 cases), with narrower width on the
rostral side of the implant.
These analyses show primarily a rostrocaudal effect on the intensity of activation, present in
most rats. Stimulation at rostral locations generates activity with lower spike counts, lower
widths and higher thresholds than stimulation at caudal locations. Rostral locations are also
associated to higher CFs. Overall, the parameters are more stable along the lateromedial
dimension, the long dimension of the array. Particularly, 6/7 rats show threshold variations of
at most 1 voltage step along the lateromedial dimension (when considering the pairs located
centrally, between -200 and 200μ, along the rostrocaudal axis). This might be resulting from a
good contact of the array along the lateromedial axis, a clear advantage of using a conformable
array.
CF LM CF RC CF int W LM W RC W int
1 0.218 3.9e-3 1e-4 0.102 7.7e-3 5.7e-3
2 3.1e-3 2.1e-3 0.092 0.060 5.6e-3 0.079
3 0.029 9e-8 0.752 0.281 1.2e-7 0.060
4 1.7e-5 0.023 0.073 0.308 0.661 7.5e-3
5 8.9e-5 1.4e-8 0.102 5.5e-4 1.2e-8 0.368
6 0.079 8.8e-8 0.647 0.461 2.3e-6 0.809
7 0.144 0.155 0.564 3.9e-4 0.030 0.382
T LM T RC T int N LM N RC N int
1 0.505 0.382 0.015 1.4e-5 0.034 0.030
2 0.543 0.174 0.550 0.010 0.024 5.8e-3
3 0.078 0.316 0.202 0.021 1.6e-4 0.833
4 0.220 0.021 0.478 1.4e-4 3.7e-5 0.065
5 3.8e-3 3.5e-6 0.750 1.4e-9 2.2e-13 2.0e-3
6 2.3e-3 2.6e-3 0.920 5.2e-9 5.6e-22 1.9e-3
7 0.536 4.1e-3 0.027 4.1e-8 1.4e-7 1.2e-4
Table 3.2: P-values of the statistical tests of single rats
p-values of the multiple regression analyses of characteristic frequency (CF), width (W), best
threshold (T) and spike count (N) for each single rat. For each test, the p-value for the
lateromedial (LM) and rostrocaudal (RC) position factors, as well as for the interaction factor
are shown. Signiﬁcant values (p < 0.05) are shown in blue.
3.6.2 Location-speciﬁc activity
Average subtraction
This section presents a processing strategy that reﬁnes the response maps by subtracting their
average activity. This strategy was employed because IC response maps from electrode pairs
located at different lateral-to-medial positions show a common pattern of activity with similar
CFs. Subtraction of this common pattern might highlight location-speciﬁc components that
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are present but masked in the raw IC response maps. The average activity, calculated by
averaging all IC response maps with signiﬁcant activity for each rat, was subtracted from each
individual responsemap. Averages of allmaps (for each rat) hadCFs of 22.4 ± 1.5 kHz andwidth
of activations of 6.4 ± 0.3 recording sites. In the example shown here (Fig. 3.25A), the two IC
response maps show stronger pattern variations after average subtraction than in the raw data.
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Figure 3.25: Subtraction of average activity reveals tonotopic shift of CF. A) Top: Two bipolar
pairs of stimulating electrodes (red) chosen because they differ in lateromedial position along
the DCN’s tonotopic axis. In response to these stimulating pairs, the color plots show the raw
response maps and the maps after subtraction of the average activity. CFs for all electrode
pairs are plotted in the matrices on the right, with color-coded segments (see scales) between
the two electrodes of each pair, across the DCN’s lateromedial (x axis) and rostrocaudal (y
axis) dimensions. Some maps with raw activity below average show no remaining activity
after average subtraction (grey segments). B) Color-coded matrices of CFs (left) before (top)
and after (bottom) subtraction of average activity, averaged across all rats. The preferred
orientations of the CF shift are indicated by the dotted lines. Plot of CF (middle) before
and after average subtraction and for all pairs and their lateromedial position. Plot of width
of activation (right) before and after average subtraction for all pairs and their lateromedial
position. Shaded areas are calculated with the regression of the top and bottom of the standard
errors.
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Tonotopic organisation before and after average subtraction
After average map subtraction, the response CF of individual maps is positively correlated with
the electrode pair position along the lateromedial axis in 5/7 rats (vs. 4/7 before subtraction,
multiple linear regression, p < 0.05 in 5 signiﬁcant cases). Multiple regression analyses with
the data from the 7 rats demonstrate signiﬁcant interactions between before vs. after average
subtraction and the lateromedial coordinate (p < 0.05 for the interaction factor, N=7). Such
interaction resulted in a greater range of CFs after average subtraction than for the raw data. In
one example (Fig 3.25A), the range of CFs found in the IC was larger after average subtraction
(8.1 to 51.4 kHz, 2.67 octaves) compared to the raw data (12 to 31.6 kHz, 1.4 octaves). Data
from all subjects (Fig. 3.25B, middle panel) after average subtraction also showed a greater
range of CFs (8.4 to 49.9 kHz, 2.57 octaves) compared before average subtraction (17.2 to
35.3 kHz, 1.04 octaves). We deﬁne a vector across the DCN characterizing the orientation of
the CF variations. The orientation of this vector, the “CF shift orientation” is determined by
performing a linear regression of corresponding CF values of IC responses according to the
electrode pair position along the lateromedial and rostrocaudal axes of the DCN (Fig. 3.25B,
left panels). The orientation is 68° for the raw data, and 51° after average subtraction, with
respect to the lateromedial axis.
Intensity parameters before and after average subtraction
The width of activation is on average lower after subtraction of the average activity than in raw
data (multiple linear regression, N=7 rats, p < 0.05), showing higher frequency selectivity in
the IC (Figure 3.25B, right panel and 3.26C). These ﬁndings suggest that the common activity
is widespread, because the subtraction of the average map results in more frequency-speciﬁc,
narrower widths of activation. In addition, the width of activation shows a signiﬁcant corre-
lation with the lateromedial position of the stimulating electrode after average subtraction
(multiple linear regression, N=7, p < 0.05).
After subtraction of average activity, best thresholds are on average higher and spike counts
are lower than in raw data (multiple linear regression, N=7, p < 0.05 in both cases; Figure
3.26A-B). The analysis of these parameters shows a lower intensity of the activity after average
subtraction than in the raw data, consistent with the fact that the location-speciﬁc represents
a subset of the raw activity.
3.6.3 Early and late phases of activity
Separation between early and late spikes
This section presents a processing strategy that reﬁnes the response map by segregating the
responses into two temporal windows. This strategy is employed because the responses,
as measured by poststimulus time histograms (PSTHs), show an early phase with a sharp,
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time-aligned pattern and a later phase with a wider, longer-lasting pattern (Fig. 3.27).
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Figure 3.26: Average IC map parameters variations over the CN surface following different
processing types. Color-coded values of threshold (A), normalized spike count (B) and width
of activation (C) for all tested pairs of stimulation on the CN surface. Bottom: Average over
surface and standard errors of the same parameters, for each processing type.
Despite the consistency of this pattern, the limit between the early and late phases is variable
across runs between and within animals. An automatization of the limit determination is
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excluded because of this variability, so the limit is individually ﬁxed for each run and each IC
recording site. This limit is determined at the transition between the early and late phases,
knowing that in most cases some minimal overlap is present.
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Figure 3.27: Post-stimulus time histograms (PSTH) from IC recording sites for various stim-
ulation pairs for the seven rats. Cutoff time between early and late activity are indicated by
the red arrows. Columns 1 and 2 show typical patterns of response with early and late activity
clearly discernable. Column 3 shows examples of PSTHs with strong early activity, and weak
or absent Gaussian-shaped late activity. Column 4 shown examples of PSTHs with weak or
absent early activity.
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Average cutoff times across all runs and IC recording sites in each of the 11 rats ranged from
6.91 to 7.39 ms post stimulus. A signiﬁcant effect of the IC recording site on the cutoff time
was observed in 3 rats out of 11 (one-way Anova, N=55 runs, p < 0.05 in these 3 cases), with
low IC recording site numbers (high acoustic frequencies) having earlier cutoffs than high
IC recording site numbers (low acoustic frequencies). The maximal difference in cutoff time
across all recording sites for a single rat was 0.81 ms. For the remaining 8 rats, no effect of the
IC recording site was obtained (one-way Anova, N=55, p > 0.05 in the 8 cases).
Timing properties of the early phase of activity
Figure 3.28 shows post-stimulus time histograms (PSTH) of early phase of responses of ﬁve
different IC recording sites, following stimulation with ﬁve different pairs at the surface of the
DCN. Responses have a variety of shapes and timings, but are most often organised in one or
several time-aligned bursts of spikes.
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Figure 3.28: PSTHs of the early phase of response of ﬁve IC recording sites following DCN
surface stimulation with ﬁve different stimulation pairs (from rat 3).
In the example shown here, shallow IC recording sites (corresponding to low CFs) have weaker
responses than deep IC recording sites (corresponding to high CFs). In addition, the stimu-
lation pair located on the rostro-medial edge of the array generates very weak activity. The
responses thus show a dependence on the IC recording site, as well as on the stimulation
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location.
Timing properties of the late phase of activity
The timing of the late, gaussian-shaped activity is analyzed by extracting the time centroid
of this activity (Figure 3.29A). This parameter is extracted for each run at each level and IC
recording site, and the values at a stimulation level 1 V higher than threshold are considered
for further analysis.
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Figure 3.29: A: PSTH showing the early and late activity, and the measured time centroid of
the late activity. B: Time centroid of late activity along the 16 IC recording sites, following
DCN surface stimulation at different lateromedial positions. Maximal and minimal values of
time centroid are shown with a black circle. C-D: Same data as B plotted as a function of DCN
lateromedial coordinate for different IC recording sites (C), and as a function of IC recording
site for different lateromedial positions (D). Signiﬁcant differences between the IC recording
sites (C) or DCN stimulation lateromedial positions (D) (multiple linear regression, p < 0.05)
are indicated with a star.
The time centroid of activity following DCN surface stimulation at different locations along
the lateromedial axis and recorded from all IC recording sites is color-coded and displayed
on Figure 3.29B. The activity is occuring later at shallow IC locations, corresponding to low
frequency ﬁbers activity, than at deep IC locations, corresponding to high frequency ﬁber
activity, for all lateromedial stimulation locations (multiple linear regression, N=7, p < 0.05 for
the IC recording site factor in all cases). Figure 3.29C shows the time centroid values for 6 IC
recording sites at all lateromedial locations. The increase in time centroid with IC recording
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site is signiﬁcant for all lateromedial positions, indicated with a star.
The second effect is highlighted in Figure 3.29D, showing the time centroid variations with IC
recording site number for all lateromedial locations. It shows that at low IC recording sites
(high frequencies), the time centroid is smaller for medial stimulation sites (high frequencies)
than for lateral stimulation sites. This effect is signiﬁcant for IC recording site 4 (multiple
linear regression, N=7, p < 0.05 for the lateromedial position effect, for the IC recording site 4).
On the other hand, for high IC recording site numbers (low frequencies), the time centroid is
lower for lateral stimulation locations (low frequencies) than for medial stimulation locations.
Signiﬁcance is reached for IC recording sites 7,8,9,10,11 and 13 (multiple linear regression,
N=7, p < 0.05 for the lateromedial position effect, for the IC recording sites 7-10 and 12).
Overall, it means that the time centroid of late activity is minimal when the characteristic
frequency of the IC recording site matches that of the stimulation location on the DCN.
These results mean that IC neurons with low characteristic frequency respond slower than IC
neurons with high characteristic frequency. This might be because of different speeds of ﬁbers,
or because they are activated in different ways, direct or indirect. The small lateromedial
location dependence effect can be linked to the small lateromedial location dependence of
other studied parameters in the late activity (CF, width...), described in the next section. This
conﬁrms that the great majority of activity in the late phase of responses is likely not location
speciﬁc.
Tonotopic organisation of the early and late phases of response
Compared to the late phase of response, the early phase shows more correlation of response
CF with the electrode pair position along the lateromedial axis (positive correlation in 7/7
rats vs. 4/7 rats in the late phase of response, multiple linear regression, p < 0.05 in all cases).
Considering data from one rat (Fig. 3.30A, left), the range of CF shift is greater than seen
with the late phase of response (8.1 to 51.4 kHz, 2.66 octaves vs. 14 to 36.1 kHz, 1.37 octaves).
Considering all seven rats (Fig. 3.30B), the early phase of response shows an access to the
mid-frequency range (15.3 to 35.8 kHz, 1.23 octaves), only slightly larger than the range of CFs
accessed in the late phase of responses (17.2 to 35.1 kHz, 1.03 octaves). However, the early and
late phases of response vary dramatically in their CF shift orientation (4° orientation for the
early phase of responses and 76° orientation for the late phase of responses). There is a larger
CF change with lateromedial position for the early vs. the late phase of response (Fig. 3.30B,
middle panel; mult.lin.reg, N=7, p < 0.05 for the interaction between latency and position).
The late phase of responses shows a pattern that is very close to the raw data, both in the range
of accessed CFs (17.2 to 35.1 kHz vs 17.2 to 35.3 kHz, 1.03 vs 1.04 octaves) and in the CF shift
orientation (76° vs 68°).
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Figure 3.30: Tonotopic shift of CF in early and late phases of response. A) Top: Two bipolar
pairs of stimulating electrodes (red) chosen because they differ in lateromedial position along
the DCN’s tonotopic axis. In response to these stimulating pairs, the color plots show the
response maps of early and late phases of activity. CFs for all electrode pairs are plotted in the
matrices on the right, with color-coded segments (see scales) between the two electrodes of
each pair, across the DCN’s lateromedial (x axis) and rostrocaudal (y axis) dimensions. Some
maps show no signiﬁcant activity (grey segments). B) Color-coded matrices of CFs (left) in
the early (top) and late (bottom) phases of activity, averaged across all rats. The preferred
orientations of the CF shift are indicated by the dotted lines. Plot of CF (middle) for the early
and late phases of response, for all pairs and their lateromedial position. Plot of width of
activation (right) for the early and late phases of response, for all pairs and their lateromedial
position. Shaded areas are calculated with the regression of the top and bottom of the standard
errors.
Intensity parameters of the early and late phases of response
In the early phase of responses, the width of activation is signiﬁcantly correlated with the ros-
trocaudal location of stimulation, with lower values on the rostral side of the array (mult.lin.reg,
N=7, p < 0.05 for the rostrocaudal location factor). Multiple linear regression analysis of the
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normalized spike count shows a signiﬁcant effect of the lateromedial position, the rostro-
caudal position as well as a signiﬁcant interaction factor between the two (p < 0.05 for all 3
factors). The highest spike counts are observed at the medial-caudal corner of the array. The
best threshold of activation does not show any signiﬁcant correlation with the position of
the stimulation pair (Figure 3.26, page 77) (mult.lin.reg, p > 0.05 for the lateromedial and
rostrocaudal position factors, and for the interaction factor).
In the late time window, the width of activation is signiﬁcantly correlated with the rostrocaudal
location of stimulation, with lower values on the rostral side of the array, similarly to the
early phase of responses (mult.lin.reg, N=7, p < 0.05 for the rostrocaudal position factor). The
normalized spike count also shows a similar behavior than in the early phase of responses,
with all three factors of the multiple regression analysis being signiﬁcant (N=7, p < 0.05 for the
lateromedial and rostrocaudal position and their interaction). The best threshold however
shows a different behavior than in the early time window and is signiﬁcantly correlated to the
rostrocaudal position of stimulation, with larger threshold values on the rostral part of the
array (mult.lin.reg, N=7, p < 0.05 for the rostrocaudal position factor).
In the comparison of both phases of responses, the width of activation is signiﬁcantly lower
for the early phase compared to the late phase of responses (Figure 3.26 and 3.30B, right;
mult.lin.reg, N=7, p < 0.05), showing a higher frequency selectivity in the IC. Both phases
show no signiﬁcant dependence on lateromedial position (mult.lin.reg, N=7, p > 0.05 for the
lateromedial position factor in both cases). In the early phase of responses, the best threshold
of activation is signiﬁcantly higher than in the late phase of responses and the normalized
spike count is signiﬁcantly lower (mult.lin.reg, N=7, p < 0.05 in both cases).
3.6.4 Combined processing - average subtraction on the early phase of activity
Why combine both types of processing?
Previous analyses show that average subtraction and extraction of the early phase of response
isolates activity with different properties from all the IC recorded spikes. Location-speciﬁc
spikes obtained after average subtraction show a large range of CFs over the surface, but an
orientation of the CF shift that does not match the underlying DCN tonotopic organisation.
Spikes recorded in the early phase of activity show a CF shift over the array surface that is in
the same orientation as the DCN tonotopic organisation. The range of CFs obtained by stimu-
lating at different locations on the surface is however smaller. In addition, both processings
generate a lower width of activation in the IC than raw data and late phase of responses.
Here, we propose a combination of the two processing strategies, namely subtraction of
the average map of the early phases of responses. If the early phase of responses consists
of a mix between location-speciﬁc and general activity, this combined strategy will allow an
extraction of the location-speciﬁc spikes within the early phase of activity that might show a
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tonotopic organisation closely matching that of the DCN.
Tonotopic organisation after combined processing
After a combined processing strategy that subtracts the average IC response map of only the
early phase of response, there was better correlation of the response CF with the electrode pair
position (now in 5/7 rats vs. 4/7 rats before, mult.lin.reg, p < 0.05 for 5 signiﬁcant cases). The
correlation between the CF and the lateromedial position is signiﬁcantly different between
the combined processing and each individual processing (Fig. 3.31A, mult.lin.reg, p < 0.05
for the interaction between the lateromedial position and the processing type in both cases).
The range of CFs obtained across the DCN, 8.34 to 39.4 kHz (2.24 octaves), is larger than for
the early phase of response, 15.3 to 35.8 kHz (1.23 octaves), but slightly smaller than for the
average subtraction, 8.4 to 49.9 kHz (2.57 octaves). The preferred orientation of the CF shift is
12° (Fig. 5A, inset), close to the CF shift orientation obtained with the early phase of response
(4°) but very different than raw data (68°) and average subtraction (51°).
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Figure 3.31: A) Plot of CF after extraction of the early phase of responses, after subtraction of the
average activity, and after both processing types combined for all pairs and their lateromedial
position. Inset: Color-coded matrices of CFs after extraction of early activity and subtraction
of average activity. B) Plot of width of activation for the same processing types as in A for all
pairs and their lateromedial position.
Intensity parameters after combined processing
The width of activation after combined processing is narrower than after each individual
processing (mult.lin.reg, N=7, p < 0.05 in both cases), conﬁrming that this processing extracts
the spikes with the most frequency speciﬁc activation in the IC. After combined processing, it
is signiﬁcantly correlated to the lateromedial and the rostrocaudal positions of the stimula-
tion pair (mult.lin.reg, N=7, p < 0.05 for the lateromedial and rostrocaudal position factors).
The best threshold of activation after combined processing is signiﬁcantly higher than after
average subtraction (mult.lin.reg., N=7, p < 0.05), but similar to the early phase of responses
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(mult.lin.reg., N=7, p > 0.05). Similarly to the early phase of responses, the best threshold
after combined processing is not signiﬁcantly correlated to the position of the stimulation
pair (mult.lin.reg., N=7, p > 0.05 for the lateromedial and rostrocaudal position factors). The
normalized spike count is signiﬁcantly lower than after both individual processing types
(mult.lin.reg., N=7, p < 0.05 in both cases), and corresponds to a small portion of the total
generated spikes. It is correlated to both the lateromedial and the rostrocaudal positions
of stimulation (mult.lin.reg., N=7, p < 0.05 for the lateromedial and rostrocaudal position
factors).
3.6.5 Synthesis
The different processing strategies presented are tools to better understand the different com-
ponents of the multiunit activity generated in the IC following electrical stimulation of the
DCN surface. The structures that are stimulated are likely to be a mix between wide and narrow
frequency tuned neurons, ﬁbers of passage and neuronal somata, fast and slow conducting
axons, and monosynaptic and polysynaptic pathways. Thus, extracting location-speciﬁc
activity, and discriminating between the early and late phase of responses depending on the
timing pattern of activity generated in the IC allows the extraction of different components of
this response.
The comparison of early and late time windows is particularly interesting to consider in
this respect, as it shows that both phases of responses have different patterns of activation and
tonotopic organisations. Particularly, the early phase of responses consists of one or several
short, time-aligned bursts of spikes starting as early as 1-2 ms after stimulus, and having a
lateromedial tonotopic organisation covering part of the rat hearing range. The late phase
of responses shows a very different pattern with wider activity and a larger number of spikes
spanning a longer time interval, with a rostrocaudal range of CFs. The time centroid of activity
shows mainly a dependence on the IC recording site, and only minimally on the lateromedial
location of stimulation. These different behaviors suggest that the two phases of responses
might be generated by the activation of different neuronal populations. This will be further
discussed in the general discussion of this chapter.
One of the main interests of this study is the quantiﬁcation of the access to the tonotopic axis
of the DCN: what is the range of frequencies that can be accessed, what is the width of activity
in the IC? It is known that the tonotopic axis of the DCN follows a lateromedial orientation,
and this information is used as a guide during analysis. Overall, combining both strategies
allows a maximization of the range of CFs and a minimization of the width of activation in the
IC, with a (close to) lateromedial orientation of the CF shift. Because of these properties, it
is hypothesized that the extracted spikes following combined analysis are generated by the
frequency-tuned neurons along the lateromedial tonotopic axis of the DCN. For these reasons,
this combined processing strategy is used in sections 3.8 and 3.9, where the effects of different
stimulation parameters and stimulation electrodes conﬁgurations on the access to tonotopy
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are investigated.
3.7 Effect of stimulation level
3.7.1 Characteristic frequency
The effect of increasing stimulation level on the characteristic frequency of IC response maps
is shown on ﬁgure 3.32A, for the different types of processing presented earlier. The general
observed effect is a decrease in CF at increasing stimulation level. In the raw data and the late
phase of responses, this effect is signiﬁcant at nearly all lateromedial locations (mult.lin.reg,
N=7, p < 0.05). In the types of processing that were shown to extract spikes with better
tonotopic organisation however (average subtraction, early phase of responses and combined
processing), the decrease is signiﬁcant only at some medial locations (indicated with a star on
ﬁgure 3.32A) but not at lateral locations.
3.7.2 Intensity parameters
The width of IC activity (Figure 3.32B) signiﬁcantly increases with stimulation level for all
types of processing (mult.lin.reg, N=7, p < 0.05), following a close to logarithmic increase. A
higher saturation level might be reached in the early phase of responses than in the other
types of processing, and the corresponding curve shows a close to linear increase in width
with stimulation level.
It is interesting to notice here that the average subtraction has a greater effect at high stimula-
tion levels than at low stimulation levels on the width. Indeed, the width obtained with raw
data and average subtraction is similar at threshold, and higher for raw data at higher levels.
The width obtained in the early phase of responses and with combined processing is similar
at threshold, and is higher for the early phase of response at higher stimulation levels. The
average subtraction thus induces a decrease in width of activation at high stimulation levels,
but not at threshold.
The spike count, normalized for each rat to the highest spike count measured in the raw
data (Figure 3.32C), also shows an increase with stimulation level (mult.lin.reg, N=7, p < 0.05).
The increase in spike count is more linear than the increase of width and does not seem to
reach a plateau in the tested range of levels.
If the spikes in the early and late time window come from different neuronal populations, it is
interesting to look at the ratio of all generated spikes that are in the early phase of responses
and its variation with stimulation level. It can be an indicator of different behaviors of activa-
tion of the different populations of neurons. Here, the fraction of early spikes is signiﬁcantly
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larger at medial locations at high stimulation levels (signiﬁcance is reached at 1.5 V above
threshold and higher, mult.lin.reg, N=7, p < 0.05). No effect of the stimulation level is however
identiﬁed (Figure 3.32D).
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Figure 3.32: A) Characteristic frequencies obtained following stimulation at different latero-
medial positions with increasing stimulation current (from blue to red), after the different
processing strategies. B-C) Effect of increasing stimulation level following a linear (top) or
logarithmic (bottom) scale on the width of IC activity (B) and the normalized spike count (C),
after the different processing strategies. D) Fraction of spikes in the early phase of responses
following stimulation at different lateromedial positions with increasing stimulation level.
Statistically signiﬁcant differences between levels are indicated with a star.
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3.7.3 Synthesis
The analysis of effect of stimulation level on the IC response map characteristic frequencies
shows a general decrease in CFs at higher voltages, together with an increase in width and
spike count. The increased volume of activation following stimulation with higher voltage
could help explain the obtained results. The higher widths can be explained by the greater
lateral extent of stimulation. The decrease in CF could be explained by the increased depth
of stimulation if the deeper layers correspond to neurons with lower CFs. A similar change
in CF with stimulation level in ABI patients might lead to altered pitch perception when the
stimulation level is changed, and an increased loudness would be combined to a change
of pitch in amplitude modulation strategies. This might help explain the difﬁculty in pitch
ranking of the different electrodes experienced by some ABI patients[13,112].
As described earlier, the decrease in CF at increasing stimulation levels does not show the
same behavior in the tonotopically-organized activity (average subtraction and early phase
of responses). Particularly, CFs don’t decrease at lateral stimulation sites, even if the width of
activation and spike count increase. This could be explained by the fact that the neurons gen-
erating the tonotopically-organized activity are forming a thin layer. In that case, increasing
the stimulation level would generate an increase in width and spike count due to the increased
lateral extent of stimulation, but no decrease in CF since no tonotopically-organized neurons
with lower CFs would be present at deeper locations.
3.8 Stimulation pairs orientations and interelectrode distances
During bipolar electrical stimulation, the current is passed between two electrodes of small
(and usually similar) area in contact with the tissue. The voltage ﬁeld generated in the tissue
depends on the distance between the two electrodes and on the orientation of the bipole.
Additionally, in the case of surface stimulation of an anisotropic tissue containing ﬁbers with a
speciﬁc orientation, the shape of the volume of activation is inﬂuenced by the anisotropy[126].
The orientation of the dipole can thus potentially have an effect on the activation properties
of these ﬁbers.
In the stimulation of the auditory brainstem, it is interesting to investigate whether the dis-
tance between the two stimulation electrodes and the orientation of the pair compared to the
lateromedial axis have an inﬂuence on the recorded IC parameters, both in terms of tonotopic
organisation and selectivity. Two speciﬁc arrays are designed for this purpose, one to study
the effect of stimulation with very close pairs (200 μm center-to-center distance, described in
section 3.4.1), and the second to have a regular coverage of the whole surface of the DCN with
a hexagonal conﬁguration to study the independent effects of orientation and distance, at all
stimulation pair positions on the surface of the DCN (described in section 3.4.2).
88
3.8. Stimulation pairs orientations and interelectrode distances
3.8.1 14-electrode array with 200 μm spaced pairs
The ﬁrst tested electrode array consists of 14 electrode sites arranged in 7 pairs of electrodes
covering the surface of the DCN (Figure 3.33A). Pairs with interelectrode distances between
200 and 800 μm and various orientations are tested. In order to analyze the effect of distance
and orientation, the results from all stimulation pairs are separated into 12 groups, each with a
speciﬁc distance and orientation (shown in different colors on the plot). As mentioned earlier,
due to the correlation between distance and orientation in this design, the main interest is to
compare the group with 200 μm distance to the other groups. Data with 200 μm distance will
be referred to as ’close pairs’ in the following analyses of this section.
The percentage of runs with signiﬁcant activity for each group is important to consider in
this context, to assess if stimulation pairs with the smallest tested interelectrode distance
can still efﬁciently stimulate the neurons that generate activity in the IC. In raw data, the
percentage of signiﬁcant maps generated with close pairs is not smaller than any other groups,
and is even signiﬁcantly larger than the pairs with 800 μm distance and 0◦ orientation (Figure
3.33C, mult.lin.reg, N=3, p < 0.05). After average subtraction, close pairs generate activity
in signiﬁcantly less runs than pairs with a distance of 412 μm and an orientation of -14◦
(mult.lin.reg, N=3, p < 0.05), but no other groups (p > 0.05). In the early time window, no
signiﬁcant differences between close pairs and other groups is obtained (mult.lin.reg, N=3, p >
0.05 in all cases). After combined analysis, close pairs generate activity in signiﬁcantly less
runs than pairs with a distance of 412 μm and an orientation of -14◦ (mult.lin.reg, N=3, p <
0.05), but no other groups (mult.lin.reg, N=3, p > 0.05). The percentage of responses generated
by close pairs is thus not signiﬁcantly lower than all other groups in all processings, suggesting
that the neurons generating responses in the IC are stimulated as efﬁciently as with larger
interelectrode distance pairs.
Tonotopic organisation
Figure 3.33B shows the lateromedial variations of characteristic frequency (CF) following the
different types of processing presented in the previous sections. Averages of the N=3 datasets
and standard errors are plotted, as well as the linear regression line for each group. Multiple
regression analysis is performed for each group to identify signiﬁcant correlations of CFs (or
other parameters) with lateromedial or rostrocaudal coordinates. All pairs of groups are also
compared with multiple linear regression, considering the effect of the factors (lateromedial
and rostrocaudal positions, and group) and the interactions between factors. In the raw data,
no signiﬁcant correlation between the lateromedial position and the CF are identiﬁed in any
groups (p > 0.05 in all cases). In the comparison between groups, the CFs obtained with close
pairs show no signiﬁcant differences with any other group (p > 0.05 in all cases). In the average
subtraction and the early phase of response, although the lateromedial effect of CF is clear in
most groups, the correlation between CF and lateromedial position is signiﬁcant only in two
groups, the group with a distance of 412 μm and an orientation of 14◦ and the group with a
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distance of 500 μm and an orientation of -36◦ (p < 0.05 in both cases).
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Figure 3.33: A) Illustration of the different groups considered for the analysis, each with a
speciﬁc interelectrode distance and orientation of the pair. B) Variations of characteristic
frequency (CF) with lateromedial position of stimulation for all processing types. C) Effect
of the Angle/Distance groups on the percentage of runs with signiﬁcant activity, the width of
activity in the IC, the best threshold and the normalized spike count, for each processing type.
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The lack of signiﬁcance in other groups (p > 0.05) is likely due to the variability of the data and
the low number of datasets (N=3). The access to tonotopy by close pairs is not signiﬁcantly
different than any other groups (p > 0.05). In the early phase of response, the CFs obtained
with close pairs are signiﬁcantly higher than most other groups. This difference is signiﬁcant
with the group with 412 μm distance and 14◦ orientation, and the group with 500 μm distance
and -36◦ orientation (p < 0.05 in both cases). After combined processing, no signiﬁcant latero-
medial effect of CF is identiﬁed (p > 0.05 in all cases). The CFs obtained with close pairs are
not signiﬁcantly different than other groups (p > 0.05 in all cases).
Overall, these results mean that the access to the tonotopic organisation of the IC does not
seem to be better with the smallest interelectrode distance (200 μm) compared to the other
groups. In the early time window, the average CF obtained with close pairs is on average
higher than with pairs with larger interelectrode distances, indicating a potentially important
difference in DCN neurons activation by these close pairs that will be discussed in following
sections.
Intensity parameters
In the raw activity, the width of activation is smaller for close pairs than for two other groups
of data, the group with a distance of 500 μm and an orientation of -36◦, and the group with
a distance of 640 μm and an orientation of -51◦ (p < 0.05 in both cases). In the data after
average subtraction and in the early phase of responses, no signiﬁcant differences in widths
are obtained in the groups comparisons (p > 0.05 in all cases). In the combined analysis, the
close pairs induce a signiﬁcantly lower width that the group with a distance of 640 μm and an
orientation of 51◦ (p < 0.05), but not the other groups.
No signiﬁcant differences between close pairs and other groups are obtained on the best
threshold of activation, in any of the processing types (p > 0.05 in all cases). The larger values
of threshold observed with the group with a distance of 800 μm and an orientation of 90◦ are
obtained with only one datapoint. This is due to the low percentage of signiﬁcant responses of
this group and the relatively low total number of datasets (N=3). They can therefore not be
considered in the analysis.
In raw data and early phase of responses, normalized spike counts are smaller for close
pairs than for most groups with distances between 400 and 640 μm (p < 0.05). At higher
distances, the normalized spike rate is not signiﬁcantly different from close pairs (p > 0.05
in all cases). In the data after average subtraction or after combined analysis, no signiﬁcant
differences between groups is present (p > 0.05 in all cases).
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Synthesis
The effect on all parameters obtained with 200 μm distance pairs are consistent with the fact
that the volume of activation is smaller than with larger interelectrode distances. Particularly
in the early phase of responses, a tonotopic organisation is observed in the responses obtained
with 200 μm spaced pairs. The width of activation and spike count are also smaller with
200 μm spaced pairs than with most responses obtained with larger distances. This is not
associated to an increase in threshold, showing that the efﬁciency of stimulation is not affected.
The higher average CF in the early time window can be related to the higher CFs obtained on
average at lower stimulation levels in section 2.7 (effect of stimulation level), suggesting that
the deeper layer have lower CFs than shallower layers. By using a smaller current level (thus a
more spatially speciﬁc stimulation), the depth of activated neurons is smaller and the low CFs
of deeper layers are not reached. These results conﬁrm that the spatial selectivity might be
higher with the smallest interelectrode distances, without however improving the tonotopic
organization of responses.
3.8.2 20-electrode array with hexagonal conﬁguration of electrodes
The second tested electrode array consists of 20 electrode sites arranged in a hexagonal
conﬁguration, covering a slightly larger surface than the 14-electrode array (1.9 mm x 1.1 mm
vs 1.7 mm x 0.9 mm). The hexagonal arrangement of electrodes is similar to the arrangement
of electrode sites used in the clinical ABIs (with one extra line) and allows an independent
study of orientation and distance of the electrode pair, as the electrode sites are equidistant in
all three orientations. The distance between two neighbouring electrodes is 400 μm, and the
three orientations are -60◦, 0◦ and 60◦ (Figure 3.34).
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Figure 3.34: Schematic of the stimulation array showing the inter-electrode distance (400
and 800 μm), and the three orientations (-60, 0 and 60°), with respect to the lateromedial
(horizontal) axis.
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Figure 3.35: A, B) Comparison of tonotopic gradient for pairs with the three orientations (-60,
0 and 60 degrees), for 400 μm (A) and 800 μm (B) distance, for the raw data. C, D, E) Effect
of distance and orientation of the stimulation pair on measured best threshold (C), width of
activation (D) and normalized spike count (E).
Raw data
Analysis of distance and orientation effects on raw data (Fig. 3.35) shows that the only group
with signiﬁcant correlation between CF and lateromedial position is the group with 400 μm
distance and negative orientation (mult.lin.reg, N=7, p < 0.05 for the lateromedial position
factor). Other groups, with a distance of 400 μm and an orientation of 0◦ or 60◦, and with a dis-
tance of 800 μm and all three orientations, do not show any signiﬁcant correlation between CF
and lateromedial position (p > 0.05 in all cases). No signiﬁcant differences between groups are
obtained (mult.lin.reg, N=7, p > 0.05 in all cases). In the considered intensity parameters (best
threshold, width and spike count), the only signiﬁcant effect is a larger spike count following
stimulation with 800 μm distance pairs compared to 400 μm distance pairs (mult.lin.reg, N=7,
p < 0.05; Fig. 3.35E).
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Combined processing
After combined processing, when only the data obtained with the larger inter-electrode
distance (800 μm) are considered, fewer rats (4/7 vs. 6/7 with 400 μm distance) show a
signiﬁcant correlation between CF and lateromedial position (mult.lin.reg, p < 0.05 for these
4 rats). The range of CFs accessed is also smaller (15 to 36.1 kHz, 1.27 octaves in Fig. 3.36B
versus 9 to 52.3 kHz, 2.54 octaves in Fig. 3.36A). At 800 μm distance, the range of CFs is larger
at a -60° orientation (15 to 36.1 kHz, 1.27 octaves) than at the two other orientations, 0° (16 to
28.3 kHz, 0.82 octaves) and 60° (19.7 to 34.2 kHz, 0.8 octaves). At this distance, the correlation
between CF and lateromedial position is signiﬁcant for 0° and -60° orientation (mult.lin.reg,
N=7, p < 0.05), but not for 60° orientation (mult.lin.reg, N=7, p > 0.05).
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Figure 3.36: A, B) Comparison of tonotopic gradient for pairs with the three orientations , for
400 μm (A) and 800 μm (B) distance, for the early activity after average subtraction. C,D,E)
Effect of distance and orientation of the stimulation pair on measured best threshold (C),
width of activation (D) and normalized spike count (E). Signiﬁcant differences (p-value < 0.05)
are indicated with a star.
Larger inter-electrode distance also broadens the width of activation, for all orientations
combined (One-way Anova, N=7, p < 0.05). For a 400 μm inter-electrode distance, the width is
on average 3.17 recording sites in IC, whereas for 800 μm the width is on average 3.6 recording
sites (Fig. 3.36D). Again, the only effect of electrode pair orientation is for 800 μmdistance, and
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the pairs with a -60° orientation are different (they generate a narrower width than the other
orientations, One-way Anova, N=7, p<0.05). This orientation also shows the best tonotopic
organisation at that distance. It is close to orthogonal to the CF shift following combined
processing identiﬁed in previous sections (12° orientation, angle of 72° between the two).
Synthesis
These analyses highlight several properties of the results obtained with an interelectrode
distance of 800 μm compared to 400 μm. First, 800 μm spaced pairs generate higher spike
counts in raw data. Then, in combined processing, they lead to higher widths and a lower
range of CFs. At this distance, the orientation also seems more critical and generates lower
widths and a better tonotopic organisation when it is close to orthogonal to the tonotopic axis.
No signiﬁcant changes in normalized spike count are obtained between the different distance
and orientation conditions, indicating a similar intensity of activation in the IC. While the
’loudness level’ cannot be measured as such in animals, the normalized spike rate can be used
to estimate it.
These results are consistent with a higher volume of activation generated by the 800 μm
distance data. Additionally, when the two electrode sites of a pair are located at different
locations along the tonotopic axis (i.e. the orientation of the pair is close to the orientation of
the tonotopic axis), it is likely that there is a volume of activation below each stimulation site
that correspond to different CFs, thus generating higher width in the IC and poorer tonotopic
organisation.
Following these analyses, it can be concluded that smaller distances are preferable in order to
generated more spatial selectivity of stimulation, with similar loudness levels. A limitation in
density is however likely to come from the limitation in the total number of electrode sites
covering the surface of the CN. In order to maximize the tonotopic organisation of responses
and minimize the width of activation in the case of larger interelectrode distances, it might also
be important to use an orientation of the electrode pair close to orthogonal to the tonotopic
axis.
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3.9 Comparison between monopolar and bipolar stimulation
3.9.1 Effect on tonotopic organisation of responses
5 10 15
0
2
4
16.58 kHz
5 10 15
0
2
4
24.46 kHz
5 10 15
0
2
4
24.11 kHz
5 10 15
0
2
4
21 kHz
5 10 15
0
2
4
17.25 kHz
5 10 15
0
2
4
18.05 kHz
Neural firing rates
200
0
100
sp/s
5 10 15
0
2
4
17.18 kHz
5 10 15
0
2
4
19.5 kHz
5 10 15
0
2
4
18.48 kHz
5 10 15
0
2
4
21.97 kHz
5 10 15
0
2
4
21.99 kHz
5 10 15
0
2
4
16.94 kHz
5 10 15
0
2
4
18.65 kHz
5 10 15
0
2
4
25.72 kHz
5 10 15
0
2
4
21.99 kHz
IC recording site
St
im
. l
ev
el
 (V
)
Bipolar Monopolar 
 
−800 −400 0 400 800
−400
0
400
 
−800 −400 0 400 800
−400
0
400
Characteristic frequency in IC
Early time window, after average subtraction
 
−800 −400 0 400 800
−400
0
400
 
−800 −400 0 400 800
−400
0
400
Characteristic frequency in IC
Raw data
A B
C
DCN lateromedial coordinate (μm)
D
CN
 ro
st
ro
ca
ud
al
 c
oo
rd
in
at
e 
(μ
m
)
Characteristic Frequency (kH
z)
10
20
30
40
50Bipolar 
Monopolar 
Bipolar 
Monopolar 
DCN lateromedial coordinate (μm)
D
CN
 ro
st
ro
ca
ud
al
 c
oo
rd
in
at
e 
(μ
m
)
Figure 3.37: A) IC response maps (raw data) to bipolar electrical stimulation with ﬁve differ-
ent bipolar pairs along the lateromedial axis (left column), and in response to monopolar
stimulation with the corresponding individual electrodes (middle and right columns) in an
individual rat (11). B) CF matrices (raw data) for bipolar stimulation (top) or monopolar
stimulation (bottom). C) CF matrices (after combined processing) for bipolar stimulation
(top) or monopolar stimulation (bottom).
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In this section, results following stimulation with the 20-electrode array (section 3.4.2) are
presented. Response patterns from monopolar stimulation do not differ greatly from those
described for bipolar stimulation. Figure 3.37A shows raw IC response maps following bipolar
stimulation with ﬁve different pairs vs. monopolar stimulation with the 10 corresponding
stimulation sites. Qualitatively similar spatial variations are observed both in raw data (Fig.
3.37B) and after combined processing (Fig. 3.37C).
Results show no signiﬁcant differences in the access to tonotopy between monopolar and
bipolar data (multiple linear regression, N=4, p > 0.05 both for the ﬁrst order stimulation
conﬁguration effect and for the interaction stimulation conﬁguration / position), both in the
raw data and after combined processing (Fig. 3.38A-B).
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Figure 3.38: A) Correlation between CFs of raw IC response maps and their lateromedial
position for monopolar and bipolar stimulation. B) Correlation between CFs after combined
processing and their lateromedial position, for monopolar and bipolar stimulation. C, D, E)
Threshold (C), width of activation (D) and normalized generated spike rate (E) for monopolar
and bipolar stimulation, for raw data and after combined processing.
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3.9.2 Effect on intensity parameters
After combined processing, evoked spike rates are signiﬁcantly higher in monopolar stimula-
tion than in bipolar stimulation (Fig 3.38; One-way Anova, N=4, p < 0.05). This effect is also
observed in the raw data but does not reach signiﬁcance (One-way Anova, N=4, p > 0.05). No
signiﬁcant difference in threshold or width of activation is found between monopolar and
bipolar stimulation, both before and after processing (Fig 3.38; One-way Anova, N=4, p >
0.05).
3.9.3 Synthesis
The main conclusion for this study of comparison betweenmonopolar and bipolar stimulation
is that the access to the tonotopy does not signiﬁcantly differ, but that the larger spike rate
obtained in monopolar than in bipolar stimulation suggests that the volume of activation
following bipolar stimulation might be smaller. Even if this does not result in an increased
frequency selectivity in the IC, it can potentially be used on the edge of the CN to better shape
the volume of activation and thus minimize side effects due to off-target stimulation. This will
be further discussed in the discussion of this chapter.
3.10 Using alternative stimulation pulse waveforms
3.10.1 Range of tested waveforms
The goal of this section is to investigate the effect of different pulse waveforms of stimula-
tion on the properties of the IC response maps. The effect of the polarity of stimulation
(cathodic-anodic or anodic-cathodic) with a symmetric biphasic waveform and of the dura-
tion of the phases are investigated. The effect of asymmetry between the two phases (with
charge-balanced pulses) on the properties of activation is also tested. Lastly, a waveform ini-
tially designed to temporarily inactivate the neurons closest to the electrodes while activating
neurons at larger distances is tested, in an attempt to bypass the neuronal layer at the surface
of the DCN and directly stimulate the pyramidal neurons present in the second layer.
In order to test these different elements, eight waveforms are used to stimulate ﬁve elec-
trode sites of the 20-electrode array (section 3.4.2) located at different positions along the
lateromedial axis (at a rostrocaudal coordinate of 173 μm), in a monopolar conﬁguration
(Figure 3.39, left):
A: biphasic symmetric, 0.2ms/phase, cathodic-anodic
B: biphasic symmetric, 0.2ms/phase, anodic-cathodic
C: biphasic symmetric, 0.1ms/phase, cathodic-anodic
D: biphasic symmetric, 0.1ms/phase, anodic-cathodic
E: biphasic asymmetric, 0.4ms/0.1ms, charge balanced, cathodic-anodic
F: biphasic asymmetric, 0.4ms/0.1ms, charge balanced, anodic-cathodic
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G: triphasic asymmetric, 0.4ms/0.1ms/0.2ms, charge balanced, cathodic pre-pulse below
threshold, cathodic-anodic
H: triphasic asymmetric, 0.4ms/0.1ms/0.2ms, charge balanced, anodic pre-pulse below thresh-
old, anodic-cathodic
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Figure 3.39: Left: Illustration of the 8 tested waveforms. A: Raw IC response maps recorded
from the IC following stimulation with each waveform at two different stimulation sites. B:
Early phases of the IC response maps shown in A.
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The ﬁrst effect of interest here is the tonotopic organisation of response and the frequency
selectivity measured in the IC. The goal is to investigate whether a speciﬁc waveform allows a
better access to different frequencies and can bring better tonotopic cues than others. The
effect on the stimulation threshold and more generally the intensity of activation resulting
from stimulation with the different waveforms can be linked to the efﬁciency of stimulation.
This is important to consider in the context of power consumption for implants, as well as for
the chronic safety of stimulation.
3.10.2 IC response maps characterization
Figure 3.39 shows IC response maps following stimulation with the eight different waveforms,
with two electrode sites varying in their lateromedial position. Average spike rates over the 30
ms time window after stimulation (containing all generated spikes) and over the early phase
of responses as in the previous sections are displayed.
The waveform has a qualitative effect on the IC response maps, in their intensity of acti-
vation but also in some cases on their width of activation and location of activity along the
IC recording array. As seen in the datasets presented in earlier sections, there is also here
a large variability between datasets, and extracting relevant effect of different waveforms is
challenging. A similar strategy is then used, with separation between early and late phases of
responses, and subtraction of the average activity to highlight local effects. Effects of each of
the waveforms on the different components of responses will be presented in the following
sections.
3.10.3 Effect of polarity on symmetric pulses
First, we will consider the effect of polarity on a 0.2 ms/phase pulse. Waveforms of both polari-
ties (A and B) show signiﬁcant correlation between characteristic frequency and lateromedial
position of stimulation in the early phase of activity, as well as in the combined processing (Fig
3.40A, mult.lin.reg, N=7, p < 0.05, signiﬁcant lateromedial variations indicated with a star).
No signiﬁcant difference in CF variation is obtained between the two polarities in any of the
processing types (mult.lin.reg, N=7, p > 0.05).
The width of activation varies signiﬁcantly with lateromedial position in raw data, average
subtraction data and early time window data for A and B, and in combined processing for B,
showing lower widths at lateral locations (mult.lin.reg, N=7, p < 0.05). No signiﬁcant difference
between the two polarities are obtained (mult.lin.reg, N=7, p > 0.05; Fig 3.40B). For the other
parameters, the average values obtained by stimulating all locations on the DCN are consid-
ered for the comparison (Fig 3.41). No signiﬁcant differences between the two polarities are
obtained in the threshold, in the normalized spike rate of in the width of activation (One-way
Anova, N=7, p > 0.05).
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Figure 3.40: A) Characteristic frequencies and B) widths of activation at different lateromedial
positions for the four tested symmetrical waveforms, measured on raw data, after average
subtraction, on the early phase of responses and following combined processing.
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Considering the effect of polarity on shorter pulses (0.1 ms/phase) leads to slightly different
results. The cathodic/anodic waveform (C) shows a signiﬁcant correlation between CF and
lateromedial position of stimulation in the early time window (mult.lin.reg, N=7, p < 0.05),
but not the opposite waveform (D) (mult.lin.reg, N=7, p > 0.05; Fig 3.40A). Both polarities
generate lower width of activity when stimulating from lateral positions compared to medial
positions (mult.lin.reg, N=7, p < 0.05 in both cases; Fig 3.40B).
Direct comparison of the two polarities shows that the cathodic-anodic waveform gener-
ates lower thresholds than the anodic-cathodic waveform in the raw data and the early phase
of responses (One-way Anova, N=7, p < 0.05 in both cases), and is thus more efﬁcient in
generating activity in the IC (Fig 3.41C-D). No other parameters show signiﬁcant differences
between the two polarities (One-way Anova, N=7, p > 0.05 in all cases) with this shorter pulse
duration (0.1 ms/phase).
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Figure 3.41: Effect of waveform on A) width of activity in the IC, B) normalized spike rate, C)
current threshold and D) charge threshold, for the different processing types.
3.10.4 Effect of phase duration on symmetric pulses
The effect of the phase duration on the different analyzed parameters can be investigated by
direct comparison of waveforms A and C (cathodic-anodic, 0.2 and 0.1 ms/phase) and B and
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D (anodic-cathodic, 0.2 and 0.1 ms/phase). No effect of phase duration is obtained on the
correlation between CF or width and the location of stimulation electrode (mult.lin.reg, N=7,
p > 0.05 in all cases), showing a similar access to the tonotopy of the DCN by waveforms of
different phase durations.
The difference between threshold stimulation level and associated charge in the analysis
of phase duration effect is important to consider (Fig 3.41C-D). Larger thresholds are obtained
at 0.1 ms/phase than at 0.2 ms/phase for both polarities, although the difference is signiﬁcant
only for the anodic-cathodic polarity (One-way Anova, N=7, p < 0.05). However, a longer
phase duration lead to a higher charge per phase for the same stimulation level. The charge
threshold is signiﬁcantly smaller at 0.1 ms/phase than at 0.2 ms/phase for both polarities
(One-way Anova, N=7, p < 0.05 in both cases). This behavior is well known, and characterized
by the strength-duration and phase-duration curves, describing the relationships between
threshold current/charge and pulse duration[134]. As pulse duration is reduced, the voltage
threshold increases but the charge threshold decreases, a behavior that depends on the time
constant of the stimulated neuronal elements. Test with a greater range of pulse durations
would be necessary to fully characterize the system and measure its time constant.
In these data, considering that all other response map parameters do not show signiﬁcant
effects of phase duration, shorter phase durations should then be privileged because they
provide efﬁcient stimulation at much lower charge per phase, with only marginal increase in
stimulation level. Since the damage was shown to primarily depend on the current density
and the charge per phase, the range between stimulation and damage threshold can thus be
increased by using small phase durations.
3.10.5 Asymmetric stimulation pulses
In the asymmetric pulses, the effective stimulation phase has a duration of 0.1 ms/phase,
similar to the symmetric pulses with short duration (waveforms C and D) presented in the
previous section. They are thus directly compared to investigate the effect of asymmetry on
pulses with similar charge per phase.
The cathodic-anodic asymmetric waveform (E) shows a signiﬁcant correlation between lat-
eromedial position and CF in the early phase of responses and after combined processing
(mult.lin.reg, N=7, p < 0.05 in both cases). In the other polarity (F), these correlations don’t
reach signiﬁcance (mult.lin.reg, N=7, p > 0.05 in all cases). Direct comparison of waveforms
C, D, E and F shows that the tonotopic organisation of responses with waveform E is signiﬁ-
cantly different compared to waveforms D and F, with a larger range of CFs and a larger slope
(mult.lin.reg, N=7, p < 0.05). Indeed, the results of multiple linear regression analysis show a
signiﬁcant interaction between the waveform and the lateromedial position of stimulation, in
the early phase of responses for E vs F and E vs D, and after combined processing for E vs F.
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Waveform E thus shows better tonotopic organisation than the other waveforms, both in the
early phase of responses and after combined processing (Fig 3.42A).
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Figure 3.42: A) Characteristic frequencies and B) widths of activation at different lateromedial
positions for waveforms C, D, E and F measured on raw data, after average subtraction, on the
early phase of responses and after combined processing.
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Waveform E also shows a lower width than C, D and F in the early phase of responses and after
combined processing at medial locations (Fig 3.42B). This difference does however not reach
signiﬁcance (mult.lin.reg, N=7, p > 0.05).
Because of the similar charge per phase of the different pulses considered in this analysis,
considering the current or charge thresholds is equivalent. The threshold of waveforms D and
E are signiﬁcantly higher than C in the early time window (One-way Anova, N=7, p < 0.05, Fig
3.41C-D). Direct comparison of spikes generated by the different waveforms shows that in the
early phase of responses, the spike rate generated by waveform E is signiﬁcantly lower than
waveform C (One-way Anova, N=7, p < 0.05; Fig 3.41B).
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Figure 3.43: Characteristic frequencies at different lateromedial positions for the four tested
cathodic-ﬁrst waveforms measured on raw data, after average subtraction, on the early phase
of responses and following combined processing.
These analyses show that the asymmetric waveform with anodic stimulation phase (E) gen-
erates the best tonotopic organisation of responses in the early phase of responses, with
however a higher threshold than the symmetric waveform with similar polarity, and lower
spike rates. This waveform might thus be more selective for tonotopically organized neurons,
or for neuronal bodies over ﬁbers of passage, and at the expense of a weaker activity might
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generated a better tonotopic organization in the responses.
3.10.6 Triphasic stimulation pulse
Direct comparison of waveforms A and G are performed since they have similar polarities,
and the effect of adding a subthreshold prepulse (waveform G) can be investigated (Fig 3.41
and 3.43). Results show that waveform A generates higher thresholds than waveform G after
combined processing (One-way Anova, N=7, p < 0.05). Otherwise, no differences between
these two waveforms are obtained.
3.10.7 Synthesis
The conclusions of this study of the effect of the stimulation waveform on IC response param-
eters can be articulated in three different points:
• While the polarity has little effect on the 0.2 ms/phase symmetric waveform, it is shown
to have an inﬂuence on 0.1 ms/phase symmetric waveforms. In this case, the anodic-
cathodic waveform generates higher thresholds of activation than the cathodic-anodic
waveform.
• The threshold mainly depends on the stimulation level rather than the charge per
phase, in the two phase durations tested here (0.1 and 0.2 ms/phase). Short pulses
(0.1 ms/phase) are thus advantageous in terms of safety, as a lower charge per phase is
necessary to generate activity.
• The analysis of asymmetric waveforms shows that the access to tonotopy in the early
phase of response is best with waveform E (long cathodic – short anodic phases). The
difference is signiﬁcant compared to the asymmetric waveform of opposite polarity, as
well as the symmetric waveforms of both polarities, with 0.1 or 0.2 ms/phase. The spike
rate generated by waveform E is signiﬁcantly smaller than cathodic/anodic symmetrical
waveforms of 0.1 and 0.2 ms/phase and anodic/cathodic symmetrical waveform of 0.2
ms/phase.
Several directions are proposed here, following this waveform study. First, reducing the
phase duration seems to lead to lower charge thresholds, which allows safer and more energy-
efﬁcient stimulation, as was suggested in[91].
Introducing an asymmetry in the pulses might lead to stimulation with a better tonotopic
organisation. The asymmetric waveforms were tested here with the hypothesis that the long
cathodic / short anodic waveform would preferentially stimulate neuronal bodies over ﬁbers
of passage, as was shown in a simulation study[124]. It is difﬁcult to say whether this is what we
achieved here, but the better tonotopic organisation of responses suggests that this waveform
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type could indeed be efﬁcient in preferentially targeting tonotopically-organised neurons.
A complete characterization of the threshold dependence on the polarity of the stimula-
tion phase would be also relevant, as psychophysical studies in ABI patients suggested that
the anodic phase is more efﬁcient than the cathodic phase[32].
This preliminary study of different waveforms of stimulation in a rat model thus highlights the
large dependence of the efﬁciency of stimulation and tonotopic organization of responses on
the stimulation waveform.
3.11 Discussion
This chapter presents a mapping of the DCN surface with electrical stimulation characterized
by ABR far-ﬁeld responses and direct multiunit recordings from the IC, with an emphasis
on the access to frequency-tuned neurons resulting in the extraction of a frequency-speciﬁc
component in IC recordings.
3.11.1 Electrodes conﬁguration effect on the tonotopic organisation of responses
Inter-electrode distance
Based on the isolated tonotopically organised responses, we propose guidelines for optimiza-
tion of the tonotopy and selectivity of stimulation. First, our results yield a more extensive
tonotopic pattern for response for small vs. large distances between electrodes of a bipolar
pair. In addition, the width of activation in the IC increased with this distance, indicating
lower frequency selectivity at large distances, for equal loudness levels.
The widest spacing used in our experiments (800 μm) is smaller than that found in the clinical
ABI electrode array (about 1 mm). Based on our data, we suggest that reducing inter-electrodes
distance would beneﬁt spatial selectivity and may lead to the reduction of extra-auditory side
effects using bipolar stimulation.
In the studies performed here, inter-electrode distances of 200 μm showed similar stimu-
lation efﬁciency than higher distances. We do not know if the efﬁciency of stimulation would
be smaller if the inter-electrode was further decreased, but the next limit to consider is the
electrode site diameter, that must be large enough to have safe current and charge density
levels. Additionally, the density of electrode sites might be limited by the total number of
stimulation sites. For these reasons, we do not foresee that further reducing the interelectrode
distance could be beneﬁcial in the development of a new ABI array.
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Orientation of the electrode pair
At larger interelectrode distances, we showed that the orientation of the pair should be close to
orthogonal to the tonotopic axis in order to optimize the tonotopic organisation of stimulation.
Optimizing the orientation of the pair thus seems to allow a shaping of the current ﬁeld within
the CN. Besides the optimization of the tonotopic organisation of responses, the possibility
to shape the activation volume could be used to reduce extra-auditory side-effects by using
bipolar stimulation with speciﬁc orientations, particularly on the edges of the CN.
Bipolar and monopolar stimulation
Although present results indicate that bipolar electrode conﬁguration alone does not result
in narrower receptive ﬁelds than monopolar conﬁguration, spike rates following monopolar
stimulation are on average higher than following bipolar stimulation, indicating a larger vol-
ume of activation with monopolar stimulation. Contrary to studies comparing monopolar
and bipolar stimulation in the cochlea[5,22,135,190,219], the threshold obtained with bipolar
stimulation is not higher than with monopolar stimulation.
In the human ABI, bipolar stimulation is used intra-operatively to assist the positioning
of the ABI array, but monopolar stimulation is used to conserve battery life for normal ev-
eryday use[75]. In a situation where the density of electrodes is increased, it would be highly
relevant to study whether the larger number of possibilities and orientations with bipolar
stimulation can lead to an improvement of audiological results, and if these advantages are
sufﬁcient to counteract the drawback of higher power requirements of bipolar stimulation.
Monopolar and bipolar stimulation conﬁgurations are not the only possible options. Tripolar
or multipolar stimulation conﬁgurations have been shown to allow greater current steering
and spatial selectivity of stimulation. However, these modes of stimulation were typically
associated to higher threshold than monopolar and bipolar stimulation and thus to require
even more power[22]. A tradeoff has to be found between current focusing and power con-
sumption in this case. Tripolar and multipolar stimulation also require more complex current
sources and stimulation protocols than the clinically-used monopolar and bipolar modes of
stimulation.
Pulse waveforms
The waveform study presented here is an attempt at improving the monopolar stimulation. As
shown in the corresponding section, using shorter pulses and introducing an asymmetry in
the pulse might be beneﬁcial in terms of chronic safety of stimulation and of power efﬁciency
and functionality. An important point to consider here is that all tests were performed at low
frequencies (28 Hz), in order to be able to measure eABRs and IC response maps following each
stimulation pulse. However, clinically-used speech processors use much higher stimulation
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pulse rates (250-300 Hz for the SPEAK processing strategy used in the Cochlear ABI device, and
600-1800 Hz for the CIS strategy used in the Med-El ABI device[113]) and ABI patients show
a frequency-dependence in the stimulation thresholds[32]. It would then be highly relevant
to test whether the effects identiﬁed in this study would be conserved at higher stimulation
pulse rates.
In the frame of this study, only a small range of parameters and waveforms were tested,
which can thus be considered as preliminary in this respect. It is used to investigate potential
directions that seem promising to follow in order to optimize the waveform of stimulation
for the ABI. The logic continuation of this study would be articulated in two phases. First,
further exploring the waveforms that are tested here, by doing a complete study of pulse
duration on symmetric and asymmetric pulses, testing different ratios of asymmetry or testing
other parameters for the triphasic pulse could validate the results obtained here and lead to a
better understanding of the selectivity of each waveform. In this study, the tested locations
were all along the same lateromedial axis. Performing a complete location study including
several rostrocaudal locations with these waveforms might also give more insight into the
stimulation of the different neuronal populations. Then, it would also be interesting to expand
this study by adding interpulse intervals, or waveforms with passive discharge in the second
phase. Testing the effect of using asymmetric waveforms in a bipolar stimulation mode is also
promising, as it might concentrate the volume of activation below one of the stimulation sites,
whereas symmetrical waveforms induce close-to-symmetrical volumes of activation below
both stimulation sites[32].
3.11.2 Neurophysiology
Variability
We found a high intersubject variability of IC response map patterns in response to electrical
stimulation. Histology conﬁrmed reliability of placement on the DCN, so large differences
in array placement do not appear to cause this variability, although some edge electrodes
were beyond the edges of the DCN. Variable position of the IC recording probe with respect to
the various neuronal populations described in the IC might also inﬂuence the recordings[117].
A potential effect of anesthesia might inﬂuence DCN neurons excitability and IC neuron
responsiveness[96,121]. A combination of all these factors and possible intrinsic differences
between the rats could help explain the observed variability.
Effect of processing
We investigated the effect of subtracting the overall spike rates because they might be gen-
erated by wide frequency tuned neuronal populations and mask location-speciﬁc activity
generated by narrow frequency-tuned neuronal populations. Despite the large variability
obtained in the general pattern of activation of the IC response maps, tonotopic organization
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became clearer after subtracting the overall activity and using the early responses. Moreover,
this residual neural activity reveals a tonotopic pattern with a larger range of CFs and higher
tuning of responses (as indicated by the diminished widths of IC response maps).
We investigated the arrival timing of spikes because they might reveal mechanisms for neu-
ral activity masking. We found a dichotomy in spike times that we called early latency and
late latency spikes. Early latency spikes appeared to be more tonotopic auditory responses
than late latency spikes. It is important to note, however, that this mechanism of extracting
tonotopic cues appears to be independent of subtraction of common evoked activity, and
that there are multiple mechanisms for neural activity masking in the auditory brainstem
stimulation. The several phases of activity in the PST histogram in response to electrical
stimulation could be explained by: 1) a fast-conducting, direct pathway from the CN to the IC,
and 2) a longer-latency pathway either consisting of slower-conducting axons or the presence
of one or more synapses. The limit between early and late activity is clear in most runs at a
latency of about 7 ms, although this latency differs from run to run and a small overlap may be
present.
Origin of early activity
We suggest that at least part of the early activity is generated by DCN pyramidal neurons,
which are immediately beneath the electrode array and have large axons that project directly
to the IC with a tonotopic organization[3,178]. The lateromedial tonotopic organisation of
responses observed in the early time window (before and after subtraction of average activity)
supports this hypothesis, as the tonotopic organisation of the pyramidal neurons follows
a dorsomedial-to-ventrolateral axis. Another population of neurons that might contribute
to the early activity is the T-stellate cells located in the VCN, which correspond to the type
I multipolar cells in the human. They are narrowly tuned to sound frequency and have a
’chopper’ pattern of response, a succession of short bursts of spikes, with direct projections to
the IC.
Origin of late activity
The origin of the late activity may be one or more of the other elements within the DCN
(polysynaptic activity involving the parallel ﬁbers), the VCN (polysynaptic activity starting
in the spherical and globular bushy cells, T stellate cells) or polysynaptic pathways in the IC.
Parallel ﬁbers are located at the surface of the DCN and have excitatory input to the pyramidal
neurons in the second layer of the DCN. They are not tonotopically organized and would
activate pyramidal neurons across the tonotopic axis of the DCN. In addition, the presence of
at least one synapse would induce later activity in the IC than a direct pathway.
The spherical and globular bushy cells are located in the AVCN and project via the ven-
tral acoustic stria to the superior olive (SO) and the lateral lemniscus (LL), where they form
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synapses with third order neurons which then project to the IC. In that case also, the presence
of a synapse would lead to later activity in the IC than a direct pathway. Finally, pyramidal
cells with ’pauser’ type of responses generate a sharp early burst of spikes followed by a longer-
lasting activity a few milliseconds later[216], which might also contribute to the late phase of
responses.
Like the DCN, the AVCN and PVCN also have their own tonotopic organisation, following a
dorsomedial-ventrolateral axis. The medial region of the AVCN is located rostrally to the DCN
in the rat, according to the 3D reconstruction shown in ﬁgure 3.6A. One hypothesis is that
stimulation of rostral sites of the DCN might stimulate high-frequency regions of the AVCN if
the current spreads. This hypothesis is supported by the larger CFs obtained when stimulating
at rostral sites in the late phase of activity. The high-frequency late activity would then be at
least partly generated by one or several AVCN cell types mentioned in the previous paragraph.
Analysis of the time centroid of the late activity shows a large dependence on the IC recording
site, but only a small dependence on the lateromedial position of stimulation. This is one
more clue that the late activity is not lateromedial location-speciﬁc. The timing dependence
on the IC recording site is more difﬁcult to explain. Low CF ﬁbers appear to generate later
activity than high CF ﬁbers, which might be a reﬂection of the lower intensity of activation of
low CF ﬁbers. This could be because the surgical approach and the array position do not seem
to allow stimulation of DCN low CF regions, located too laterally and ventrally.
Finally, a possible contribution to the late activity could be explained by the intact audi-
tory nerve of the animal model used in these experiments. Efferent activation of the auditory
neurons might be generated, which could generate a conduction of the impulses to distant
areas of the CN, thus blurring the tonotopy. The animal model of the ABI could thus be
improved by deafening.
Access to the rat hearing range
Our results suggest a portion of the auditory tonotopic axis is not accessible, even after extrac-
tion of the tonotopically-organized spikes. The audible range of frequencies in rats (0.25-80
kHz) is wider than the one we tested (1 - 45 kHz). The latter corresponds to the range of high
sensitivity[86]. In our experiments, even with the largest CF range obtained, the lowest evoked
CF is about 8 kHz, implying the lower frequency range (1 – 8 kHz) could not be accessed.
While the ﬂexible ABI conforms well to the surface of the DCN, the lower frequency region
of the DCN may be more ventrally located[174] and therefore not accessible with our surgical
approach.
As mentioned in the introduction, penetrating auditory brainstem implants (PABI) were
developed in an attempt to have a better access to the tonotopic organization of the VCN,
but did not result in an improvement of audiologic outcomes compared to surface ABIs[149].
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Following in-depth analysis of anatomical properties of the human cochlear nucleus complex,
Rosahl et al. proposed a combined surface/penetrating ABI array, with surface electrodes
on the inferior half and penetrating electrodes in the superior half [167]. However, the main
limitation of PABI strategies is the difﬁculty of placement in the VCN, due to anatomical
variability and possible distortions due to tumours. The possibility to intraoperatively tune
the placement of surface ABIs remains a critical advantage.
The complex tonotopy of the cochlear nucleus lead to the development of auditory implants
targeting other auditory structures. The auditory midbrain implant (AMI), targeting the central
nucleus of the inferior colliculus was then developed. Despite the bypass of more auditory pro-
cessing, it is thought that the clearer tonotopic organization of the inferior colliculus, as well
as the absence of tumour-induced damage, might be advantageous[180]. An AMI clinical trial
between 2006 and 2008 with a multisite single-shank penetrating array showed similar levels
of speech hearing outcomes with the AMI compared to the surface ABI. The main challenge
was the correct implantation of the electrode array into the central nucleus of the inferior
colliculus, with only one of the ﬁve implanted devices reaching the targeted implantation loca-
tion. Limited temporal integration properties were also obtained[105]. Further developments
with a double shank array and a new surgical approach suggest that better hearing outcomes
might be obtained with this improved AMI[106].
The auditory thalamus is also considered as a target for an auditory implant, and showed low
thresholds and high dynamic ranges in a feasibility study[11]. Each of the studies targeting the
central auditory nuclei add to the understanding of the artiﬁcal stimulation of the auditory
system and the role of the different structures and might thus help achieving high levels of
speech understanding for patients who are not candidates for cochlear implants.
3.11.3 eABRs vs IC
eABRs and audiologic outcomes in clinical ABIs
Electrically-generated auditory brainstem response (ABR) measurements are used during
ABI implantation surgery to assess the placement of the ABI array. However, the presence of
useful auditory sensations for a given stimulation site was not shown to directly correspond
to the presence of an ABR during intraoperative testing. However, more thorough analysis of
intraoperative eABRs suggested that the presence of one particular peak was highly correlated
to useful auditory sensations[75].
Link between IC recordings and eABRs
In these results, no correlation between the presence of signiﬁcant activity in the IC and
detectable eABRs was found. When comparing the location-dependence of the parameters
extracted from both signals however, some interesting information can be extracted. In par-
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ticular, important rostrocaudal effects were identiﬁed on both signals. A higher amplitude
and a higher number of peaks were identiﬁed in the eABRs at rostral locations. In the late
phase of responses in the IC, the characteristic frequency (CF) was shown to be higher at
rostral locations, close to the AVCN region corresponding to high CFs. These two effects could
be linked and suggest stronger activation of VCN neurons at rostral locations. Bushy cells
in the VCN are thought to be the neural correlates generating auditory brainstem responses
because of their polysynaptic projections to the IC, which generate sequential activation of
the superior olive (SO) and the lateral lemniscus (LL), before reaching the IC, thus generating
the different peaks of the ABRs[130].
Activation of CN neurons that have direct projections to the IC might be linked to eABRs
with a smaller number of peaks, as the activated pathway does not imply sequential activation
of several auditory nuclei. Particularly, stimulation of the pyramidal neurons, hypothesized
to be the main source of tonotopically-organised activity in our recordings, might not be
linked to eABRs with multiple peaks, as the projections of the pyramidal neurons to the IC are
direct. This also means that the interpretation of the neural correlates of each peak is unclear,
since the peak that corresponds to the IC activity in the polysynaptic VCN-IC pathway might
not have the same latency as in the direct pathway. Both pathways can be simultaneously
activated, further increasing the complexity of the generated eABRs.
Another information that can be extracted from the comparison between eABR and IC results
is the low lateromedial variation in thresholds in both cases. This might be linked to a good
contact of the array with the DCN surface due to the conformability of the array. Such a
close contact resulting in uniform thresholds across the array might be beneﬁcial in a clinical
context for minimization of electrode-to-neurons distance and thus of current thresholds,
which might result in decreased side-effects.
3.11.4 Potential for translation of results for clinical use
Processing to reveal tonotopic cues may have implication for comprehending frequency cues
in ABI patients. However, there are important distinctions in extending these results. Our re-
sults were obtained with animals without hearing impairment, and it is clear that impairment
changes the anatomy and function of the CN[175,177]. Secondly, it is not clear that the human
brain processes the spike responses to electrical stimuli in a way similar to that shown here to
increase the tonotopic pattern. Future prostheses should consider whether targeting speciﬁc
neurons might provide unmasked frequency cues, and thus more independent channels of
information.
Caution must be taken when translating results from rodents to humans, because of the
signiﬁcant differences between these two species. First, rat and human CN have huge dif-
ferences in size. The rat CN is about 1/16 the size of the human[167]. There are also distinct
cytoarchitectonic differences. The stratiﬁed structure of the human DCN is different than in
113
Chapter 3. New Generation Auditory Brainstem Implant (ABI)
animals, and the human may lack the numerous granule cells found in most animals[17,139].
Neurons that might correspond to the rat pyramidal neurons were identiﬁed in the human,
but they lack the radial organisation present in most mammals.
In addition to the neurophysiological differences between species, the placement of the
ABI array might not be similar in the rat and in humans. The possible anatomical targets of the
ABI in humans are the DCN surface and part of the PVCN surface, located on the ﬂoor of the
lateral recess of the 4th ventricle. It is thought that the DCN is the main target, as it is much
larger than the PVCN, and because the PVCN shows some variations in depth[201]. However,
some evidence shows that there are considerable differences in placement across patients[18]
as well as anatomical differences[167] that make the precise target of the ABI unclear and
variable.
Despite these limitations, it seems highly relevant to test whether some of the effects iden-
tiﬁed in this study, like the importance of orientation of the electrode pair during bipolar
stimulation, could be replicated with ABI patients. Particularly, the potential reduction of
side-effects due to current steering could have direct implications on the programming of
ABI devices, and could help justify further improvements of the ABI array and protocol. This
study is thus a step in the direction of improving spatial selectivity of stimulation in ABI to
reduce non-auditory side-effects, improve spectral resolution and ultimately speech hearing
outcomes. In the general discussion of this thesis, steps towards a clinical validation of the
effects highlighted in this chapter will be proposed, as well as a new ABI array design with a
higher density of stimulation sites.
Contributions
Surgeries for the animal experiments performed in the chapter were performed by A.E. Hight in
the ABI lab, Eaton-Peabody Laboratories, at the Massachusetts Eye and Ear Inﬁrmary (MEEI),
building upon a surgical protocol developed by D.J. Lee and R.U. Verma. Current sources
were designed and built by E. Foss. Recording and data acquisition setup was developed
by K. Hancock and A.E. Hight. Calculation of the maximal polyimide thickness to achieve
bending of a polyimide ﬁlm around a cylinder was performed by N. Vachicouras. A.E. Hight
participated in the design of the experimental protocol and to the data analysis, and him
and M.C. Brown contributed to the interpretation of the data. Post-experiment histology was
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Abstract
In the past 10 years, optogenetics has become a technique of critical importance in neuro-
science. It enables an in-depth analysis of the function of neuronal subtypes within complex
neural networks because of its cell-type selectivity. Additionally, optical stimulation can pro-
vide signiﬁcant advantages over electrical stimulation, including the absence of current spread
and of a stimulation artefact. In the context of spinal cord damage and repair, the development
of devices enabling chronic light delivery to the spinal cord is essential to provide a way of
stimulating key elements of the locomotor neural circuitry. The effect of optical stimulation of
speciﬁc types of neurons on the recovery can be studied, potentially leading to an optimization
of the stimulation protocol during recovery. The spinal cord is a mechanically challenging
environment, and the device must have a small size and not damage the spinal cord upon
important movements of the animal.
In this chapter, we present an LED-based stimulation array that enables optical illumina-
tion of the spinal cord over several weeks, without inducing functional damage to the spinal
cord. In a proof-of-concept in vivo study, we show that the light irradiance is high enough
to reliably generate EMGs in both legs of the animals, in the tibialis anterior (TA) and the
vastus lateralis (VL) muscles. The difference between the stimulation with single LEDs and
pairs of LEDs in series is investigated, as well as the effect of the different parameters of the
stimulation pulses (pulse duration and pulse rate). Directions for further improvements of the
device functionality and safety are proposed. The presented device brings a lot of possibilities
to dissect neural circuits, understand the role of each neuronal type and possibly optimize
recovery following injuries, in ﬁelds much wider than spinal cord research.
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4.1 Introduction
4.1.1 Optogenetics in the context of spinal cord damage and repair
Spinal cord injuries lead in half cases to chronic paralysis, due of the low ability of the central
nervous system to repair itself [198]. However, strategies that take advantage of the activity-
dependent plasticity of remaining neural circuits can be developed to partially restore the
lost function[23]. Particularly, an electrochemical neuroprosthesis was developed and showed,
after speciﬁc active training, restoration of full weight-bearing locomotion in rats with a spinal
cord injury. This neuroprosthesis combines chemical and electrical stimulation to reactivate
dormant circuits [198].
Electrode location and conﬁguration are critical to stimulate speciﬁc sections of the spinal
cord to activate preferentially ﬂexor or extensor muscles. A spatiotemporal neuromodulation
protocol combining spatially speciﬁc stimulation at selected locations with temporally speciﬁc
patterns of stimulation depending on the stage in the gait cycle was shown to improve motor
control and gait rehabilitation[206], conﬁrming the critical importance of spatially distributed
stimulation sites.
The mechanisms by which electrical stimulation of the spinal cord activate motor circuits have
been investigated by simulation and experimental studies. The main hypothesis is that the
stimulation primarily recruits the myelinated afferent ﬁbers of the dorsal roots, corresponding
to proprioceptive feedback circuits [206]. These circuits then activate spinal circuits, enabling
sensory feedback to be a source of motor control [31]. It is thought that electrical stimulation
current poorly penetrates the spinal cord but rather spreads in the cerebrospinal ﬂuid, thus
stimulating myelinated ﬁbers and not axons within the gray matter. Motor axons stimulation
at the exit of the spinal cord are also recruited, but at higher thresholds than sensory axons, and
only at some caudal locations[31]. The effect of selectively targeting different spinal structures
(motor axons and spinal cord interneurons) on the gait and rehabilitation parameters is thus
still unclear and hard to investigate with electrical stimulation.
Optogenetics is a tool that allows cell-type speciﬁc stimulation of neural tissue by ﬁrst trans-
fecting the gene coding for a light-sensitive ion channel (usually Type 2 channelrhodopsin,
ChR2) into target neurons under the control of a speciﬁc promoter, and then activating them
with light of a speciﬁc wavelength (473 nm for ChR2). Provided that cell-type speciﬁc promot-
ers can be isolated and used for the targeting of motor and sensory ﬁbers or interneurons of
the spinal cord, the effect of individually activating the different parts of the spinal cord circuits
can be investigated. Additionally, light does not spread as current does, and only neurons in
the beam of light will be activated. Developing an optogenetic stimulation platform for the
spinal cord would then allow to dissect the role of each cell type in recovery, and possibly to
optimize this recovery thanks to speciﬁcally tailored protocols.
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4.1.2 Challenges associated to chronic optogenetic stimulation of the spinal cord
In order to do optogenetic studies of the spinal cord, the light delivery device must allow for
stable chronic stimulation for two main reasons. First, the study of locomotor tasks in vivo
require awake recordings. Then, one of the main scientiﬁc questions is whether optogenetic
stimulation can improve recovery and/or walking patterns following spinal cord injury, over
the course of weeks to months. A light delivery device that is stable chronically is thus required.
Although laser-coupled optical ﬁbers are widely used for optogenetic studies, they are poorly
suited for chronic experiments. In the absence of an implantable light source, the device will
remain tethered. Additionally, the spinal cord is a mechanically challenging environment. The
small available space for implantation, the presence of soft spinal cord tissue (100-1,500 kPa)
and the large natural movements of the spinal cord (up to 30% of dynamic strain) prevent
the safe chronic use of stiff implants that induce spinal cord damages leading to walking
impairements[136].
Using an LED-based implant can overcome these challenges, and has the additional ad-
vantage of having a large design ﬂexibility and the possibility to have a spatial distribution of
LEDs. This can enable for instance a design with LEDs located on both sides of the spinal cord.
The lateral selectivity of stimulation can be studied, as well as the effect of simultaneous bilat-
eral stimulation. An LED-based device implanted epidurally also enables surface stimulation
of the spinal cord, as opposed to the laser-coupled optical ﬁber approach, usually used with
ﬁbers penetrating the neural tissue[28].
The size and mechanical properties of the implant are critical. The device integrating the
LEDs and their encapsulation must be thin and conformable enough to be slid below the
vertebrae during surgery. The spinal cord must also not be compressed and damaged, even
upon important movements of the animal. Thermal safety must also be considered, as the
LEDs generate heat when powered, and can induce chronic damage to the tissue. In the
second chapter of this thesis, a parameter space for thermally safe stimulation of neural tissue
was deﬁned and will be used as a guide in this study.
4.1.3 Goals of the study
• Obtain a proof of principle of optical stimulation of the spinal cord in a mouse model for
chronic experiments, in order to validate a technology that can potentially be used to
dissect neuronal circuitry in the spinal cord and to better understand the mechanisms
of recovery following spinal cord damage.
• Assess the location selectivity of spinal cord stimulation with EMG recordings in a device
integrating 4 LED.
• Study the EMG recruitment curves and the effects of stimulation parameters - pulse
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duration and pulse rate - on the evoked responses.
• Analyse the chronic variation of threshold and other EMG response properties
• Investigate the chronic thermal and mechanical safety of the device with histological
analysis of the tissue and detection of any impairement of normal walking due to the
device.
4.2 Optoelectronic device for spinal cord stimulation
4.2.1 Device with 4 LEDs for lateral spinal cord stimulation
The device developed for chronic stimulation of the spinal cord is integrating two LEDs for
the stimulation of the left side and two for the stimulation of the right side of the spinal cord
(Figure 4.1A), following the process ﬂow for optoelectronic devices presented in the ﬁrst
chapter of this thesis .
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Figure 4.1: A) Design of the spinal cord optical stimulation device, showing the labelling of the
LEDs according to their position: left rostral (LR), left caudal (LC), right rostral (RR) and right
caudal (RC). B) Photograph of the ﬁnished device (scale bar: 2 mm). C) Illustration of the four
possibilities to power two LEDs in series to stimulate the right (i) or left (ii) side of the spinal
cord, or bilaterally on a more rostral (iii) or caudal (iv) locations.(scale bars: 1 mm)
The four LEDs are labeled according to their position, on the right (R), left (L), and on the
rostral (R) or caudal (C) side of the implant (according the anatomical orientations after
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implantation). Following this notation, the four LEDs are then labeled RR, RC, LR and LC.
The shape of the substrate is designed for epidural implantation of the device below the
mice vertebrae. In order to maximize the lateral positioning of the LEDs and facilitate the
implantation of the device, a slit in the substrate along the midline of the device is designed.
The center-to-center distance between two LEDs is 750 μm in both directions. Due to the
design of the connections, LEDs can be powered individually or by pairs (Figure 4.1C). The two
LEDs on each side of the spinal cord can be powered in series, in order to maximize the light
power delivered on one side and to study the lateral selectivity of stimulation. Alternatively,
the two LEDs located at the same level in the spinal cord can be powered in series, in order to
test the effect of simultaneous bilateral stimulation.
4.2.2 Experimental model
The experimental models are transgenic mice expressing channelrhodopsin (ChR2) under the
control of the Thy1 promoter, widely expressed in projection neurons. This model is known to
have a low threshold to optical stimulation, due to the robust expression of the ChR2[215].
In order to record motor activity generated by optical stimulation of the spinal cord, EMG
recording electrodes are implanted in two different muscles of each leg. These muscles are
the vastus lateralis (VL), a knee extensor muscle, and the tibialis anterior (TA), a ankle ﬂexor
muscle, in the right (R) and the left (L) leg. The four EMG channels are thus labeled RTA, RVL,
LTA and LVL in the following sections.
4.2.3 Characterization of device placement
During implantation surgery, the mice are anesthetized with isoﬂurane and three different
laminectomies are performed, at the levels T12-T13, T13-L1 and L2-L3. The implant is then
passed through the third laminectomy and slided below the vertebrae, until the four LEDs are
placed against the spinal cord at the spinal level L3. The connector is then secured in place
with sutures, and the percutaneous amphenol connector (Omnetics) is secured on the skull of
the animal with dental cement.
A microCT scan conﬁrming the placement of the implant is shown on ﬁgure 4.2. On this
image, we can see the four LEDs below the vertebrae, as well as the platinum tracks and the
connector. Although the connector slightly slided on the left, the active part of the device is
located along the midline. Figure 4.2C shows a rostral view of the spinal canal, with the LEDs
located dorsally against the spinal cord (not visible here).
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Figure 4.2: MicroCT images conﬁrming the device position, with the active part located below
the vertebrae, along the midline.
4.3 Functional validation
4.3.1 Experimental setup and stimulation protocol
The LEDs are powered by a custom-built current source. EMG signals are recorded using a
RZ5 processing unit (Tucker-Davis Technologies, sampling frequency 12 kHz), for the 4 EMG
channels simultaneously. Signals are pre-ampliﬁed and pre-ﬁltered (10-2,000 Hz bandpass)
by an AM-ampliﬁer. Responses following 10 to 20 pulses are obtained for each condition and
the signals are analysed ofﬂine with programs written in MATLAB.
These experiments present the results obtained on two mice. The ﬁrst mouse provides a
proof of principle for chronic optical stimulation, with optical pulses of 5 ms duration, at a
pulse rate of 1 Hz. Recordings are obtained at day 8, 24, 44 and 57 after surgery. The second
mouse is used for a more systematic testing of the threshold and the effect of pulse duration (5
- 20 ms) and pulse rate (1 - 20 Hz) on the responses. Recordings are obtained on day 7, 14, 21,
28 and 35 after surgery.
4.3.2 Raw EMG responses
Strong and consistent EMG recordings following optical stimulation of the spinal cord are
obtained (Figure 4.3). In the examples displayed on ﬁgure 4.3A, EMGs recorded in four
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muscles (RTA, RVL, LTA and LVL) are shown following stimulation with two pairs of LEDs at
different current levels, on the right side (RR + RC) and the left side (LR + LC) of the spinal cord.
These awake recordings are obtained 7 days after device implantation.
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Figure 4.3: A) EMG recordings from four different muscles (LTA, LVL, RTA, RVL) following
stimulation with the pair of LEDs on the right side (RR: Right Rostral; RC: Right Caudal) and
the left side (LR: Left Rostral; LC: Left Caudal) of the spinal cord, for three different currents
powering the LEDs. The insets display enlarged versions of the 5ms stimulation pulse, showing
the absence of stimulation artefact. B) EMG recordings following stimulation with LEDs with
reversed connections, conﬁrming the absence of current leak in the device. C) EMG recording
illustrating the extraction of peak-to-peak amplitudes of the three phases of responses, the
early response (ER), middle response (MR) and late response (LR).
The ﬁrst observation is the lateral selectivity of activity in the displayed recordings (Figure
4.3A). Indeed, the pair of LEDs located on the right generates activation in the muscles of the
right leg (RTA and RVL), and the pair of LEDs on the left generates activation in the muscles of
the left leg (LTA and LVL). The lateral selectivity shows some variations, as described in the
following sections.
It is necessary here to provide evidence that the activity is not the result of an electrical
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leak in the device. First, electrical stimulation is associated to a stimulation artefact after
the pulse. Here, the pulse duration is 5 ms, and it is likely that a separate artefact would
be generated by the beginning and the end of the pulse. An artefact following the end of
the pulse would be masked by the generated EMG, so impossible to detect. However, an
artefact following the beginning of the pulse would likely be visible before the onset of the
EMG. The insets of ﬁgure 4.3A show enlarged versions of the ﬁrst 6 ms following stimulus
onset. Small variations in the signals are observed, but they are not consistent between the
different stimulation current levels. It is then concluded that they are not stimulation artefacts,
and are rather generated by random movements of the animal.
The second control that is performed in order to check that the stimulation is not the re-
sult of an electrical leak in the device is to reverse the connection of the LEDs (+/-). As a result,
the LEDs block the current and do not generate any light. If there was a leak in the device, a
path for the current would be present and electrical stimulation of the spinal cord could be
induced. Figure 4.3B shows examples of two pairs of LEDs with reversed connections, with
the stimulation parameters being otherwise the same as the example shown in panel A. No
activity or stimulation artefact can be observed in these runs. It is then concluded that the
observed activity is not the result of an electrical leak in the insulation of the device, but is
rather generated by optical stimulation.
4.3.3 EMG parameters characterization
To perform quantitative analysis of the recorded EMGs, several parameters are extracted from
all four channels. First, the root mean square (RMS) of the generated signal is measured. This
represents the energy of the signal and provides a characterization of the intensity of activity
in each muscle. Then, as illustrated in ﬁgure 4.3C, the EMG activity was identiﬁed to occur in
one or several of three different phases, with limits at about 15 and 25 ms after stimulus onset.
The maximal peak-to-peak amplitude of the signal during the early, middle and late responses
(ER, MR and LR) are extracted following each individual pulse. For each response parameter
R , the lateral selectivity L is measured in each muscle as L = Ripsi lateral
Ripsi lateral +Rcontralateral
, with
Ripsi lateral and Rcontralateral , values of the response parameter respectively in the ipsilateral
and contralateral muscle with respect to the stimulation. Values vary between 0 and 1, from
purely contralateral (0) to purely ipsilateral response (1).
The effect of stimulation with pulsed LEDs powered with different current levels on the four
parameters extracted from the generated EMGs are displayed on ﬁgure 4.4. These data are
obtained from the second mouse, 7 days after implantation, with a pulse duration of 5 ms and
a pulse rate of 1 Hz. In the ﬁrst column, the data following stimulation with the left pair of
LEDs(LR + LC) is presented. Columns 2 and 3 show the data generated by stimulation of the
two single LEDs (LC and LR).
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Stimulation with the pair of LEDs generates stronger activity with lower thresholds than
single LEDs, an effect visible in all four analysed parameters. The pair consists of two LEDs
connected in series and located 750 μm apart (center-to-center), which corresponds to about
500 μm spacing, along the same side of the spinal cord. A larger response by the pair of LEDs
can be explained by the higher total power brought to the tissue. The relatively low distance
between the two LEDs indicates that a partial overlap of the light is very likely, especially
because of the non-directionality of the LED light.
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phase (MR) and D) the late phase (LR) of responses following stimulation at different current
levels of the left pair of LEDs and of the two individual LEDs.
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The thresholds were visually determined during experiments, for each of the two lateral pairs
of LEDs, as the lowest current level generating a visible and repeatable movement of the leg. In
the example shown on ﬁgure 4.4, the visually determined threshold was 6 mA for the pair LR
+ LC. It visually corresponds to the increase in peak-to-peak amplitude of at least one of the
three phases of activity. For the LEDs LR + LC, EMG parameters from all four EMG channels
show signiﬁcant increase of activity at threshold compared to below threshold (mult.lin.reg,
N=10 repetitions, p < 0.05).
For each of the two considered muscles (TA and VL), the lateral selectivity (or fraction of
ipsilateral activity) following stimulation on each side of the spinal cord is measured. A value
of lateral selectivity higher than 0.5 thus indicates that the ipsilateral activity is stronger than
the contralateral activity. In the amplitude of the early response, ipsilateral muscles show
stronger responses than contralateral muscles (Fig. 4.5), showing the lateral selectivity of
stimulation, as indicated by a lateral selectivity higher than 0.5. This selectivity means that
LEDs located on one side of the spinal cord preferentially stimulate the leg muscles on the
same side. For both leg muscles and both sides of stimulation, the lateral selectivity decreases
in most cases at later phases of response. The peak-to-peak amplitude of the late response
shows in some cases contralateral muscles having stronger responses than ipsilateral muscles,
as indicated by a measure of lateral selectivity lower than 0.5. It shows that contralateral
responses preferentially occur later in the responses, which can be due to left-right circuit
communication in the spinal cord.
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Figure 4.5: Fraction of ipsilateral activation for the early, middle and late phases of response in
A) the tibialis anterior (TA) and B) the vastus lateralis (VL) muscles
4.3.4 Parametric study
The effect of varying the pulse duration and pulse rate are investigated in this section. Since
there can be variations in the current threshold used to power single or pairs of LEDs that
generate EMGs, both parametric studies are performed at a current of 5 mA above threshold,
visually determined with a pulse duration of 5 ms and a pulse rate of 1 Hz. These parameters
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were chosen because they generate stable EMGs, on which the effect of varying stimulation
parameters can be studied. Pulse duration and pulse rate experiments are performed on
mouse 2 at days 7, 14, 21, 28 and 35 after surgery.
Pulse duration
Figure 4.6A presents the peak-to-peak amplitude of the early, middle and late responses
following stimulation with the two pairs of LEDs RR + RC and LR + LC, at day 7 after surgery.
Pulse durations of 5, 10 and 20 ms are tested. Stimulation of the right pair of LEDs shows a
signiﬁcant correlation between the pulse duration and the amplitude of the late response
in both right leg muscles (mult.lin.reg, N=10 repetitions, p < 0.05 in both cases). The other
parameters, including the parameters of the EMG channels in the left leg, do not show a
signiﬁcant correlation with pulse duration (mult.lin.reg, N=10 repetitions, p > 0.05 in all cases).
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Figure 4.6: A) Stimulation pulse duration effect on the EMG peak-to-peak amplitude of the
early, middle and late responses, for the pairs of LEDs stimulating the right (RR + RC) and left
(LR + LC) sides of the spinal cord. B) Stimulation pulse duration effect on the lateral selectivity
of activation in the tibialis anterior (TA) and vastus lateralis (VL) muscles.
Following stimulation with the left pair of LEDs, all LTA parameters show a signiﬁcant correla-
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tion with the pulse duration (mult.lin.reg, N=10 repetitions, p < 0.05 for all LTA parameters).
Unlike the stimulation on the right side, some contralateral EMG parameters also increase
with pulse duration: The amplitude of the early and late responses in the RTA muscle, and the
amplitude of the middle and late responses in the RLV muscle (mult.lin.reg, N=10 repetitions,
p < 0.05 in both cases).
The lateral selectivity of stimulation (Figure 4.6B) shows a different behavior for the two
considered muscles, the tibialis anterior (TA) and the vastus lateralis (VL). While the lateral
selectivity in the TA increases with pulse duration until reaching values higher than 0.7 for
all parameters, no trends can be identiﬁed in the lateral selectivity of the VL muscle. We can
then conclude from this study that increasing the pulse duration generates an increase in the
intensity of generated EMGs, mainly on the same side as the stimulation. The lateral selectivity
of stimulation increases with pulse duration in the TA muscle.
Pulse rate
Figure 4.7A shows the variations in the EMG parameters following stimulation at 1, 2, 10 and
20 Hz with the right pair of LEDs, and 1, 2, 5, 10 and 20 Hz with the left pair of LEDs on day 14
after surgery.
Stimulation with the right pair of LEDs (RR + RC) shows a signiﬁcant negative correlation
between the pulse rate and the amplitude of the early and middle responses in the right
EMG channels (mult.lin.reg, N=10 repetitions, p < 0.05 in both cases). The correlation is also
signiﬁcant in the LTA muscle for the amplitude of the middle and late responses (mult.lin.reg,
N=10 repetitions, p < 0.05 in both cases). Following stimulation with the left pair of LEDs (LR +
LC), the only parameter that shows a signiﬁcant variation with pulse rate is the peak-to-peak
amplitude of the middle response for the left EMG channels (mult.lin.reg, N=10 repetitions, p
< 0.05). The lateral selectivity seems to decrease with pulse rate in the VL muscles, and shows
no identiﬁable trend in the TA muscle (Figure 4.7B).
These results indicate that increasing the pulse rate generates a strong decrease in the EMG
intensity parameters, primarily on the ipsilateral side. In fact, ChR2 decreases in synchronicity
of spikes as the frequency of stimulation is increased[20,76]. However, ChR2 was shown to
follow pulse rates up to about 40 Hz[20,70]. Since all frequencies were tested with the same light
intensity in our experiments, it is possible that increased pulse rates simply lead to increased
thresholds.
This behavior could be explained by the relatively slow kinetics of the ChR2 that shows an off
time constant τo f f of about 10 ms and a slow recovery following inactivation (50% recovery
after about 5 sec)[70,108]. If the recovery following inactivation is not complete when the next
light pulse is generated, the following neuronal activation will be less synchronized and thus
the potential generated EMG will be of reduced amplitude. This effect can be expected to hap-
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pen at all tested frequencies, but is much more important as the frequency increases. Other
opsin contructs, like Chronos[76], ReaChR[107] or ChR2 mutants (ET/TC)[20] could potentially
overcome this problem because of their faster kinetics.
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Figure 4.7: A) Stimulation pulse rate effect on the EMG peak-to-peak amplitude of the early,
middle and late phase of responses, for the pairs of LEDs stimulating the right (RR + RC) and
left (LR + LC) sides of the spinal cord. B) Stimulation pulse rate effect on the lateral selectivity
of activation in the tibialis anterior (TA) and vastus lateralis (VL) muscles.
4.4 Chronic stability and safety
4.4.1 EMG parameters chronic variations
During each experiment on the second tested mouse, the current threshold generating a
visible and repeatable movement of the leg is visually determined for each of the two lateral
pairs of LEDs. The threshold variations over time during the ﬁve weeks of testing are displayed
on ﬁgure 4.8A. The general trend that can be observed is a decrease in threshold between the
ﬁrst and the second weeks after implantation (-3 mA for both pairs), followed by a stabilization
with variations of ±1 mA between each of the following tests. This behavior can be explained
by residual blood that might still be present at day 7, absorbing part of the light. This blood
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would then be cleared between day 7 and 14 as the healing progresses, resulting in a decrease
in threshold, followed by a stabilization in the following weeks.
Figure 4.8B displays an overlay of EMGs obtained with the right pair of LEDs (RR + RC)
at each tested post-implantation day. Although there are some variations in amplitude, the
latencies of the responses do not change over time. For instance, RTA recording shows an early
and middle response in all cases.
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Figure 4.8: Chronic variations of EMG parameters. A) Visually determined threshold obtained
for the two lateral pairs of LEDs over time. B) EMGs obtained with the right pair of LEDs (RR +
RC) at each post-implantation day. Insets: Zoom in the ﬁrst 6 ms following stimulation onset,
showing a stimulation artefact increasing over time in some cases. C) Chronic variations of
the EMG peak-to-peak amplitude of the early, middle and late responses in the ipsilateral
TA muscle, for the pairs of LEDs stimulating the right (RR + RC) and left (LR + LC) sides of
the spinal cord (pulse rate: 1Hz, pulse duration: 5 ms, current level: 5 mA above visually-
determined threshold). D) Lateral selectivity of TA muscle activation over time, for the early,
middle and late responses, for the right and left pairs of LEDs.
In some cases, a stimulation artefact appears over time, visible here in the LTA recording.
Several clues indicate that the responses are not generated by parasitic electrical stimulation.
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First, this artefact is not present in all runs and recordings and is not necessarily linked to
the presence of an EMG in the recordings. Then, the response does not qualitatively change
over time, which would likely be the case if the stimulation mode was going from optical
to electrical. For instance, electrically-generated EMGs could follow pulse trains at higher
frequency (40 Hz)[31], which is not the case here in any of the tests, even at day 28 and 35,
although is could be due to an increase in threshold. Additionally, tests with opposite polarity
of current were performed each week in all LEDs, and none of them show any artefact or
EMG responses, conﬁrming the absence of leak in the device. Examination of the devices
after sacriﬁcing the animals showed signiﬁcant damage on some wires of the stimulation and
the recording devices at the level of the headplug. This damage typically appears over time,
and could explain the presence of a stimulation artefact in the recordings. These clues then
strongly suggest that the appearance over time of a stimulation artefact is not due to a damage
in the device encapsulation at the level of the LED active sites, but rather to a damage in the
insulation of the wire at the level of the headplug.
Analysis of the parameters extracted from the generated EMGs show no consistent change
over time. The current level used to power the LEDs at each time point and for each pair of
LEDs in this ﬁgure is 5 mA above visually determined threshold, to compensate for chronic
threshold variations (Figure 4.8C). The lateral selectivity of the activity recorded in the TA
muscle over time (Figure 4.8D) also shows no identifyable general trend, although the higher
lateral selectivity of early response compared to late responses seems to be conserved at each
time point.
These analyses mean that ﬁrst, we are able to generate and record EMGs over time, up to
35 days in mouse 2 (and up to 57 days in mouse 1, not displayed here). Since the presented
analyses focus on data obtained in one mouse, only general trends can be observed. A higher
number of mice is necessary in order to show and explain speciﬁc variations over time.
4.4.2 Integrity of the walking functionality
In order to investigate the integrity of the walking functionality, recordings of mice walking
on a horizontal ladder with random distances between each rung are obtained. Functional
damages of the spinal cord can be detected by an increase of the ’slip’ and ’miss’ steps, when
the foot is not placed at the right position and slides from, or misses the rung. The random
distances between the rungs make the task challenging, thus highlighting potential walking
impairements due to spinal cord damages.
The test was performed on two different mice, before implantation and on day 35 after im-
plantation. The total percentage of ’hit’ was measured before and after implantation. Results
show very similar percentages of ’hit’ in the two conditions, suggesting that no impairement
of functionality due to the presence of the device or the stimulation is generated.
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Figure 4.9: A) Illustration of the ladder test. B) Percentage of ’Hit’ steps before and after device
implantation. C) Coronal sections of the right side of the spinal cord at the level L2, with
and without LED implant, with labeling of glial ﬁbrillary acidic protein (GFAP), a marker of
inﬂammation shown in white. The dotted line is the separation between white and grey matter
in the spinal cord.
4.4.3 Histological analysis
Histological analysis of the explanted tissue with highlighted GFAP, a marker for astrocytes
associated with tissue inﬂammation is shown on ﬁgure 4.9C. More astrocytes seem to be
present on the spinal cord with LED implant, suggesting that some inﬂammation is generated
by the implant. Quantitative analysis of different markers of inﬂammation would be necessary
to fully characterize the extent of this inﬂammation.
4.5 Discussion
4.5.1 Optical power and thermal heating
The presented results provide a proof of principle of optogenetic stimulation of the spinal cord
with a device integrating an array of LEDs. The power generated by these LEDs was shown to
be sufﬁcient to generate EMG responses in the leg muscles following unilateral spinal cord
stimulation, both in the ipsilateral and contralateral leg muscles.
The threshold for both pairs of LEDs after stabilization (about two weeks) is 3-5 mA. Measure-
ments of LEDs power in the ﬁrst chapter of this thesis at a current of 5 mA showed optical
power of about 2.5 mW per LED, so about 5 mW per pair of LEDs, and a voltage bias for a
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pair of LEDs of about 7 V. The surface of light generation for each LED is about 190 x 230 μm2,
so a power of 5 mW corresponds to a power density of about 57.2 mW/mm2. At the single
cell level, the necessary power density to generate channelrhodopsin activation is about 1
mW/mm2 [215]. Considering that the light of these LEDs is not completely directional, the
power density at the tissue level is lower than at the surface of the LED. Additionally, the
neurons or the projections expressing ChR2 are not necessarily at the surface of the spinal
cord. Due to absorption and scattering in the tissue, the power decreases exponentially with
depth. These two elements can thus explain the discrepancy between the ChR2 activation
threshold and the visually determined threshold for leg movement.
Chronic increases of temperature as low as 1◦C have been shown to induce differences in
the neurophysiological properties of neurons, and the ofﬁcial regulations prevent a chronic
increase of temperature larger than 2◦C[51,119]. As seen in chapter 2 of this thesis, the chronic
increase in temperature mainly depends on the duty cycle and the current. A model of thermal
heating was developed based on measurements in air at the surface of the device, in order
to predict the average increase at the surface of the tissue for each condition. The standard
parameters of pulse rate and pulse duration used in these experiments (1 Hz and 5 ms) corre-
spond to a duty cycle of 0.5%, at which chronic increases in temperature are below 1◦C at 20
mA, the highest tested current level.
For the pulse rate studies, a maximal duty cycle of 10% at a pulse rate of 20 Hz and a pulse
duration of 5 ms was used. At that duty cycle, the current generating an average temperature
increase of 1◦C is about 2.6 mA, well below the current levels between 8 and 12 mA used
here. The highest pulse rate used in this study is thus not safe for chronic stimulation. For a
pulse duration of 5 ms and a stimulation current of 5 mA (close to the threshold value after
stabilization), the pulse rate generating an average increase in temperature at the surface of
the tissue of 1◦C is 10 Hz. The pulse rate thus needs to be lower than this value to achieve
chronic thermal safety at threshold.
The pulse duration studies performed suggest that longer pulse durations might generate
stronger EMGs than shorter pulse durations, perhaps because more ﬁbers are recruited. The
three pulse durations tested (5, 10 and 20 ms) correspond, at 1 Hz, to duty cycles of 0.5, 1 and
2%. At a duty cycle of 2%, an average temperature increase of 1◦C is generated by a current of
about 10 mA, slightly below the maximal current of 12 mA used in these experiments. This
pulse duration might then be too long in terms of chronic thermal safety, and shorter pulse
durations should be favoured. The optimal pulse duration then has to be determined as a
tradeoff between efﬁciency and thermal heating.
4.5.2 Device
In the two mice, all 4 LEDs were still functional on the last tested day, respectively on day 57
and 35 post implantation. It is thus not the limiting factor for chronic experiments, the wear
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of the cables at the level of the headplug inducing failure of the EMGs before a failure of the
LEDs. In order to increase the total implantation time and the quality of recordings, it is then
important to use a setup that allows an improved chronic stability of the EMGs.
The absence of functional damage to the spinal cord validates the possibility to use this
device in our experiments. Despite the fact that the LEDs are rigid, and that the wires connect-
ing the LEDs to the neighbouring pads increase the total thickness of the device, the PDMS
encapsulation allows to have a soft surface of contact that prevents any functional damage of
the spinal cord upon natural movements of the animal, for several weeks of implantation.
However, the presence of markers of inﬂammation on the surface of the spinal cord sug-
gests that the device could be improved in order to provide a better interface with the spinal
cord with minimal inﬂammation. For instance, using an alternative technique than wire-
bonding to connect the LEDs, like eutectic bonding, would lead to thinner devices, that are
thus less invasive and safer for the spinal cord. Developing a completely soft interface could
also further decrease the mechanical mismatch with the spinal cord tissue. Indeed, even if
thinner LEDs are used compared to the LEDs used in this project (50 μm), the soft-to-hard
transition remain a mechanical challenge in the long term function of the device, especially
under mechanical constraints. Flexible LEDs are under development[39,80,102,189] and might
be a potential future solution for soft optoelectronic interfaces.
Decreasing the average heating in the tissue could lead to thermally safe stimulation at higher
illumination levels. One of the ways to achieve this could be to use a thermally-conductive
epoxy at the back of the LEDs in order to act as a heat sink. The device could also be improved
by optimizing the light extraction. This could be achieved by adding a micromirror on the
backside of the LEDs[21]. Although the device would be thicker, the total light brought to the
tissue at a certain current level could be increased. This could then potentially lower the tissue
heating for the same functionality.
4.5.3 Potential applications
We provided a proof of principle of chronic optogenetic stimulation of the spinal cord in a
mouse model with broad ChR2 expression in projection neurons. We presented a platform
that is transferrable to speciﬁc applications, such as selective targeting of motor ﬁbers, or
speciﬁc interneurons of the spinal cord, among others. For each of these neuronal subtypes,
the precise role in the spinal cord processing and motor control can be studied, as well as their
potential role in the recovery mechanism.
The effect of stimulation location can be investigated by directly targeting neurons in the
spinal cord as opposed to ﬁbers on the side of the spinal cord. Indeed, the main hypothesis
for electrical stimulation is that it stimulates the ﬁbers on the sides of the spinal cord, at the
level of the DRGs. As optical stimulation targets the neurons that are located directly in the
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beam of light, a greater control on the location of stimulation can be achieved. Some further
understanding of the mechanisms of recovery could be obtained by comparing different
locations and modes of stimulation. The developed device thus has a great potential as a
spinal cord stimulation research platform to better understand the role of each neuronal type
in the processing and potentially also in the recovery mechanisms following a spinal cord
injury.
Contributions
Surgeries for animal experiments presented in this chapter were performed in the laboratory
of Prof. G. Courtine at EPFL, by L. Asboth, N. Pavlova and P. Shkorbatova. MicroCT images
were obtained by J. Gandar. Histology was performed by L. Asboth. Part of the stimulation
setup was optimized by M. Jobin.
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5 Discussion
5.1 Selectivity of stimulation
One of the main goals of this thesis is to deﬁne technological routes to improve selectivity of
surface stimulation of nervous tissue. Beyond auditory brainstem or spinal cord stimulation,
the main contributions can thus be related to the spatial, structural and cell-type selectivity of
neuronal stimulation and used for other surface nervous system stimulation applications.
Spatial selectivity
• Using microfabrication strategies to decrease the area of stimulation sites and increase
their density enables a greater tailoring of the stimulation conﬁguration (bipolar or
monopolar, various inter-electrode distances and orientations), which in turn may
increase the possibilities of current steering. In bipolar stimulation, interelectrode dis-
tance and electrode pair orientation can be tuned to obtain higher frequency selectivity
at similar loudness levels. Safety of stimulation and minimal power consumption can be
provided by an electrode coating increasing the charge injection capacity and decreasing
the impedance of the electrode sites.
• The conformability of the array enables a close contact with the target tissue, resulting
in most cases in uniform minimal thresholds over the surface. Decrease of the current
levels might then lead to a minimization of current spread.
• The use of optical stimulation did not lead to an improved spatial selectivity of stimula-
tion as such, because of the relatively large LEDs and their absence of directionality, but
using optogenetics can nevertheless avoid the problem of current spread in the tissue,
thus effectively also contributing to an increased spatial selectivity of stimulation of
neural tissue.
Structural selectivity
An asymmetric waveform (long cathodic, short anodic) was shown in simulation studies to
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preferentially activate neuron somata over ﬁbers of passage. With this particular waveform,
we obtained better tonotopic organisation and lower width of activation than with other
waveforms. Results need to be conﬁrmed and tested in different contexts, but this suggests
that asymmetric waveforms in monopolar or bipolar conﬁgurations could be also used in
other applications to achieve structural selectivity with preferential stimulation of neuronal
somata.
Cell-type selectivity
• In this thesis a technological platform that enables chronic optical stimulation of se-
lected cell-types in mice is presented, with a proof of concept of spinal cord optogenetic
stimulation. Because of the advantages of the microfabrication process allowing for a
large ﬂexibility in design, many other systems can be targeted, like the surface of the
cortex, the peripheral nerves or the surface of the brainstem.
• Although no true cell-type selectivity can be achieved with electrical stimulation, an op-
timization of the stimulation protocol leading to optimal levels of spatial and structural
selectivity can result in cell-type speciﬁc stimulation, depending on the structure and
organization of the target tissue.
5.2 Strategies towards an improvement of ABI outcomes
This section proposes potential routes to improve the surface auditory brainstem implant,
and presents an ’ideal’ ABI array. Hypotheses on the mechanical and geometrical properties
of the electrode array as well as on the stimulation protocol are based on the studies presented
in this thesis and on previous studies and clinical reports of ABIs.
5.2.1 Substrate
First, increasing the conformability of the array compared to current clinical ABI arrays might
be one of the keys to decreasing the distance to target neurons and obtaining uniform and
minimal current thresholds over the whole surface of an array. This can be achieved by using
thin-ﬁlm technologies based on ﬂexible substrates and mesh-like structures, as presented
in this thesis. The use of softer substrates, such as elastomers, is dependent on the minimal
feature size of the metallization achievable compared to the size requirements for a human
ABI. This might be possible since the available surface of the human CN (about 3-by-8 mm2)
is much larger than the rat DCN surface (1-by-2 mm2) accessible in the experimental setup
presented in chapter 3, and because of potential technological improvements allowing for
elastomer-based electrode arrays with feature sizes smaller than 100μm.
Designing a soft ABI would however induce important implantation challenges. During
implantation, the electrode array is slid between the brainstem and the cerebellum[180], so
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using a soft array would induce a buckling of the substrate[81,100]. A solution to this chal-
lenge would be to temporarily stiffen the back of the array. This can be achieved for instance
with stiff bioresorbable coatings based on silk[88,210] or polymers[55,196], or with mechanically
adaptable materials [204]. An important point is the kinetics of the changes in mechanical
properties. Indeed, after initial placement of the ABI array during implantation surgery, the
possibility to evoke auditory brainstem responses (ABR) from different pairs of the array is
assessed, in order to detect any misplacement and to correct it. Several changes in placement
and ABR measurements might then be performed, a time during which the ABI must remain
stiff.
Designing an array with a soft substrate with engineered temporary stiffness might then
optimally combine conformability and ease of insertion for a new ABI. A new design (Figure
5.1) with an 8 μm thick polyimide layer integrating platinum tracks and electrode sites is
proposed here, similar to what is presented in this thesis. In order to improve the conformabil-
ity of the substrate around the curved human brainstem, the substrate is only slightly larger
(about 25 μm) than the tracks and the electrode sites. Bioresorbable silk coatings are very
promising for temporary stiffening of the back of the device, as the dissolution time (usually
of a few min) is dependent on the silk thickness, and can be increased to about 1 hr with an
ethanol treatment prior to implantation[88].
5.2.2 Electrode sites diameter
In terms of geometrical properties of the implant, we propose several changes. First, the total
footprint of the electrode pad in the clinical device is about 3.5-by-8 mm2 (Cochlear) and
3-by-5.5 mm2 (Med-El). However, the actual footprint covered by the electrode sites is smaller
than this, about 2.3-by-7.8 mm2 (Cochlear) and 2.3-by-4.7 mm2 (Med-El). Making the total
footprint of the electrode array larger than the target CN surface, with the actual footprint
covered with electrode sites of about 3-by-8 mm2 would increase the potential number of
useful stimulation sites on the CN surface.
As mentioned in this thesis, an increase of the density of electrode sites would increase the
number of possibilities to shape the current ﬁeld, potentially improving the spectral resolution
of ABIs. Currently, the ABI array contains 15-21 electrode sites with diameters between 550
and 700 μm, and center-to-center distances of about 1 mm. The minimal diameter must be
carefully considered, in terms of current and charge thresholds, current density and charge
injection capacity of the electrode material. Audiological measures in ABI patients show
thresholds between 10 and 200 nC/phase[186]. These threshold values, obtained with pulses
of 300 μs duration and electrode diameters of 700 μm, correspond to charge densities of
about 2.6 to 52 μC/cm2. The dynamic range was usually between 10 and 20 dB. The highest
measured value for the maximal comfortable loudness level across all tested patients was
1 mA. This current value is then used in the following calculations as the maximal current
level to achieve, although it may vary substantially with pulse duration and electrode diameter.
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Tissue damage due to chronic overstimulation was shown to depend on the charge den-
sity and charge per phase for macroelectrodes (area > 0.001 cm2, corresponding to a diameter
> 356 μm for circular electrodes)[44], according to the formula: log (
Q
A
)= k− log (Q), withQ:
charge per phase, A: electrode geometrical area and k: a factor varying between 1.5 and 2
depending on the experimental conditions[122,134,185]. Using a conservative value of k=1.5,
a pulse duration (used in most experiments of this thesis) of 0.2 ms/phase and a maximal
current of 1 mA, the electrode diameter allowing for safe stimulation is about 400 μm. This
value is thus the selected diameter for the proposed ABI design, and represents a substantial
decrease compared to the clinical ABI electrode diameters of 550 μm (Med-El) or 700 μm
(Cochlear).
5.2.3 Density of electrode sites
In the clinical implants, the center-to-center distance is about 1.1 mm (Cochlear) and 1.05
mm (Med-El), corresponding to gaps between electrodes of respectively 400 μm and 500
μm. With the electrode diameter tested here (400 μm), a tradeoff must be found between
increasing the density of electrodes and limiting their number. We propose here a design that
limits the number of electrode sites to 42, with center-to-center distances of 800 μm, which
corresponds to a decrease in distance of about 27% for twice as many channels compared to
the 21-channels ABI.
An insight into the ﬁeld of retinal prostheses where the spatial resolution and the number of
channels are crucial for the visual acuity shows that such a high number of channels is feasible
for a clinical implant. Indeed, the Argus II retinal implant system integrates an electrode array
with 60 stimulation sites[116]. However, important challenges associated to the strong increase
in number of channels are envisioned here. First, the size of the lead connecting the internal
processing system to the array must contain the tracks for the 42 channels. We envision, with
the polyimide/platinum microfabrication technology, that the width of the tracks can be as
small at 50 μm, with a similar gap between two tracks. This would result in a total width of the
lead of about 4.2 mm, for a thickness of a few micrometers. In the clinical ABIs, the diameter
of the lead is about 1.2 mm (Cochlear) and 1.3 mm (Med-El). A comparison of the sections
of the lead shows that this should not be an important challenge: In the clinical implant,
the section is 1.13 to 1.32 mm2, while on the proposed design, even with an overestimated
substrate thickness of 100 μm, the section would be 0.42 mm2.
The second challenge associated to increasing the number of channels is the extra time
required in the programming sessions in order to test all the possible stimulation sites and
conﬁgurations. Here, a protocol could be developed where, after initial test of all stimulation
sites, only the stimulation sites showing the best perceptual performances can be included
for further testing and programming of the device. A more automated ﬁtting process for the
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implant could also potentially reduce the time of tests [112].
Metallization
Substrate
1 mm
Figure 5.1: Proposed clinical ABI design
5.2.4 Stimulation electrode material
The charge density corresponding to a current level of 1 mA with a pulse duration of 0.2 ms and
an electrode diameter of 400 μm is 0.16 mC/cm2, which is thus considered as the necessary
charge injection capacity of the stimulation material. As mentioned in chapter 2 of this thesis,
the charge injection capacity also depends on the pulse rate and the exact in vivo conditions.
Platinum and platinum/iridium have a charge injection capacity of about 0.05-0.15 mC/cm2,
depending on the electrode area and geometry[44,168]. The charge injection capacity thus
needs to be improved.
Additionally, decreasing the electrode diameter compared to the clinical ABI electrodes will
lead to an increase in impedance modulus, which is not favourable for power consumption of
the implant. Here, we also propose to test bipolar stimulation conﬁgurations, leading to more
power consumption than monopolar stimulation. Decreasing the impedance modulus of
the electrode through a modiﬁcation of the electrode surface might thus decrease the power
requirements, compensating for the smaller diameters and bipolar conﬁgurations.
The Argus II retinal prosthesis system uses an array of stimulation electrodes of 200 μm
diameter[116]. In order to increase the surface area of the electrode sites, they use a speciﬁcally
tailored electroplated platinum (’Platinum grey’, patent US 6974533 B2). Standard electro-
plated platinum (platinum black) results in an increase of surface area of about 200 times,
with however a weak structure of the coating and a low stability over time. Due to the different
electroplating protocol including a slower rate, the stability of the platinum grey is greater than
that of platinum black, with a fractal design leading to an increase of the electrode surface
area of about 5 times associated to a decrease in impedance modulus and increase in charge
injection capacity. Platinum grey is thus an example of successful coating used for neural
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stimulation electrode.
The coating presented in this thesis, electropolymerized PEDOT:PSS, induces a decrease
in impedance modulus of more than one order of magnitude and an increase in CIC to about
1.6 mC/cm2 for a 0.6 μm thick coating. These properties are thus ideal for a clinical implant.
In fact, clinical tests of a recording array with PEDOT:PSS coatings on the electrode sites
were performed intraoperatively and showed the possibility to record single spikes from the
surface of the cortex due to the efﬁcient interface provided by the coating[87]. However, PE-
DOT:PSS coatings were shown to have low stability over time, with loss of electrochemical
properties and delamination upon long-term stimulation[61]. Stabilizing the structure might
be an efﬁcient way to increase the electrochemical stability of conducting polymers, as the
main hypotheses of failure mechanisms are the stress in the ﬁlm or volume changes due
to ion transport[10]. Composites of conducting polymers with other polymers[85] or carbon
nanotubes (CNT)[10,115] might be a way to improve chronic stability of the coatings, and seem
promising to reach the level of stability necessary for a chronic implantation of many years.
5.2.5 Stimulation protocol
In terms of stimulation parameters, clinical stimulators can generate symmetric biphasic
pulses with interphase intervals, with different pulse durations and pulse rates. However, their
ﬂexibility is still limited, and the use of other pulse shapes, like asymmetric pulses, is not
possible. Here, we suggest that enabling a greater ﬂexibility in the design of the stimulation
protocol might be beneﬁcial.
First, the different types of stimulation protocols investigated in this thesis (monopolar/bipo-
lar, various interelectrode distances and orientations, various pulse waveforms) were shown
to inﬂuence the neuronal recruitement properties and to potentially enable a tuning of the
spatial or structural selectivity of stimulation. Although rat and human CNs show distinct
differences[17], they contain in both cases a multitude of neuronal types, playing different
roles in the processing of speech. In our rat experiments, varying the stimulation protocol
was shown to affect the responses both in their frequency tuning properties, but also in their
general intensities (threshold and spike rate). Knowing that these waveforms could be further
optimized and were sampled in a great amount of potential waveforms, the total variations in
response properties due to the stimulation protocol might be very large.
Moreover, large subject variations were identiﬁed in clinical ABIs[13,18,167,180]. They might
be due to the different conditions of the CN (affected or not by tumours), to differences in
placement, in surgery, in the device itself, or even to intrinsic neurophysiological differences.
Although the cause of the variability might not be the same, we also observed an important
subject-to-subject variability in our rat experiments. A stimulation protocol optimized for one
patient might thus not be as efﬁcient for another patient, and individual adaptability seems
of high importance. There might also be differences between subjects and between different
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stimulation electrodes within a single subject in the resolution of spectral and temporal infor-
mation. Thus, some electrodes might be better suited for transmission of spectral information,
and some others of temporal information[127]. Adapting stimulation protocols to the spectral
and temporal properties of stimulation of each electrode site might then also lead to better
speech understanding.
Although there are uncertainties in the applicability of the obtained results in humans, en-
abling a greater ﬂexibility in the stimulation protocol, as well as personalized tuning of the
stimulation parameters over time might be of high importance on the path to improved
hearing outcomes of ABI patients. This illustrates that the physical array is not the only pos-
sible aspect of technical improvement of the ABI. A modiﬁcation of the stimulator enabling
more programming ﬂexibility also seems of critical importance to bring true changes in the
outcomes of ABI users.
5.2.6 Clinical validation
In light of the differences between the auditory systems of the rat experimental model and hu-
mans, it seems highly important, in order to justify the implementation of proposed changes,
to study the effect of different electrodes conﬁguration with the existing clinical device. In
particular, a systematic test of bipolar conﬁgurations with small interelectrode distances on
the pitch ranking of electrodes compared to larger interelectrode distances might determine
whether this part of our results is transferrable. The bipolar stimulation used clinically during
intraoperative testing is usually performed with large interelectrode distances, in order to test
the eABR elicited by stimulation at the edges of the array[75], and is not used for pitch ranking.
Additionally, testing whether using different orientations of electrode pairs has an effect on
the pitch ranking has not been done, to our knowledge, and might also have similar results
than in our animal study.
Several audiological studies have been performed on the effect of pulse rate, pulse dura-
tion, polarity and number of stimulation sites[13,32,105,127,184]. For instance, the threshold to
electrical stimulation was shown to decrease as the pulse rate was increased, up to about 200
to 300 Hz where it reached a plateau. These studies are limited to the range of stimulation
parameters allowed by the clinical stimulators. If changes in the array or stimulator can be im-
plemented, the proposed tests would include the effect of stimulation conﬁguration, location,
waveform and pulse parameters (pulse rate, pulse train duration) on:
• the threshold for acoustic perception,
• the presence or absence of extra-auditory side-effects,
• the pitch ranking, particularly the redundancy of different sites for the same frequency,
and the resolution on the frequency axis (that might be represented by a ’tone-like’ or a
’click-like’ perception),
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• the transmission of temporal informations of speech (vowel durations, consonants),
• the speech hearing outcomes and their improvement over time until reaching stable
performances.
The challenge to consider here is the large increase in parametric space, and the resulting
complexity of the tests. Solutions to narrow the parametric space to ’potentially good’ conﬁgu-
ration would have to be found, including a partial automatization of tests, in order to limit
the time of ﬁtting for each patient. In a research context, ﬁnding a few patients that agree to
undergo substantial testing of the different potential stimulation protocols might be feasible,
but clear and fast protocols should be found for general implementation in the clinics. The big
challenge will thus be to implement this while keeping as much ﬂexibility and personalization
as possible.
5.3 Clinical translation of optogenetics
Many potential applications of optogenetics in a research context were mentioned in this
thesis, and the list is not exhaustive. This technique clearly has a bright future for elucidating
neural circuits, not only in spinal cord research or neuroprosthetic research, but in the whole
neuroscience ﬁeld. As a result, several clinical applications are emerging, and could have a
great impact on treatment of many neurological conditions. However, there are still challenges
to overcome in order to foresee a clinical translation of optogenetics-based therapies.
While the channelrhodopsin protein does not seem to disturb the normal function of the
neurons in the absence of light stimulation[50], the transfection of the gene in the target cells
in a safe and controlled way is the ﬁrst challenge to overcome. One possibility is viral delivery
of genes, a technique that has been developed and tested for several years for gene therapy.
There are some ongoing clinical trials for the treatment of Parkinson’s disease[207] and retina
degenerative diseases[41] that might pave the way for viral transfection of opsin genes for
optogenetic applications. Another strategy that is being considered is the transplantation
of cells containing the ChR2 gene at the site of light delivery. The main challenge with this
strategy is the proper integration of the transplanted cells into the neuronal circuitry[207].
Promising studies in diabetic mice show the possibility to better regulate glucose levels follow-
ing transplantation of opsin-containing cells in the pancreas and light illumination[40].
Targeting the retina for diseases such as retinitis pigmentosa is one of the applications most
likely to lead to clinically-approved optogenetic therapy in the near future[25,79]. Indeed, the
eye is quite ’isolated’ from an immunological point of view, and removing it in case of problems
would not induce further damage to an already blind individual. The safety consideration
is thus less of a problem compared to the targeting of other more central systems, such as
the brainstem, deep brain nuclei or the spinal cord. In fact, a clinical trial for optogenetic
treatment of retinitis pigmentosa has recently started[163].
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The next challenge is in terms of light delivery. The requirements for devices themselves
were discussed in the fourth chapter of this thesis, but other aspects associated to light deliv-
ery should also be considered, like the temperature increase in the tissue due to illumination
with high light intensities[9,194]. Thermal measurements at the surface of the tissue showed
signiﬁcant heating due to light illumination. This parameter must be considered, for instance
by changing the wavelength of light, as red light was shown to induce less heating than blue
light.
Clinical translation of optogenetics has started with the application on the retina, which
will hopefully pave the way for the clinical trials and approval of therapies for other nervous
system dysfunctions.
5.4 Clinical translation of microfabricated implants
Microfabrication technologies have several features that make them very advantageous for
neuroprostheses, including a great ﬂexibility in design with rapid prototyping, batch fabri-
cation and the possibility to design conformable arrays with small feature sizes (<100 μm).
Further decreasing the mechanical mismatch between the microfabricated thin-ﬁlm implants
and the target tissue to optimize the conformability, functionality and integration is the subject
of promising research for many applications[81,100,136].
However, further development is necessary to make thin-ﬁlm microfabricated arrays im-
plantable and functional for several years for stimulation and/or recording, as is required for
many neuroprostheses. While the thick silicone rubber encapsulation of clinical implants
might provide a sufﬁcient hermeticity over several years[199], the hermeticity of miniatur-
ized devices is an important challenge, because layers of elastomers or ﬂexible polymers
of a few μm thickness are not completely impermeable over time, affecting the integrity of
the implants[33]. This is due to the gap between the polymeric chains, allowing diffusion of
small molecules such as water through the layer. Some solutions for the hermetic sealing
of miniaturized implantable components, such as implantable pulse generators (IPGs) are
envisioned, based for instance on a stacking of layers of Parylene-C and SiO2 [77]. However, the
integration with soft conformable devices is still a great challenge, and solutions for long-term
implantable thin ﬁlm implants will have to be developed.
The corrosion of the metals, particularly with small electrode sites, is also a challenge to
consider. The corrosion of platinum[217] can lead to damaging reaction by-products and
failure of the implant over time. Use of non-metallic coatings, such as conducting polymers or
other coatings[44] can, in addition to improving the charge transduction, protect the underly-
ing metallic layer and thus prevent corrosion. The use of conducting polymer coatings thus
seem also promising in this respect, provided that their long-term stability can be improved.
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Finding long-term solutions to these challenges will enable the clinical translation of many
thin-ﬁlm microfabricated devices, with the potential to improve the outcomes of neuropros-
thetic devices. Some thin-ﬁlm devices, such as soft microelectrocorticography (micro-ECoG)
for the localization of the source of epilepsy, have much shorter term requirements (days
to weeks) and might reach the clinics much faster, with already acute tests that can be per-
formed[87].
5.5 Outlook: towards closed-loop sensory neuroprostheses
A critical point highlighted in this thesis is the necessity to consider the neuronal structure
of the system to be stimulated, in order to tailor the stimulation selectivity and reach the tar-
geted function. Additionally, there might be important differences between subjects in terms
of responses to the electrical/optical stimulation, injury location and type, location of the
implant or neurophysiological properties that can explain potential differences in outcomes
of neuroprosthetic devices. A greater ﬂexibility in the stimulation protocol might help com-
pensating for inter-individual differences. In this context, closed-loop control strategies of the
stimulation might be considered, in order to personalize and dynamically adapt stimulation
in such neuroprostheses.
Closed-loop strategies for the control of neuroprostheses are based on the combination
of stimulation and recording capabilities. The stimulation-evoked activity is recorded and
used as a feedback in the control of the stimulation. Many different control algorithm can
be used for real-time adaptation of the stimulation protocol based on recorded feedback, as
detailed in[209].
Closed-loop strategies were ﬁrst considered in the control of upper-arm prostheses, as the lack
of sensory feedback was hypothesized to be a reason for poor performance[38]. Closed-loop
motor neuroprostheses show improved performance compared to open-loop neuroprosthe-
ses, facilitating subject learning and optimally taking advantage of neuroplasticity to optimize
performances[147]. A bidirectional hand neuroprosthesis enabling real-time sensory feedback
also showed an improvement in efﬁcacy of hand prostheses[160]. In deep brain stimulation,
closed-loop control systems showed better identiﬁcation of pathological neural patterns
and subsequently more efﬁcient amelioration of Parkinson’s disease symptoms in a primate
model[169]. Closed-loop control was also shown to be possible with optogenetics, opening the
door to many new developments in neurological research[64].
While many papers describe the implementation of closed-loop control systems in motor
neuroprostheses, very few are targeted towards sensory neuroprostheses. Yet, they are also
potentially useful, since most of the protocols of stimulation in auditory and visual implants
are based on ﬁxed algorithms decoding the environmental stimulus (sound/image), selecting
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the electrode sites and sending the stimulation with a pre-deﬁned protocol. Some elements of
this protocol, including the stimulation level and the selection of stimulation electrode sites,
can be adapted based on behavioral feedback or evoked potential recordings during a selected
number of ﬁtting sessions in the months following implantation . However, it is known that
neural plasticity plays an important role in the adaptation to artiﬁcial stimulation[47,131,154],
and an adaptation of the stimulation protocol based on real-time recordings of the sensory
system might lead to an optimization of performances.
In the auditory system, closed-loop strategies are being investigated for cochlear implants[128]
(Fig. 5.2A). The potential use of several evoked potentials from the peripheral and central
auditory systems and of extracochlear electrodes are being tested. These recordings can
provide feedback on the threshold and comfort levels, the bilateral loudness balance or even
in some cases speech perception. It can potentially provide great advantages in the ﬁtting of
the implant, particularly in infants, where the behavioral feedback is very limited.
A B
ABI
Auditory brainstem
 response
Auditory evoked potentials
Auditory brainstem
 response
Auditory evoked potentials
Recordings from 
ABI device
MEG
MicroECoG
Figure 5.2: A) Schematic of open-loop and closed-loop cochlear implant control system, and
B) its modiﬁcations for ABIs (Adapted from[128]). BTE=behind the ear
Developing a closed-loop ABI might provide several advantages. First, one of the challenges
associated with increasing the number of electrodes and the ﬂexibility of stimulation protocol
is the resulting increased complexity of implant ﬁtting and associated time. A closed-loop
system could automatically optimize the parameters to what can achieve the best speech
hearing outcomes. Second, it is difﬁcult to assess behaviorally the optimal frequency selectiv-
ity that is possible to achieve, and which protocol can generate it. Developing a closed-loop
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system with information on the frequency selectivity might provide a way to optimally repli-
cate complex patterns of sound. This is shown in a paper exploring the potential of using
reinforcement-based learning for closed-loop auditory implants using CN microstimulation
and IC recordings[101]. The authors showed that stimulation patterns in the CN optimally
replicating frequency-speciﬁc acoustic stimulation could be learned over 20 minutes of testing,
without any user input.
While auditory evoked potentials can be used to obtain information on the threshold of
stimulation, they cannot provide information on the frequency content of stimulation. Us-
ing implanted recording microelectrodes in the IC[101] for this purpose is too invasive to be
implemented in human patients. The potential recordings for a closed-loop ABI system are
presented on ﬁgure 5.2B. One potential solution is the recording of activity generated from
ABI electrode sites that are not used for stimulation. It should be investigated whether these
recordings can be relevant as a feedback for the ABI ﬁtting protocol. Alternatively, recordings
from the auditory cortex could be used to obtain information on the tonotopic selectivity of
stimulation, as the tonotopic organization of the auditory cortices, although very complex,
has been well characterized[176]. This could potentially be done with a soft, high-density
micro-ECoG array implanted at the surface of the auditory cortex. However, implanting
an additional electrode array at the surface of the cortex is invasive, and thus difﬁcult to
justify without evidence of a clear improvement in speech hearing outcomes with such a
system. A non-invasive alternative with high spatial (2-3 mm) and temporal (1 ms) resolution
is magnetoencephalography (MEG), but it requires complex instrumentation and cannot be
portable[73]. It could however be used for research, to investigate the potential beneﬁts of a
closed-loop system for ABIs, initially for a few number of ﬁtting sessions.
Achieving closed-loop sensory neuroprostheses might lead to a new, higher-level type of
selectivity. Instead of aiming for optimal spatial, structural or cell-type selectivity at the neu-
ronal level, we could achieve ’systems’ selectivity, with limited a prioris on what would be the
optimal way to stimulate the system. This selectivity would be based on the functional clinical
outcomes and would optimally take advantage of neuroplasticity, with a continuous, dynamic
and personalized adaptation of the stimulation protocol. It might be through such strategies
that a leap in the clinical outcomes of sensory neuroprostheses will be achieved.
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